Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Article type

Page Path
HOME > BROWSE ARTICLES > Article type
2470 Article type
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Articles
Thyroid
Bisphenols and Thyroid Hormone
Min Joo Kim, Young Joo Park
Endocrinol Metab. 2019;34(4):340-348.   Published online December 23, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.4.340
  • 8,688 View
  • 230 Download
  • 60 Web of Science
  • 64 Crossref
AbstractAbstract PDFPubReader   ePub   

In recent decades, attention has been directed toward the effects of bisphenol A (BPA) on human health. BPA has estrogenic activity and is regarded as a representative endocrine disruptor. In addition, mounting evidence indicates that BPA can disrupt thyroid hormone and its action. This review examined human epidemiological studies to investigate the association between BPA exposure and thyroid hormone levels, and analyzed in vivo and in vitro experiments to identify the causal relationship and its mechanism of action. BPA is involved in thyroid hormone action not only as a thyroid hormone receptor antagonist, but also through several other mechanisms. Since the use of bisphenols other than BPA has recently increased, we also reviewed the effects of other bisphenols on thyroid hormone action.

Citations

Citations to this article as recorded by  
  • The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and Controversies
    Maria Dalamaga, Dimitrios Kounatidis, Dimitrios Tsilingiris, Natalia G. Vallianou, Irene Karampela, Sotiria Psallida, Athanasios G. Papavassiliou
    International Journal of Molecular Sciences.2024; 25(1): 675.     CrossRef
  • Environmental toxicology of bisphenol A: Mechanistic insights and clinical implications on the neuroendocrine system
    Tongbing Qi, Dongqing Jing, Kexin Zhang, Junfeng Shi, Hongyan Qiu, Chengxia Kan, Fang Han, Chunyan Wu, Xiaodong Sun
    Behavioural Brain Research.2024; 460: 114840.     CrossRef
  • Antioxidant compounds from the Arthrospira platensis protect against Bisphenol A-induced nephrotoxicity in rats
    Khadidja Chouala, Kahina Boudjema, Yahia Khelef, Sadok Nani, Kheireddine Ouali, Mahieddine Boumendjel, Amel Boumendjel, Mahfoud Messarah
    Toxicology and Environmental Health Sciences.2024;[Epub]     CrossRef
  • Associations of urinary non-persistent endocrine disrupting chemical biomarkers with early-to-mid pregnancy plasma sex-steroid and thyroid hormones
    Brad A. Ryva, Diana C. Pacyga, Kaitlyn Y. Anderson, Antonia M. Calafat, Jason Whalen, Max T. Aung, Joseph C. Gardiner, Joseph M. Braun, Susan L. Schantz, Rita S. Strakovsky
    Environment International.2024; 183: 108433.     CrossRef
  • Prospective role of lusianthridin in attenuating cadmium-induced functional and cellular damage in rat thyroid
    Teng Gao, Sijia Luo, Hongguang Li, Zijie Su, Qinghui Wen
    Heliyon.2024; 10(5): e27080.     CrossRef
  • Exposure to Bisphenol A, S, and F and its Association with Obesity and Diabetes Mellitus in General Adults of Korea: Korean National Environmental Health Survey (KoNEHS) 2015–2017
    Min Kyong Moon, Min Joo Kim, Inae Lee, Sunmi Kim, Sohyeon Choi, Jeongim Park, Yoon Hee Cho, Sooyeon Hong, Jiyoung Yoo, Hyunwoong Park, Gi Jeong Cheon, Young Joo Park, Kyungho Choi
    Exposure and Health.2023; 15(1): 53.     CrossRef
  • Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patients
    Vincenzo Marotta, Lucia Grumetto, Ilaria Neri, Giacomo Russo, Anna Tortora, Giulia Izzo, Ilaria Panariello, Domenico Rocco, Luciano Pezzullo, Mario Vitale
    Environmental Pollution.2023; 316: 120478.     CrossRef
  • A case-control study of urinary concentrations of bisphenol A, bisphenol F, and bisphenol S and the risk of papillary thyroid cancer
    Lei Zhang, Jiahuai Zhang, Sai Fan, Yuxin Zhong, Jingguang Li, Yunfeng Zhao, Song Ni, Jiaying Liu, Yongning Wu
    Chemosphere.2023; 312: 137162.     CrossRef
  • Endocrine disruptors and endometriosis
    Sudipta Dutta, Sakhila K. Banu, Joe A. Arosh
    Reproductive Toxicology.2023; 115: 56.     CrossRef
  • Bisphenol A alternatives continuously contribute to the endocrine disruption in cetaceans
    Yongwei Guo, Wei Shi, Zhiwei Liu, Xian Sun, Jiaxue Wu, Yuping Wu
    Environment International.2023; 171: 107679.     CrossRef
  • Environmental endocrine disruptors and amphibian immunity: A bridge between the thyroid hormone axis and T cell development
    Connor C. McGuire, Jacques R. Robert
    Developmental & Comparative Immunology.2023; 140: 104617.     CrossRef
  • Transient developmental exposure to low doses of bisphenol F negatively affects neurogliogenesis and olfactory behaviour in adult mice
    Pieter Vancamp, Lucile Butruille, Anni Herranen, Anita Boelen, Jean-Baptiste Fini, Barbara A. Demeneix, Sylvie Remaud
    Environment International.2023; 172: 107770.     CrossRef
  • A Fast Method for Determination of Seven Bisphenols in Human Breast Milk Samples with the Use of HPLC-FLD
    Szymon Szubartowski, Tomasz Tuzimski
    Molecules.2023; 28(3): 1432.     CrossRef
  • Risk Assessment of Bisphenol A in the Korean General Population
    Myungsil Hwang, Seon-Joo Park, Hae-Jeung Lee
    Applied Sciences.2023; 13(6): 3587.     CrossRef
  • Current Evidence on Bisphenol A Exposure and the Molecular Mechanism Involved in Related Pathological Conditions
    Ylenia Della Rocca, Enrico Matteo Traini, Francesca Diomede, Luigia Fonticoli, Oriana Trubiani, Alessia Paganelli, Jacopo Pizzicannella, Guya Diletta Marconi
    Pharmaceutics.2023; 15(3): 908.     CrossRef
  • The associations between concentrations of gestational bisphenol analogues and thyroid related hormones in cord blood: A prospective cohort study
    Jianya Xi, Xiujuan Su, Ziliang Wang, Honglei Ji, Yao Chen, Xiaofang Liu, Maohua Miao, Hong Liang, Wei Yuan
    Ecotoxicology and Environmental Safety.2023; 256: 114838.     CrossRef
  • Zebrafish (Danio rerio) TRβ- and TTR-based electrochemical biosensors: Construction and application for the evaluation of thyroid-disrupting activity of bisphenols
    Yuejiao Li, Zhenzhong Zhang, Jun Wang, Yeqi Shan, Hua Tian, Pengfei Cui, Shaoguo Ru
    Environmental Pollution.2023; 330: 121745.     CrossRef
  • Iodine Deficiency, Maternal Hypothyroxinemia and Endocrine Disrupters Affecting Fetal Brain Development: A Scoping Review
    Rolf Grossklaus, Klaus-Peter Liesenkötter, Klaus Doubek, Henry Völzke, Roland Gaertner
    Nutrients.2023; 15(10): 2249.     CrossRef
  • Bisphenol A Analogues Inhibit Human and Rat 11β-Hydroxysteroid Dehydrogenase 1 Depending on Its Lipophilicity
    Hong Wang, Jianmin Sang, Zhongyao Ji, Yang Yu, Shaowei Wang, Yang Zhu, Huitao Li, Yiyan Wang, Qiqi Zhu, Renshan Ge
    Molecules.2023; 28(13): 4894.     CrossRef
  • Bisphenol A-Induced Endocrine Dysfunction and its Associated Metabolic Disorders
    Meenu Maniradhan, Latchoumycandane Calivarathan
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2023; 23(4): 515.     CrossRef
  • Origin, dietary exposure, and toxicity of endocrine-disrupting food chemical contaminants: A comprehensive review
    Leila Peivasteh-roudsari, Raziyeh Barzegar-bafrouei, Kurush Aghbolagh Sharifi, Shamimeh Azimisalim, Marziyeh Karami, Solmaz Abedinzadeh, Shabnam Asadinezhad, Behrouz Tajdar-oranj, Vahideh Mahdavi, Adel Mirza Alizadeh, Parisa Sadighara, Margherita Ferrante
    Heliyon.2023; 9(7): e18140.     CrossRef
  • Bisphenol analogues induce thyroid dysfunction via the disruption of the thyroid hormone synthesis pathway
    Chao Hu, Yeqing Xu, Mingmin Wang, Shixuan Cui, Hangjun Zhang, Liping Lu
    Science of The Total Environment.2023; 900: 165711.     CrossRef
  • Distinct inhibitory strength of bisphenol A analogues on human and rat 11β-hydroxysteroid dehydrogenase 1: 3D quantitative structure-activity relationship and in silico molecular docking analysis
    Han Lu, Shaowei Wang, Jingyi Zheng, Yang Zhu, Yiyan Wang, Huitao Li, Ren-shan Ge
    Ecotoxicology and Environmental Safety.2023; 267: 115638.     CrossRef
  • Systematic Review on Safety of Bisphenol A: from Invention to the Present
    Hananeh KORDBACHEH, Bensu KARAHALİL
    Eurasian Journal of Toxicology.2023; 5(2): 37.     CrossRef
  • Bisphenol S dysregulates thyroid hormone homeostasis; Testicular survival, redox and metabolic status: Ameliorative actions of melatonin
    Aishwarya Sahu, Rakesh Verma
    Environmental Toxicology and Pharmacology.2023; 104: 104300.     CrossRef
  • Structural binding perspectives of common plasticizers and a flame retardant, BDE‐153, against thyroxine‐binding globulin: potential for endocrine disruption
    Ishfaq Ahmad Sheikh, Mohd Amin Beg
    Journal of Applied Toxicology.2022; 42(5): 841.     CrossRef
  • New insights on the effects of endocrine-disrupting chemicals on children
    Barbara Predieri, Crésio A.D. Alves, Lorenzo Iughetti
    Jornal de Pediatria.2022; 98: S73.     CrossRef
  • Toxic Metal Concentrations in Drinking Water and Possible Effect on Sex Hormones among Men in Sabongida-Ora, Edo State, Nigeria
    Osaro Ogie Enehizena, Mathias A. Emokpae
    Medicines.2022; 9(1): 4.     CrossRef
  • Bisphenols impact hormone levels in animals: A meta-analysis
    Alexander M. Rubin, Frank Seebacher
    Science of The Total Environment.2022; 828: 154533.     CrossRef
  • The effects of prenatal and lactational bisphenol A and/or di(2-ethylhexyl) phthalate exposure on female reproductive system
    Gizem Ozkemahli, Aylin Balci Ozyurt, Pinar Erkekoglu, Naciye Dilara Zeybek, Nilgun Yersal, Belma Kocer-Gumusel
    Toxicology Mechanisms and Methods.2022; 32(8): 597.     CrossRef
  • Associations of Phthalate Metabolites and Bisphenol A Levels with Obesity in Children: The Korean National Environmental Health Survey (KoNEHS) 2015 to 2017
    Moon Young Seo, Shinje Moon, Shin-Hye Kim, Mi Jung Park
    Endocrinology and Metabolism.2022; 37(2): 249.     CrossRef
  • Associations of bisphenol exposure with thyroid hormones in pregnant women: a prospective birth cohort study in China
    Huishen Huang, Jun Liang, Peng Tang, Chuanxiang Yu, Haoran Fan, Qian Liao, Jinghua Long, Dongxiang Pan, Xiaoyun Zeng, Shun Liu, Dongping Huang, Xiaoqiang Qiu
    Environmental Science and Pollution Research.2022; 29(58): 87170.     CrossRef
  • Bisphenols A, F, S and AF trigger apoptosis and/or endoplasmic reticulum stress in human endometrial stromal cells
    Ricardo Ferreira, Cristina Amaral, Georgina Correia-da-Silva, Marta Almada, Margarida Borges, Sara Cristina Cunha, José Oliveira Fernandes, Natércia Teixeira
    Toxicology.2022; 478: 153282.     CrossRef
  • Association between phenols and thyroid hormones: The role of iodothyronine deiodinase genes
    Blanca Sarzo, Reem Abumallouh, Natalia Marín, Sabrina Llop, Andrea Beneito, Inmaculada Lopez-Flores, Nerea Ferrero, Amrit Kaur Sakhi, Ferran Ballester, Maria-Jose Lopez-Espinosa
    Environmental Pollution.2022; 311: 119926.     CrossRef
  • Bisphenol A as a Factor in the Mosaic of Autoimmunity
    Zora Lazurova, Ivica Lazurova, Yehuda Shoenfeld
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2022; 22(7): 728.     CrossRef
  • Zebrafish as an emerging tool for drug discovery and development for thyroid diseases
    Poonam Yadav, Lopmudra P. Sarode, Ravinder Reddy Gaddam, Puneet Kumar, Jasvinder Singh Bhatti, Amit Khurana, Umashanker Navik
    Fish & Shellfish Immunology.2022; 130: 53.     CrossRef
  • Review of in silico studies dedicated to the nuclear receptor family: Therapeutic prospects and toxicological concerns
    Asma Sellami, Manon Réau, Matthieu Montes, Nathalie Lagarde
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Use of high-resolution metabolomics to assess the biological perturbations associated with maternal exposure to Bisphenol A and Bisphenol F among pregnant African American women
    Rachel Tchen, Youran Tan, Dana Boyd Barr, P. Barry Ryan, ViLinh Tran, Zhenjiang Li, Yi-Juan Hu, Alicia K. Smith, Dean P. Jones, Anne L. Dunlop, Donghai Liang
    Environment International.2022; 169: 107530.     CrossRef
  • Effects of bisphenol A on pancreas and thyroid gland of young and adult female Sprague Dawlеy rats
    D. Yahia, H. Hamdy, D. A. Salem, S. Afifi
    BULGARIAN JOURNAL OF VETERINARY MEDICINE.2022; 25(3): 426.     CrossRef
  • Bisphenol A analogues induce a feed-forward estrogenic response in zebrafish
    Silvia Karim, Ruixin Hao, Caroline Pinto, Jan-Åke Gustafsson, Marina Grimaldi, Patrick Balaguer, Maria Bondesson
    Toxicology and Applied Pharmacology.2022; 455: 116263.     CrossRef
  • Mediterranean Diet and Thyroid: An Interesting Alliance
    Giuseppe Bellastella, Lorenzo Scappaticcio, Francesco Caiazzo, Maria Tomasuolo, Raffaela Carotenuto, Mariangela Caputo, Stefania Arena, Paola Caruso, Maria Ida Maiorino, Katherine Esposito
    Nutrients.2022; 14(19): 4130.     CrossRef
  • Endocrine Disrupting Chemicals’ Effects in Children: What We Know and What We Need to Learn?
    Barbara Predieri, Lorenzo Iughetti, Sergio Bernasconi, Maria Elisabeth Street
    International Journal of Molecular Sciences.2022; 23(19): 11899.     CrossRef
  • Single and repeated bisphenol A treatment induces ROS, Aβ and hyperphosphorylated-tau accumulation, and insulin pathways disruption, through HDAC2 and PTP1B overexpression, leading to SN56 cholinergic apoptotic cell death
    Andrea Flores, Paula Moyano, Emma Sola, José Manuel García, Jimena García, María José Anadon, María Teresa Frejo, Maria Victoria Naval, Maria de la Cabeza Fernadez, Javier del Pino
    Food and Chemical Toxicology.2022; 170: 113500.     CrossRef
  • Application of High-Performance Liquid Chromatography Combined with Fluorescence Detector and Dispersive Liquid–Liquid Microextraction to Quantification of Selected Bisphenols in Human Amniotic Fluid Samples
    Szymon Szubartowski, Tomasz Tuzimski
    International Journal of Environmental Research and Public Health.2022; 20(1): 297.     CrossRef
  • The Association between Phenols and Thyroid Hormones: The Role of Iodothyronine Deiodinase Genes
    Blanca Sarzo, Reem Abumallouh, Natalia Marin, Sabrina Llop, Andrea Beneito, Inmaculada Lopez-Flores, Nerea Ferrero, Amrit Kaur Sakhi, ferran ballester, Maria-Jose Lopez-Espinosa
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Bisphenols emerging in Norwegian and Czech aquatic environments show transthyretin binding potency and other less-studied endocrine-disrupting activities
    Pavel Šauer, Helena Švecová, Kateřina Grabicová, Farah Gönül Aydın, Tomáš Mackuľak, Vít Kodeš, Line Diana Blytt, Liv Bruås Henninge, Roman Grabic, Hana Kocour Kroupová
    Science of The Total Environment.2021; 751: 141801.     CrossRef
  • Endocrine Disrupting Chemicals and Thyroid Cancer: An Overview
    Mathilda Alsen, Catherine Sinclair, Peter Cooke, Kimia Ziadkhanpour, Eric Genden, Maaike van Gerwen
    Toxics.2021; 9(1): 14.     CrossRef
  • Thyroid-Modulating Activities of Olive and Its Polyphenols: A Systematic Review
    Kok-Lun Pang, Johanna Nathania Lumintang, Kok-Yong Chin
    Nutrients.2021; 13(2): 529.     CrossRef
  • Human biomonitoring of bisphenol A along pregnancy: An exposure reconstruction of the EXHES-Spain cohort
    María Ángeles Martínez, Neus González, Anna Martí, Montse Marquès, Joaquim Rovira, Vikas Kumar, Martí Nadal
    Environmental Research.2021; 196: 110941.     CrossRef
  • Dietary Intake of Endocrine Disrupting Substances Presents in Environment and Their Impact on Thyroid Function
    Aneta Sokal, Sara Jarmakiewicz-Czaja, Jacek Tabarkiewicz, Rafał Filip
    Nutrients.2021; 13(3): 867.     CrossRef
  • BPA and BPA alternatives BPS, BPAF, and TMBPF, induce cytotoxicity and apoptosis in rat and human stem cells
    Kristen G. Harnett, Ashley Chin, Sonya M. Schuh
    Ecotoxicology and Environmental Safety.2021; 216: 112210.     CrossRef
  • Bisphenols and the Development of Type 2 Diabetes: The Role of the Skeletal Muscle and Adipose Tissue
    Fozia Ahmed, Maria Pereira, Céline Aguer
    Environments.2021; 8(4): 35.     CrossRef
  • Involvement of Thyroid Hormones in Brain Development and Cancer
    Gabriella Schiera, Carlo Maria Di Liegro, Italia Di Liegro
    Cancers.2021; 13(11): 2693.     CrossRef
  • Environmental Factors Affecting Thyroid-Stimulating Hormone and Thyroid Hormone Levels
    Mirjana Babić Leko, Ivana Gunjača, Nikolina Pleić, Tatijana Zemunik
    International Journal of Molecular Sciences.2021; 22(12): 6521.     CrossRef
  • Thyroid health in big city realities
    Liudmila L. Kamynina
    City Healthcare.2021; 2(2): 84.     CrossRef
  • Adverse effects of bisphenol B exposure on the thyroid and nervous system in early life stages of zebrafish
    Qian Yang, Zhenzhu Zhu, Qin Liu, Lihong Chen
    Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology.2021; 250: 109167.     CrossRef
  • Teratogenicity and toxicity of the new BPA alternative TMBPF, and BPA, BPS, and BPAF in chick embryonic development
    Kristen G. Harnett, Lucy G. Moore, Ashley Chin, Isabel C. Cohen, Rylee R. Lautrup, Sonya M. Schuh
    Current Research in Toxicology.2021; 2: 399.     CrossRef
  • A Review on the Occurrence, Exposure, and Health Impacts of Bisphenol A
    Prince Sharma, Khushboo Sharma, Geetika Sharma, Pooja Chadha
    Toxicology International.2021; : 337.     CrossRef
  • Thyroxine-binding globulin, peripheral deiodinase activity, and thyroid autoantibody status in association of phthalates and phenolic compounds with thyroid hormones in adult population
    Sohyeon Choi, Min Joo Kim, Young Joo Park, Sunmi Kim, Kyungho Choi, Gi Jeong Cheon, Yoon Hee Cho, Hye Li Jeon, Jiyoung Yoo, Jeongim Park
    Environment International.2020; 140: 105783.     CrossRef
  • Clinical expression of endocrine disruptors in children
    Lorenzo Iughetti, Laura Lucaccioni, Maria E. Street, Sergio Bernasconi
    Current Opinion in Pediatrics.2020; 32(4): 554.     CrossRef
  • Combined effects of di (2-ethylhexyl) phthalate and bisphenol A on thyroid hormone homeostasis in adolescent female rats
    Xuan Zhang, Yuejiao Zhao, Cheng Cheng, Liuli Li, Mingyang Xiao, Guopei Zhang, Xiaobo Lu
    Environmental Science and Pollution Research.2020; 27(32): 40882.     CrossRef
  • How microplastic components influence the immune system and impact on children health: Focus on cancer
    Mariana Segovia‐Mendoza, Karen E. Nava‐Castro, Margarita I. Palacios‐Arreola, Claudia Garay‐Canales, Jorge Morales‐Montor
    Birth Defects Research.2020; 112(17): 1341.     CrossRef
  • Perinatal exposure to Bisphenol A disturbs the early differentiation of male germ cells
    Romina Pagotto, Clarisa G. Santamaría, María Belén Harreguy, Julián Abud, María Laura Zenclussen, Laura Kass, Martina Crispo, Mónica M. Muñoz-de-Toro, Horacio A. Rodriguez, Mariela Bollati-Fogolín
    Reproductive Toxicology.2020; 98: 117.     CrossRef
  • Novel Biobased Furanic Diols as Potential Alternatives to BPA: Synthesis and Endocrine Activity Screening
    Catherine A. Sutton, Alexander Polykarpov, Keimpe Jan van den Berg, Alexander Yahkind, Linda J. Lea, Dean C. Webster, Mukund P. Sibi
    ACS Sustainable Chemistry & Engineering.2020; 8(51): 18824.     CrossRef
Close layer
Thyroid
Current Status and Future Perspectives in Differentiated Thyroid Cancer
Tae Yong Kim, Won Gu Kim, Won Bae Kim, Young Kee Shong
Endocrinol Metab. 2014;29(3):217-225.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.217
  • 4,230 View
  • 35 Download
  • 75 Web of Science
  • 61 Crossref
AbstractAbstract PDFPubReader   

Thyroid cancer is increasing all over the world. The exact cause of this increase is still debated and there are conflicting reports. Sophisticated molecular studies suggest that environmental chemicals may have effects of thyroid carcinogenesis. The development of powerful molecular biology techniques has enabled targeted next-generation sequencing for detection of mutations in thyroid cancer, and this technique can make a specific diagnosis of thyroid cancer in cytologically indeterminate cases. The initial treatment of well-differentiated thyroid cancer (DTC) is surgery followed by radioiodine remnant ablation. However, further studies are needed to determine the optimal dosage of radioactive iodine for DTC patients with lateral neck metastasis. DTC is an indolent tumor and may cause death even decades later. Thus, long-term follow-up is mandatory. Recently, dynamic risk stratification (DRS) has begun to use stimulated thyroglobulin level at 1 year after the initial treatment and restratified the risk in accordance with the response to the initial treatment. This DRS strategy accurately predicts disease free survival and can be widely used in daily clinical settings. For the iodine refractory metastatic disease, redifferentiation therapy and targeted therapy are two promising alternative treatments. Sorafenib is the first approved agent for the treatment of progressive iodine refractory advanced thyroid cancer in Korea and may be very helpful for radioactive-refractory locally advanced or metastatic DTC. Selumetinib may be an effective redifferentiating agent and could be used within several years.

Citations

Citations to this article as recorded by  
  • Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea
    Hyemi Kwon, Kyung-Do Han, Sun Joon Moon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1095.     CrossRef
  • Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids
    Hélène Lasolle, Andrea Schiavo, Adrien Tourneur, Pierre Gillotay, Bárbara de Faria da Fonseca, Lucieli Ceolin, Olivier Monestier, Benilda Aganahi, Laura Chomette, Marina Malta Letro Kizys, Lieven Haenebalcke, Tim Pieters, Steven Goossens, Jody Haigh, Vinc
    Oncogene.2024; 43(3): 155.     CrossRef
  • Clinical significance and diagnostic value of QPCT, SCEL and TNFRSF12A in papillary thyroid cancer
    Tairong Liang, Xiuqian Wu, Lan Wang, Zhengzhong Ni, Ying Fan, Peishan Wu, Hongzhi Wang, Yongdong Niu, Haihua Huang
    Pathology - Research and Practice.2023; 245: 154431.     CrossRef
  • Thyroidkeeper: a healthcare management system for patients with thyroid diseases
    Jing Zhang, Jianhua Li, Yi Zhu, Yu Fu, Lixia Chen
    Health Information Science and Systems.2023;[Epub]     CrossRef
  • Repeated Low High-Density Lipoprotein Cholesterol and the Risk of Thyroid Cancer: A Nationwide Population- Based Study in Korea
    Jinyoung Kim, Mee Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Kyungdo Han, Hyuk-Sang Kwon
    Endocrinology and Metabolism.2022; 37(2): 303.     CrossRef
  • Comparison of the prognostic value of AJCC cancer staging system 7th and 8th editions for differentiated thyroid cancer
    Y. J. Morosán Allo, L. Bosio, A. Morejón, C. Parisi, M. C. Faingold, V. Ilera, A. Gauna, G. Brenta
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Immune Profiling of Advanced Thyroid Cancers Using Fluorescent Multiplex Immunohistochemistry
    Jonghwa Ahn, Meihua Jin, Eyun Song, Yeon-mi Ryu, Dong Eun Song, Sang-Yeob Kim, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon, Won Gu Kim
    Thyroid.2021; 31(1): 61.     CrossRef
  • A double mutation of BRAF L597Q and V600E in situ and solitary brain metastasis of occult papillary thyroid carcinoma
    Ling Chen, Yue Wu, Huili Bai, Huandong Liu, Xiaosong Li
    Medicine.2021; 100(6): e24458.     CrossRef
  • Mutation in Genes Encoding Key Functional Groups Additively Increase Mortality in Patients with BRAFV600E-Mutant Advanced Papillary Thyroid Carcinoma
    Eyun Song, Meihua Jin, Ahreum Jang, Min Ji Jeon, Dong Eun Song, Hye Jin Yoo, Won Bae Kim, Young Kee Shong, Won Gu Kim
    Cancers.2021; 13(22): 5846.     CrossRef
  • Current Status and Future Perspective of the Treatment for Radioiodine Refractory Differentiated Thyroid Cancer
    Young Kee Shong
    International Journal of Thyroidology.2021; 14(2): 98.     CrossRef
  • Comprehensive evaluation of risk factors for lymph node metastasis in patients with papillary thyroid carcinoma
    Yan Dong, Dan Wang, Yisheng Luo, Ling Chen, Huili Bai, Yifan Shen, Yangli Zhang, Xueping Chen, Xinliang Su, Jinqiu Zhao, Huandong Liu, Jungao Lu, Zuoyi Yao, Yajing Zhao, Changlong He, Xiaosong Li
    Oncology Letters.2021;[Epub]     CrossRef
  • Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in Korea
    Eyun Song, Mijin Kim, Eui Young Kim, Bo Hyun Kim, Dong Yeob Shin, Ho-Cheol Kang, Byeong-Cheol Ahn, Won Bae Kim, Young Kee Shong, Min Ji Jeon, Dong Jun Lim
    Thyroid.2020; 30(5): 732.     CrossRef
  • Radioiodine ablation in thyroid cancer patients: renal function and external radiation dose rate at discharge according to patient preparation
    Yeon-Hee Han, Hwan-Jeong Jeong, Myung-Hee Sohn, Sun Y. Lee, Seok T. Lim
    The Quarterly Journal of Nuclear Medicine and Molecular Imaging.2020;[Epub]     CrossRef
  • Metabolic Syndrome and the Risk of Thyroid Cancer: A Nationwide Population-Based Cohort Study
    Joo-Hyun Park, Moonyoung Choi, Jung-Hun Kim, Jaemin Kim, Kyungdo Han, Bongsung Kim, Do-Hoon Kim, Yong-Gyu Park
    Thyroid.2020; 30(10): 1496.     CrossRef
  • Serum Adiponectin and Progranulin Level in Patients with Benign Thyroid Nodule or Papillary Thyroid Cancer
    Hyemi Kwon, Se Eun Park, Ji-Sup Yun, Cheol-Young Park
    Endocrinology and Metabolism.2020; 35(2): 396.     CrossRef
  • The role of Slit2 as a tumor suppressor in thyroid cancer
    Min Ji Jeon, Seonhee Lim, Mi-hyeon You, Yangsoon Park, Dong Eun Song, Soyoung Sim, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Won Gu Kim
    Molecular and Cellular Endocrinology.2019; 483: 87.     CrossRef
  • Metabolic Obesity Phenotypes and Thyroid Cancer Risk: A Cohort Study
    Hyemi Kwon, Yoosoo Chang, Ara Cho, Jiin Ahn, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Hocheol Shin, Seungho Ryu, Eun-Jung Rhee
    Thyroid.2019; 29(3): 349.     CrossRef
  • Impact of delayed radioiodine therapy in intermediate‐/high‐risk papillary thyroid carcinoma
    Mijin Kim, Minkyu Han, Min Ji Jeon, Won Gu Kim, In Joo Kim, Jin‐Sook Ryu, Won Bae Kim, Young Kee Shong, Tae Yong Kim, Bo Hyun Kim
    Clinical Endocrinology.2019; 91(3): 449.     CrossRef
  • Myxedema coma precipitated by diabetic ketoacidosis after total thyroidectomy: a case report
    Jin Joo Kim, Eun Young Kim
    Journal of Medical Case Reports.2019;[Epub]     CrossRef
  • Comprehensive analysis for diagnosis of preoperative non-invasive follicular thyroid neoplasm with papillary-like nuclear features
    Hye Seung Lee, Jae-Wook Lee, Ji Hyun Park, Wan-Seop Kim, Hye Seung Han, Seung Eun Lee, Paula Soares
    PLOS ONE.2019; 14(7): e0218046.     CrossRef
  • Rutin Scavenges Reactive Oxygen Species, Inactivates 5′-Adenosine Monophosphate-Activated Protein Kinase, and Increases Sodium–Iodide Symporter Expression in Thyroid PCCL3 Cells
    Carlos Frederico Lima Gonçalves, Mariana Lopes de Freitas, Rodrigo Soares Fortunato, Leandro Miranda-Alves, Denise P. Carvalho, Andrea Claudia Freitas Ferreira
    Thyroid.2018; 28(2): 265.     CrossRef
  • Prevalence of BRAFV600E Mutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in a BRAFV600E Prevalent Area
    Hyereen Kim, Bo Hyun Kim, Young Keum Kim, Jeong Mi Kim, Seo Young Oh, Eun Heui Kim, Min Jin Lee, Jong Ho Kim, Yun Kyung Jeon, Sang Soo Kim, Byung Joo Lee, Yong Ki Kim, In Joo Kim
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • Whole-Exome Sequencing Identifies Two Discrete Druggable Signaling Pathways in Follicular Thyroid Cancer
    Neeta J. Erinjeri, Norman G. Nicolson, Christine Deyholos, Reju Korah, Tobias Carling
    Journal of the American College of Surgeons.2018; 226(6): 950.     CrossRef
  • Efficacy and Affecting Factors of 131I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
    Chen Wang, Hongcui Diao, Ping Ren, Xufu Wang, Yangang Wang, Wenjuan Zhao
    Frontiers in Oncology.2018;[Epub]     CrossRef
  • Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
    Eyun Song, Min Ji Jeon, Hye-Seon Oh, Minkyu Han, Yu-Mi Lee, Tae Yong Kim, Ki-Wook Chung, Won Bae Kim, Young Kee Shong, Dong Eun Song, Won Gu Kim
    European Journal of Endocrinology.2018; 179(3): 135.     CrossRef
  • SPC24 is critical for anaplastic thyroid cancer progression
    Huabin Yin, Tong Meng, Lei Zhou, Haiyan Chen, Dianwen Song
    Oncotarget.2017; 8(13): 21884.     CrossRef
  • Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis
    Renfei Wang, Yueqian Zhang, Jian Tan, Guizhi Zhang, Ruiguo Zhang, Wei Zheng, Yajing He
    Medicine.2017; 96(19): e6809.     CrossRef
  • Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication
    Hye In Kim, Tae Hyuk Kim, Hosu Kim, Young Nam Kim, Hye Won Jang, Jae Hoon Chung, Seong Mi Moon, Byung Woo Jhun, Hyun Lee, Won-Jung Koh, Sun Wook Kim, Dongmei Li
    PLOS ONE.2017; 12(1): e0169775.     CrossRef
  • Delayed TSH recovery after dose adjustment during TSH‐suppressive levothyroxine therapy of thyroid cancer
    Hye In Kim, Tae Hyuk Kim, Hosu Kim, Young Nam Kim, Hye Won Jang, Jung‐Han Kim, Kyu Yeon Hur, Jae Hoon Chung, Sun Wook Kim
    Clinical Endocrinology.2017; 87(3): 286.     CrossRef
  • Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease
    Yun Mi Choi, Won Gu Kim, Tae Yong Kim, Sung Jin Bae, Hong-Kyu Kim, Eun Kyung Jang, Min Ji Jeon, Ji Min Han, Young Kee Shong, Won Bae Kim
    The Korean Journal of Internal Medicine.2017; 32(1): 102.     CrossRef
  • Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?
    Mijin Kim, Young Nam Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Hyeon Seon Ahn, Sin-Ho Jung, Sun Wook Kim, Won Bae Kim, Jae Hoon Chung, Young Kee Shong, Tae Hyuk Kim, Tae Yong Kim
    Clinical Endocrinology.2017; 86(3): 438.     CrossRef
  • Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung
    Mijin Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Jong Jin Lee, Jin-Sook Ryu, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Thyroid.2017; 27(1): 49.     CrossRef
  • Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations
    Tae Hyuk Kim, Chang-Seok Ki, Hye Seung Kim, Kyunga Kim, Jun-Ho Choe, Jung-Han Kim, Jee Soo Kim, Young Lyun Oh, Soo Yeon Hahn, Jung Hee Shin, Hye Won Jang, Sun Wook Kim, Jae Hoon Chung
    The Journal of Clinical Endocrinology & Metabolism.2017; 102(5): 1757.     CrossRef
  • Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer
    Mijin Kim, Won Gu Kim, Hye-Seon Oh, Suyeon Park, Hyemi Kwon, Dong Eun Song, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Tae-Yon Sung, Min Ji Jeon
    Thyroid.2017; 27(9): 1149.     CrossRef
  • Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma
    Mijin Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Sang Min Lee, Jeong Hyun Lee, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Thyroid.2017; 27(7): 915.     CrossRef
  • Preoperative clinicopathological characteristics of patients with solitary encapsulated follicular variants of papillary thyroid carcinomas
    Hyemi Kwon, Min Ji Jeon, Jong Ho Yoon, Suck Joon Hong, Jeong Hyun Lee, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Won Gu Kim, Dong Eun Song
    Journal of Surgical Oncology.2017; 116(6): 746.     CrossRef
  • Prescribed Activity of 131I Therapy in Differentiated Thyroid Cancer
    Douglas Van Nostrand
    Journal of Nuclear Medicine.2017; 58(5): 697.     CrossRef
  • Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy
    Xingchen Shang, Xia Zhong, Xingsong Tian
    Tumor Biology.2016; 37(8): 11163.     CrossRef
  • Recent Updates on the Management of Medullary Thyroid Carcinoma
    Bo Hyun Kim, In Joo Kim
    Endocrinology and Metabolism.2016; 31(3): 392.     CrossRef
  • Intraoperative Near‐infrared Imaging for Parathyroid Gland Identification by Auto‐fluorescence: A Feasibility Study
    Frederic De Leeuw, Ingrid Breuskin, Muriel Abbaci, Odile Casiraghi, Haïtham Mirghani, Aïcha Ben Lakhdar, Corinne Laplace‐Builhé, Dana Hartl
    World Journal of Surgery.2016; 40(9): 2131.     CrossRef
  • Papillary thyroid carcinoma: different clinical behavior among pT3 tumors
    Maria Joana Santos, Maria João Bugalho
    Endocrine.2016; 53(3): 754.     CrossRef
  • Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma
    Hyemi Kwon, Won Gu Kim, Tae‐Yon Sung, Min Ji Jeon, Dong Eun Song, Yu‐Mi Lee, Jong Ho Yoon, Ki‐Wook Chung, Suck Joon Hong, Jung Hwan Baek, Jeong Hyun Lee, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Journal of Surgical Oncology.2016; 113(2): 152.     CrossRef
  • Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography
    BIN LONG, MENGDI YANG, ZHIWEN YANG, HEQING YI, LINFA LI
    Oncology Letters.2016; 11(2): 965.     CrossRef
  • Usefulness of PET/CT in the diagnosis of recurrent or metastasized differentiated thyroid carcinoma
    CUN-ZHI LU, SU-SHENG CAO, WEI WANG, JUN LIU, NING FU, FENG LU
    Oncology Letters.2016; 11(4): 2420.     CrossRef
  • Coexistence of papillary thyroid microcarcinoma and mucosa-associated lymphoid tissue lymphoma in a context of Hashimoto's thyroiditis
    Saul Levy-Blitchtein, Stefany Plasencia-Rebata, Domingo Morales Luna, Juana del Valle Mendoza
    Asian Pacific Journal of Tropical Medicine.2016; 9(8): 812.     CrossRef
  • Iodine-131 Therapy and Nasolacrimal Duct Obstructions: What We Know and What We Need to Know
    Mohammad Javed Ali
    Ophthalmic Plastic & Reconstructive Surgery.2016; 32(4): 243.     CrossRef
  • Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
    Min Ji Jeon, Won Gu Kim, Soyoung Sim, Seonhee Lim, Hyemi Kwon, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Endocrinology and Metabolism.2016; 31(1): 100.     CrossRef
  • Dietary evaluation of a low-iodine diet in Korean thyroid cancer patients preparing for radioactive iodine therapy in an iodine-rich region
    Dal Lae Ju, Young Joo Park, Hee-Young Paik, Min-Ji Kim, Seonyeong Park, Kyong Yeun Jung, Tae Hyuk Kim, Hun Sung Choi, Yoon Ju Song
    Nutrition Research and Practice.2016; 10(2): 167.     CrossRef
  • Features Predictive of Distant Metastasis in Papillary Thyroid Microcarcinomas
    Min Ji Jeon, Won Gu Kim, Yun Mi Choi, Hyemi Kwon, Yu-Mi Lee, Tae-Yon Sung, Jong Ho Yoon, Ki-Wook Chung, Suck Joon Hong, Tae Yong Kim, Young Kee Shong, Dong Eun Song, Won Bae Kim
    Thyroid.2016; 26(1): 161.     CrossRef
  • Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells
    Min Ji Jeon, Won Gu Kim, Seonhee Lim, Hyun-Jeung Choi, Soyoung Sim, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Molecular and Cellular Endocrinology.2016; 419: 113.     CrossRef
  • Differentiated Thyroid Cancer in Asians
    Bo Hyun Kim
    Endocrinology and Metabolism.2016; 31(1): 62.     CrossRef
  • Sub-Classification of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma by Pathologic Criteria
    Min Ji Jeon, Won Gu Kim, Eun Kyung Jang, Yun Mi Choi, Dong Eun Song, Tae-Yon Sung, Jong Ho Yoon, Ki-Wook Chung, Suck Joon Hong, Jin-Sook Ryu, Ji Min Han, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Konradin Metze
    PLOS ONE.2015; 10(7): e0133625.     CrossRef
  • The Impact of Low Adherence to the Low-iodine Diet on the Efficacy of the Radioactive Iodine Ablation Therapy
    Dal Lae Ju, Young Joo Park, Hee-Young Paik, YoonJu Song
    Clinical Nutrition Research.2015; 4(4): 267.     CrossRef
  • High metabolic tumor volume and total lesion glycolysis are associated with lateral lymph node metastasis in patients with incidentally detected thyroid carcinoma
    Bo Hyun Kim, Seong-Jang Kim, Keunyoung Kim, Heeyoung Kim, So Jung Kim, Won Jin Kim, Yun Kyung Jeon, Sang Soo Kim, Yong Ki Kim, In Joo Kim
    Annals of Nuclear Medicine.2015; 29(8): 721.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Changes in the Pulmonary Function Test after Radioactive Iodine Treatment in Patients with Pulmonary Metastases of Differentiated Thyroid Cancer
    Eun Kyung Jang, Won Gu Kim, Ho-Cheol Kim, Jin-Won Huh, Hyemi Kwon, Yun Mi Choi, Min Ji Jeon, Tae Yong Kim, Young Kee Shong, Jin-Sook Ryu, Won Bae Kim, Karen M. Tordjman
    PLOS ONE.2015; 10(4): e0125114.     CrossRef
  • Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma
    Tae Yon Sung, Mijin Kim, Tae Yong Kim, Won Gu Kim, Yangsoon Park, Dong Eun Song, Su-Yeon Park, Hyemi Kwon, Yun Mi Choi, Eun Kyung Jang, Min Ji Jeon, Young Kee Shong, Suck Joon Hong, Won Bae Kim
    Thyroid.2015; 25(9): 1020.     CrossRef
  • Thyroglobulin Level in Fine-Needle Aspirates for Preoperative Diagnosis of Cervical Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma: Two Different Cutoff Values According to Serum Thyroglobulin Level
    Min Ji Jeon, Won Gu Kim, Eun Kyung Jang, Yun Mi Choi, Yu-Mi Lee, Tae-Yon Sung, Jong Ho Yoon, Ki-Wook Chung, Suck Joon Hong, Jung Hwan Baek, Jeong Hyun Lee, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Thyroid.2015; 25(4): 410.     CrossRef
  • A Closer Look at Papillary Thyroid Carcinoma
    Won Bae Kim
    Endocrinology and Metabolism.2015; 30(1): 1.     CrossRef
  • Protecting the normal in order to better kill the cancer
    Bingya Liu, Lewis Ezeogu, Lucas Zellmer, Baofa Yu, Ningzhi Xu, Dezhong Joshua Liao
    Cancer Medicine.2015; 4(9): 1394.     CrossRef
  • Recent Changes in the Clinical Outcome of Papillary Thyroid Carcinoma With Cervical Lymph Node Metastasis
    Min Ji Jeon, Won Gu Kim, Yun Mi Choi, Hyemi Kwon, Dong Eun Song, Yu-Mi Lee, Tae-Yon Sung, Jong Ho Yoon, Suck Joon Hong, Jung Hwan Baek, Jeong Hyun Lee, Jin-Sook Ryu, Tae Yong Kim, Young Kee Shong, Ki-Wook Chung, Won Bae Kim
    The Journal of Clinical Endocrinology & Metabolism.2015; 100(9): 3470.     CrossRef
Close layer
Thyroid
Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth
Jung Suk Sim, Jung Hwan Baek
Endocrinol Metab. 2019;34(2):117-123.   Published online June 24, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.2.117
  • 9,633 View
  • 148 Download
  • 56 Web of Science
  • 60 Crossref
AbstractAbstract PDFPubReader   ePub   

Thermal ablation (TA) procedures, such as radiofrequency ablation and laser ablation, are used for the treatment of benign thyroid nodules. Short-term studies (<2 years) have demonstrated that TA is an effective and safe procedure to improve cosmetic or symptomatic problems. However, studies including a longer follow-up period show that treated thyroid nodules can increase in size after 2 to 3 years. Several studies suggest that this results from regrowth at the undertreated nodule margins. Here, we review current data on regrowth after TA and describe factors related to it and possible approaches to prevent it.

Citations

Citations to this article as recorded by  
  • From ablation to operation: Unraveling the surgical outcomes and complications of thyroidectomy after radiofrequency ablation
    Mohammad Hussein, Eman Toraih, Peter P. Issa, Mahmoud Omar, Mohamed Aboueisha, Yusef Buti, Chad P. Issa, Aaron L. Albuck, Katherine Cironi, Abdallah S. Attia, Alexandra C. LaForteza, Mohamed Shama, Emad Kandil
    Surgery.2024; 175(1): 146.     CrossRef
  • Radiofrequency Ablation for Benign Nodules and for Cancer, Too?
    Jonathon O. Russell, Kaitlyn M. Frazier
    Otolaryngologic Clinics of North America.2024; 57(1): 83.     CrossRef
  • Clinical Outcomes of Thermal Ablation Re-Treatment of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group
    Stella Bernardi, Valentina Rosolen, Fabio Barbone, Stefano Borgato, Maurilio Deandrea, Pierpaolo De Feo, Laura Fugazzola, Giovanni Gambelunghe, Roberto Negro, Salvatore Oleandri, Giampaolo Papi, Enrico Papini, Francesca Retta, Ruth Rossetto, Daniela Sanso
    Thyroid®.2024;[Epub]     CrossRef
  • An anthropomorphic thyroid phantom for ultrasound‐guided radiofrequency ablation of nodules
    Tim Boers, Wyger Brink, Leonardo Bianchi, Paola Saccomandi, Johan van Hespen, Germen Wennemars, Sicco Braak, Michel Versluis, Srirang Manohar
    Medical Physics.2024; 51(2): 826.     CrossRef
  • The safety and efficacy of radiofrequency ablation in benign pediatric thyroid disease in the US: An initial case series
    Grace S. Kim, Hilary Seeley, Julia Noel, Iram Ahmad, Kara Meister
    Laryngoscope Investigative Otolaryngology.2024;[Epub]     CrossRef
  • Comparison of the Therapeutic Efficacy and Technical Outcomes between Conventional Fixed Electrodes and Adjustable Electrodes in the Radiofrequency Ablation of Benign Thyroid Nodules
    Jae Ho Shin, Minkook Seo, Min Kyoung Lee, So Lyung Jung
    Korean Journal of Radiology.2024; 25(2): 199.     CrossRef
  • If the price is right: Cost-effectiveness of radiofrequency ablation versus thyroidectomy in the treatment of benign thyroid nodules
    Eric J. Kuo, Aaron Oh, Yinin Hu, Catherine M. McManus, James A. Lee, Jennifer H. Kuo
    Surgery.2023; 173(1): 201.     CrossRef
  • Development and validation of a nomogram model for predicting residue of partially cystic thyroid nodules after ultrasound-guided ethanol and thermal ablation
    Di Li, Xiaoer Zhang, Yutong Zhang, Tongyi Huang, Rui Zhang, Wenwen Zhou, Xiaoyan Xie, Ming Xu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Image-guided Thermal Ablation as a Promising Approach to Both Nontoxic and Toxic Autonomously Functioning Thyroid Nodules
    Long Wang, Peiqing Wang, Zhijiang Chen, Yinghe Lin, Yingshan Liu, Rong Peng, Jinlian Li, Wenfeng Luo, Jian Kuang
    Academic Radiology.2023; 30(11): 2636.     CrossRef
  • Analysis and prediction of regrowth in benign thyroid nodules undergoing radiofrequency ablation: a retrospective study with a 5-year follow-up
    Yi Li, Wen Li, Bo Jiang, Jiahang Zhao, Yan Zhang, Yukun Luo
    European Radiology.2023; 33(8): 5615.     CrossRef
  • Ultrasound (US)-Guided Ablation of Thyroid Nodules
    Byung Seup Kim
    Journal of Surgical Ultrasound.2023; 10(1): 14.     CrossRef
  • Minimally Invasive Ablative Treatments for Benign Thyroid Nodules: Current Evidence and Future Directions
    Enrico Papini, Laszlo Hegedüs
    Thyroid®.2023; 33(8): 890.     CrossRef
  • Ultrasound imaging in thyroid nodule diagnosis, therapy, and follow‐up: Current status and future trends
    Tim Boers, Sicco J. Braak, Nicole E. T. Rikken, Michel Versluis, Srirang Manohar
    Journal of Clinical Ultrasound.2023; 51(6): 1087.     CrossRef
  • Radiofrequency ablation of benign thyroid nodules: the value of anterolateral hydrodissection
    So Yeong Jeong, Jung Hwan Baek, Sae Rom Chung, Young Jun Choi, Ki-Wook Chung, Tae Yong Kim, Jeong Hyun Lee
    Ultrasonography.2023; 42(3): 432.     CrossRef
  • Radiofrequency Ablation for Benign Thyroid Nodules
    Julia E Noel, Catherine F Sinclair
    The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e12.     CrossRef
  • High-security automatic path planning of radiofrequency ablation for liver tumors
    Jing Li, Huayu Gao, Nanyan Shen, Di Wu, Lanyun Feng, Peng Hu
    Computer Methods and Programs in Biomedicine.2023; 242: 107769.     CrossRef
  • General Principles for the Safe Performance, Training, and Adoption of Ablation Techniques for Benign Thyroid Nodules: An American Thyroid Association Statement
    Catherine F. Sinclair, Jung Hwan Baek, Kathleen E. Hands, Steven P. Hodak, Timothy C. Huber, Iram Hussain, Brian Hung-Hin Lang, Julia E. Noel, Maria Papaleontiou, Kepal N. Patel, Gilles Russ, Jonathon Russell, Stefano Spiezia, Jennifer H. Kuo
    Thyroid®.2023; 33(10): 1150.     CrossRef
  • Clinical Approach for Thyroid Radiofrequency Ablation
    Jung Suk Sim
    Journal of the Korean Society of Radiology.2023; 84(5): 1017.     CrossRef
  • Contrast-enhanced ultrasound is a reliable and reproducible assessment of necrotic ablated volume after radiofrequency ablation for benign thyroid nodules: a retrospective study
    Lin Yan, XinYang Li, Jing Xiao, YingYing Li, Yaqiong Zhu, Hongying He, Yukun Luo
    International Journal of Hyperthermia.2022; 39(1): 40.     CrossRef
  • Nonsurgical Management of Thyroid Nodules: The Role of Ablative Therapies
    Marius N Stan, Maria Papaleontiou, John J Schmitz, M Regina Castro
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(5): 1417.     CrossRef
  • Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation for Benign Nonfunctional Thyroid Nodules in Children: A Retrospective Study of 62 Patients with Over Four Years of Follow-Up
    Liwen Li, Xinguang Qiu
    Thyroid.2022; 32(5): 525.     CrossRef
  • A Nomogram to Predict Regrowth After Ultrasound-Guided Radiofrequency Ablation for Benign Thyroid Nodules
    Lin Yan, Mingbo Zhang, Xinyang Li, YingYing Li, Yukun Luo
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Radiofrequency Ablation of Solid, Non-Functional Thyroid Nodules
    Michael Douek
    Techniques in Vascular and Interventional Radiology.2022; 25(2): 100821.     CrossRef
  • American Association of Clinical Endocrinology Disease State Clinical Review: The Clinical Utility of Minimally Invasive Interventional Procedures in the Management of Benign and Malignant Thyroid Lesions
    Sina Jasim, Kepal N. Patel, Gregory Randolph, Stephanie Adams, Roberto Cesareo, Edward Condon, Tara Henrichsen, Malak Itani, Maria Papaleontiou, Leonardo Rangel, John Schmitz, Marius N. Stan
    Endocrine Practice.2022; 28(4): 433.     CrossRef
  • The Use of Radiofrequency Ablation for Benign Thyroid Nodules
    Rachel Liou, Catherine McManus, Jennifer Kuo
    VideoEndocrinology.2022; 9(2): 36.     CrossRef
  • A novel parallel overlapping mode for complete ablation of large benign thyroid nodules in a single-session radiofrequency ablation
    Tao Wu, Bowen Zheng, Lei Tan, Tinghui Yin, Yufan Lian, Shicheng Xu, Jin Ye, Jie Ren
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Efficacy and safety of thermal ablation for autonomously functioning thyroid nodules: a systematic review and meta-analysis
    Hyun Jin Kim, Se Jin Cho, Jung Hwan Baek, Chong Hyun Suh
    European Radiology.2021; 31(2): 605.     CrossRef
  • Letter: Twelve-Month Volume Reduction Ratio Predicts Regrowth and Time to Regrowth in Thyroid Nodules Submitted to Laser Ablation: A 5-Year Follow-Up Retrospective Study
    Jung Suk Sim
    Korean Journal of Radiology.2021; 22(2): 291.     CrossRef
  • How to Monitor and Manage Nodule Regrowth after Thermal Ablation of Benign Thyroid Nodules
    Sang Ik Park, Jung Hwan Baek
    Korean Journal of Radiology.2021; 22(2): 293.     CrossRef
  • Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound
    Lin Yan, Yukun Luo, Jing Xiao, Lin Lin
    European Radiology.2021; 31(5): 3226.     CrossRef
  • The Adoption of Ultrasound-guided Radiofrequency Ablation of Thyroid Nodules in the United States
    Jennifer H. Kuo, James A. Lee
    Annals of Surgery.2021; 273(1): e10.     CrossRef
  • Radiofrequency ablation of benign thyroid nodules: recommendations from the Asian Conference on Tumor Ablation Task Force
    Eun Ju Ha, Jung Hwan Baek, Ying Che, Yi-Hong Chou, Nobuhiro Fukunari, Ji-hoon Kim, Wei-Che Lin, Le Thi My, Dong Gyu Na, Lawrence Han Hwee Quek, Ming-Hsun Wu, Koichiro Yamakado, Jianhua Zhou
    Ultrasonography.2021; 40(1): 75.     CrossRef
  • Thermal Treatment Options for Benign Thyroid Nodules—The Role of Radio-Frequency Ablation and Laser Therapy
    Erivelto Volpi
    Clinical Thyroidology.2021; 33(1): 17.     CrossRef
  • Residual vital ratio predicts 5-year volume reduction and retreatment after radiofrequency ablation of benign thyroid nodules but not regrowth
    Stella Bernardi, Fabiola Giudici, Giacomo Colombin, Marco Cavallaro, Fulvio Stacul, Bruno Fabris
    International Journal of Hyperthermia.2021; 38(1): 111.     CrossRef
  • Radiofrequency ablation versus reoperation for benign thyroid nodules that developed after previous thyroid surgery
    Lin Yan, Cuiai Deng, Qing Song, Nan Li, Ling Ren, HongYing He, Wen Li, Mingbo Zhang, Yukun Luo
    International Journal of Hyperthermia.2021; 38(1): 176.     CrossRef
  • Letter to the Editor Regarding “Minimally Invasive Treatment for Benign Parathyroid Lesions: Treatment Efficacy and Safety Based on Nodule Characteristics”
    Jung Suk Sim
    Korean Journal of Radiology.2021; 22(5): 861.     CrossRef
  • Unresolved Clinical Issues in Thermal Ablation of Benign Thyroid Nodules: Regrowth at Long-Term Follow-Up
    Jung Suk Sim, Jung Hwan Baek
    Korean Journal of Radiology.2021; 22(8): 1436.     CrossRef
  • Current Status and Challenges of US-Guided Radiofrequency Ablation of Thyroid Nodules in the Long Term: A Systematic Review
    Stella Bernardi, Andrea Palermo, Rosario Francesco Grasso, Bruno Fabris, Fulvio Stacul, Roberto Cesareo
    Cancers.2021; 13(11): 2746.     CrossRef
  • Long-Term Outcomes of Radiofrequency Ablation for Treatment of Cystic Warthin Tumors versus Solid Warthin Tumors
    Chih-Hung Cha, Sheng-Dean Luo, Pi-Ling Chiang, Wei-Chih Chen, Yu-Cheng Tung, Yan-Ye Su, Wei-Che Lin
    International Journal of Environmental Research and Public Health.2021; 18(12): 6640.     CrossRef
  • Comparison of Thermal Ablation and Surgery for Low-Risk Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis
    Hyun Jin Kim, Se Jin Cho, Jung Hwan Baek
    Korean Journal of Radiology.2021; 22(10): 1730.     CrossRef
  • Long-Term Outcomes of Thermal Ablation for Benign Thyroid Nodules: The Issue of Regrowth
    Jung Suk Sim, Jung Hwan Baek, Rosaria Meccariello
    International Journal of Endocrinology.2021; 2021: 1.     CrossRef
  • Matrix 3D ultrasound-assisted thyroid nodule volume estimation and radiofrequency ablation: a phantom study
    T. Boers, S. J. Braak, M. Versluis, S. Manohar
    European Radiology Experimental.2021;[Epub]     CrossRef
  • Ultrasound-Guided Thermal Ablation of Bethesda IV Thyroid Nodules: A Pilot Study
    Xinyang Li, Yu Lan, Nan Li, Lin Yan, Jing Xiao, Mingbo Zhang, Yukun Luo
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Percutaneous Microwave Ablation for Benign, Symptomatic Thyroid Nodules: Wave of the Future?
    Alaina D. Geary, Frederick Thurston Drake
    World Journal of Surgery.2020; 44(7): 2280.     CrossRef
  • Radiofrequency Ablation Systemization
    Leonardo Guimarães Rangel, Erivelto Martinho Volpi, Jose Higino Steck, Jonathon O. Russell, Ralph P. Tufano
    VideoEndocrinology.2020;[Epub]     CrossRef
  • Twelve-Month Volume Reduction Ratio Predicts Regrowth and Time to Regrowth in Thyroid Nodules Submitted to Laser Ablation: A 5-Year Follow-Up Retrospective Study
    Roberto Negro, Gabriele Greco, Maurilio Deandrea, Matteo Rucco, Pierpaolo Trimboli
    Korean Journal of Radiology.2020; 21(6): 764.     CrossRef
  • Long-Term Results of Thermal Ablation of Benign Thyroid Nodules: A Systematic Review and Meta-Analysis
    Se Jin Cho, Jung Hwan Baek, Sae Rom Chung, Young Jun Choi, Jeong Hyun Lee
    Endocrinology and Metabolism.2020; 35(2): 339.     CrossRef
  • Effectiveness of Injecting Cold 5% Dextrose into Patients with Nerve Damage Symptoms during Thyroid Radiofrequency Ablation
    Min Kyoung Lee, Jung Hwan Baek, Sae Rom Chung, Young Jun Choi, Yu-Mi Lee, Tae Yong Kim, Jeong Hyun Lee
    Endocrinology and Metabolism.2020; 35(2): 407.     CrossRef
  • Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study
    Lin Yan, Yukun Luo, Mingbo Zhang, Jing Xiao
    International Journal of Hyperthermia.2020; 37(1): 777.     CrossRef
  • Five-Year Results of Radiofrequency and Laser Ablation of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group
    Stella Bernardi, Fabiola Giudici, Roberto Cesareo, Giovanni Antonelli, Marco Cavallaro, Maurilio Deandrea, Massimo Giusti, Alberto Mormile, Roberto Negro, Andrea Palermo, Enrico Papini, Valerio Pasqualini, Bruno Raggiunti, Duccio Rossi, Luca Maria Sconfie
    Thyroid.2020; 30(12): 1759.     CrossRef
  • A practical pretreatment planning method of multiple puncturing for thermal ablation surgery
    Jing Li, Yuanqi Xu, Nanyan Shen, Lanyun Feng, Zhuang Ran, Zongqian Deng
    Biocybernetics and Biomedical Engineering.2020; 40(4): 1469.     CrossRef
  • Radiofrequency for benign and malign thyroid lesions
    Leonardo Rangel, Leonardo M. Volpi, Elaine Stabenow, Jose Higino Steck, Erivelto Volpi, Jonathon O. Russell, Ralph P. Tufano
    World Journal of Otorhinolaryngology - Head and Neck Surgery.2020; 6(3): 188.     CrossRef
  • Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules
    Lin Yan, Yukun Luo, Fang Xie, Mingbo Zhang, Jing Xiao
    International Journal of Hyperthermia.2020; 37(1): 1139.     CrossRef
  • Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma
    Xiao-Wan Bo, Feng Lu, Hui-Xiong Xu, Li-Ping Sun, Kun Zhang
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Inter-observer reliability in ultrasound measurement of benign thyroid nodules in the follow-up of radiofrequency ablation: a retrospective study
    Lin Yan, Yukun Luo, Qing Song, Nan Li, Jing Xiao, Ying Zhang, Yaqiong Zhu
    International Journal of Hyperthermia.2020; 37(1): 1336.     CrossRef
  • CT-based quantitative evaluation of the efficacy after radiofrequency ablation in patients with benign thyroid nodules
    Yangsean Choi, So-Lyung Jung, Jinhee Jang, Na-Young Shin, Kook-Jin Ahn, Bum-soo Kim
    International Journal of Hyperthermia.2020; 37(1): 742.     CrossRef
  • 2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules
    Enrico Papini, Hervé Monpeyssen, Andrea Frasoldati, Laszlo Hegedüs
    European Thyroid Journal.2020; 9(4): 172.     CrossRef
  • Efficacy of Percutaneous Thermal Ablation of Papillary Thyroid Carcinoma
    Ettore Caruso, Ettore Gagliano, Gianlorenzo Dionigi
    Journal of Endocrine Surgery.2019; 19(4): 154.     CrossRef
  • Response: Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth (Endocrinol Metab 2019;34:117–23, Jung Suk Sim et al.)
    Jung Suk Sim, Jung Hwan Baek
    Endocrinology and Metabolism.2019; 34(3): 325.     CrossRef
  • Letter: Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth (Endocrinol Metab 2019;34:117-23, Jung Suk Sim et al.)
    Tae Yong Kim
    Endocrinology and Metabolism.2019; 34(3): 323.     CrossRef
Close layer
Original Article
Clinical Study
Association between Obesity and Bone Mineral Density by Gender and Menopausal Status
Mohammad Reza Salamat, Amir Hossein Salamat, Mohsen Janghorbani
Endocrinol Metab. 2016;31(4):547-558.   Published online November 4, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.4.547
  • 5,122 View
  • 61 Download
  • 60 Web of Science
  • 59 Crossref
AbstractAbstract PDFPubReader   
Background

We investigated whether there were gender differences in the effect of obesity on bone mineral density (BMD) based on menopausal status.

Methods

We assessed 5,892 consecutive patients 20 to 91 years old who were referred for dual-energy X-ray absorptiometry (DXA) scans. All subjects underwent a standard BMD scan of the hip (total hip and femoral neck) and lumbar spine (L1 to L4) using a DXA scan and body size assessment. Body mass index was used to categorize the subjects as normal weight, overweight, and obese.

Results

BMD was higher in obese and overweight versus normal weight men, premenopausal women, and postmenopausal women. Compared to men ≥50 years and postmenopausal women with normal weight, the age-adjusted odds ratio of osteopenia was 0.19 (95% confidence interval [CI], 0.07 to 0.56) and 0.38 (95% CI, 0.29 to 0.51) for obese men ≥50 years and postmenopausal women. Corresponding summaries for osteoporosis were 0.26 (95% CI, 0.11 to 0.64) and 0.15 (95% CI, 0.11 to 0.20), respectively. Compared to men <50 years and premenopausal women with normal weight, the age-adjusted odds ratio of low bone mass was 0.22 (95% CI, 0.11 to 0.45) and 0.16 (95% CI, 0.10 to 0.26) for obese men <50 years and premenopausal women, respectively.

Conclusion

Obesity is associated with BMD of the hip and lumbar spine and overweight and obese individuals have similar degrees of osteoporosis. This result was not significantly different based on gender and menopausal status, which could be an important issue for further investigation.

Citations

Citations to this article as recorded by  
  • Can routine MRI spine T1 sequences be used for prediction of decreased bone density?
    Hrishikesh Kale, Saksham Yadav
    Acta Radiologica.2023; 64(1): 164.     CrossRef
  • Inverse association of serum osteocalcin and bone mineral density in renal transplant recipients
    Wei-Chen Lin, Ming-Che Lee, Yen-Cheng Chen, Bang-Gee Hsu
    Tzu Chi Medical Journal.2023; 35(2): 165.     CrossRef
  • Understanding the confluence of injury and obesity in a Grade 2 obesity and above population
    Richard C. Franklin, Janet L. Franklin, Jessica M. Swinbourne, Elisia Manson, Georgina Loughnan, Tania Markovic, Samantha Hocking
    Australian and New Zealand Journal of Public Health.2023; 47(1): 100008.     CrossRef
  • The association of dietary acid load (DAL) with estimated skeletal muscle mass and bone mineral content: a cross-sectional study
    Fatemeh Gholami, Niki Bahrampour, Mahsa Samadi, Niloufar Rasaei, Habib Yarizadeh, Sina Naghshi, Khadijeh Mirzaei
    BMC Nutrition.2023;[Epub]     CrossRef
  • The Relationship between Bone Mineral Densitometry and Visceral Adiposity Index in Postmenopausal Women
    Halis Elmas, Cevdet Duran, Mustafa Can, Ismet Tolu, Ibrahim Guney
    Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics.2023; 45(02): 082.     CrossRef
  • A Review of Potential Therapies to Attenuate Bone Mineral Density Loss in Obese Individuals Prior to Total Joint Replacement Surgery
    Charlotte von Hoffmann, Kayla Penta, Amanpreet Singh
    Cureus.2023;[Epub]     CrossRef
  • Association between Adiposity and Bone Mineral Density in Adults: Insights from a National Survey Analysis
    Yang Jiao, Juan Sun, Yuanmeng Li, Junduo Zhao, Jianxiong Shen
    Nutrients.2023; 15(15): 3492.     CrossRef
  • Extract of Artemisia dracunculus L. Modulates Osteoblast Proliferation and Mineralization
    Matthew C. Scott, Aleah Bourgeois, Yongmei Yu, David H. Burk, Brenda J. Smith, Z. Elizabeth Floyd
    International Journal of Molecular Sciences.2023; 24(17): 13423.     CrossRef
  • Determinants of Bone Mineral Density in Iranian Women with Polycystic Ovary Syndrome
    Fariba Karimi, Parisa Mardani
    International Journal of Endocrinology and Metabolism.2023;[Epub]     CrossRef
  • The effect of overweight or obesity on osteoporosis: A systematic review and meta-analysis
    Yupeng Liu, Yi Liu, Yufeng Huang, Siyu Le, Huinan Jiang, Binye Ruan, Xuemei Ao, Xudong Shi, Xiaoyi Fu, Shuran Wang
    Clinical Nutrition.2023; 42(12): 2457.     CrossRef
  • Association of the visceral adiposity index with femur bone mineral density and osteoporosis among the U.S. older adults from NHANES 2005–2020: a cross-sectional study
    Aochuan Sun, Jiayu Hu, Shushangzhi Wang, Fen Yin, Zhengtang Liu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • High fat diet causes inferior vertebral structure and function without disc degeneration in RAGE‐KO mice
    Danielle N. D'Erminio, Divya Krishnamoorthy, Alon Lai, Robert C. Hoy, Devorah M. Natelson, Jashvant Poeran, Andrew Torres, Damien M. Laudier, Philip Nasser, Deepak Vashishth, Svenja Illien‐Jünger, James C. Iatridis
    Journal of Orthopaedic Research.2022; 40(7): 1672.     CrossRef
  • Dosing Therapeutic Radiopharmaceuticals in Obese Patients
    Merel van Nuland, Tessa F. Ververs, Marnix G. E. H. Lam
    International Journal of Molecular Sciences.2022; 23(2): 818.     CrossRef
  • Bone Density and Structure in Overweight Men With and Without Diabetes
    Jakob Starup-Linde, Marie Juul Ornstrup, Thomas Nordstrøm Kjær, Simon Lykkeboe, Aase Handberg, Søren Gregersen, Torben Harsløf, Steen Bønløkke Pedersen, Peter Vestergaard, Bente Lomholt Langdahl
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The Relationship Between Bone Mineral Density and Body Composition Among Qatari Women With High Rate of Obesity: Qatar Biobank Data
    Abdelhamid Kerkadi, Shalima Lathief, Yasmen Khial, Toka Teleb, Grace Attieh, Md Mizanur Rahman, Zumin Shi, Abdelali Agouni
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Predicting Lumbar Vertebral Osteopenia Using LvOPI Scores and Logistic Regression Models in an Exploratory Study of Premenopausal Taiwanese Women
    Chun-Wen Chen, Yi-Jui Liu, Shao-Chieh Lin, Chien-Yuan Wang, Wu-Chung Shen, Der-Yang Cho, Tung-Yang Lee, Cheng-Hsuan Juan, Cheng-En Juan, Kai-Yuan Cheng, Chun-Jung Juan
    Journal of Medical and Biological Engineering.2022; 42(5): 722.     CrossRef
  • Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
    Harold Edward Bays, Angela Golden, Justin Tondt
    Obesity Pillars.2022; 3: 100034.     CrossRef
  • Bone mass in Saudi women aged 20–40 years: the association with obesity and vitamin D deficiency
    Mai Albaik, Jalaluddin A. Khan, Ikhlas Sindi, Kristina E. Akesson, Fiona E. A. McGuigan
    Archives of Osteoporosis.2022;[Epub]     CrossRef
  • The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity
    Dalia Ali, Michaela Tencerova, Florence Figeac, Moustapha Kassem, Abbas Jafari
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Roles of Follicle-Stimulating Hormone on Bone Metabolism in Late Postmenopausal Women
    Chaiho Jeong, Jinyoung Kim, Yejee Lim, Jeonghoon Ha, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Moo Il Kang, Ki-Hyun Baek
    Journal of Bone Metabolism.2022; 29(3): 175.     CrossRef
  • Bone Health in Adults With Prader–Willi Syndrome: Clinical Recommendations Based on a Multicenter Cohort Study
    Denise H van Abswoude, Karlijn Pellikaan, Anna G W Rosenberg, Kirsten Davidse, Muriel Coupaye, Charlotte Høybye, Tania P Markovic, Graziano Grugni, Antonino Crinò, Assumpta Caixàs, Christine Poitou, Helena Mosbah, Tessa Weir, Leo A van Vlimmeren, Joost P
    The Journal of Clinical Endocrinology & Metabolism.2022; 108(1): 59.     CrossRef
  • Does the Severity of Obesity Influence Bone Mineral Density Values in Premenopausal Women?
    Emneh Hammoud, Hechmi Toumi, Christophe Jacob, Antonio Pinti, Eric Lespessailles, Rawad El Hage
    Journal of Clinical Densitometry.2021; 24(2): 225.     CrossRef
  • Serum resistin levels as predictor of low bone mineral density in postmenopausal women
    Sundus Tariq, Saba Tariq, Saba Khaliq, Khalid Parvez Lone
    Health Care for Women International.2021; 42(1): 82.     CrossRef
  • Changes in bone mass associated with obesity and weight loss in humans: Applicability of animal models
    Vivi F.H. Jensen, Anne-Marie Mølck, Majken Dalgaard, Fiona E. McGuigan, Kristina E. Akesson
    Bone.2021; 145: 115781.     CrossRef
  • Association of some dietary ingredients, vitamin D, estrogen, and obesity polymorphic receptor genes with bone mineral density in a sample of obese Egyptian women
    Nayera E. Hassan, Salwa M. El Shebini, Sahar A. El-Masry, Nihad H. Ahmed, Ghada Nour Eldeen, Enas A. Rasheed, Manal M. Aly, Khhadija M. Alian, Mahmoud A S. Afify, Aya Khalil
    Journal of Genetic Engineering and Biotechnology.2021;[Epub]     CrossRef
  • The obesity indices mediate the relationships of blood lipids and bone mineral density in Chinese elders
    Bing Ge, Si-Qi Lu, Shu-Feng Lei
    Molecular and Cellular Probes.2021; 56: 101705.     CrossRef
  • Neurogenic Obesity and Skeletal Pathology in Spinal Cord Injury
    David W. McMillan, Mark S. Nash, David R. Gater, Rodrigo J. Valderrábano
    Topics in Spinal Cord Injury Rehabilitation.2021; 27(1): 57.     CrossRef
  • The Influence of Stochastic Resonance Whole-Body Vibration on Women over 50 Years of Age—Preliminary Studies Based on Patients’ Own Experiences
    Magdalena Hartman-Petrycka, Agata Lebiedowska, Anna Stolecka-Warzecha, Andrzej Szumski, Barbara Błońska-Fajfrowska
    Applied Sciences.2021; 11(9): 3980.     CrossRef
  • Growth hormone treatment and bone mineral density in pediatric patients with Prader–Willi syndrome
    Yuji Oto, Nobuyuki Murakami, Takeshi Inoue, Keiko Matsubara, Sohei Saima, Hiroyuki Ogata, Hiroshi Ihara, Toshiro Nagai, Tomoyo Matsubara
    Journal of Pediatric Endocrinology and Metabolism.2021; 34(9): 1181.     CrossRef
  • Bone Mineral Density Changes during Weight Regain following Weight Loss with and without Exercise
    Monica C. Serra, Alice S. Ryan
    Nutrients.2021; 13(8): 2848.     CrossRef
  • Obesity and Bone: A Complex Relationship
    Giuseppe Rinonapoli, Valerio Pace, Carmelinda Ruggiero, Paolo Ceccarini, Michele Bisaccia, Luigi Meccariello, Auro Caraffa
    International Journal of Molecular Sciences.2021; 22(24): 13662.     CrossRef
  • A study on bone mass density using dual energy X-ray absorptiometry: Does high body mass index have protective effect on bone density in obese patients?
    Azin Shayganfar, Shadi Ebrahimian, Mahsa Masjedi, Sadaf Daryaei
    Journal of Research in Medical Sciences.2020; 25(1): 4.     CrossRef
  • Relationship Between Metabolic Syndrome and Bone Fracture Risk in Mid-Aged Korean Women Using FRAX Scoring System
    Hyun Joo Lee, Seo Yoon Hwang, Seung Chul Kim, Jong Kil Joo, Dong Soo Suh, Ki Hyung Kim
    Metabolic Syndrome and Related Disorders.2020; 18(4): 219.     CrossRef
  • The Skeletal Consequences of Bariatric Surgery
    Alexandra N. Krez, Emily M. Stein
    Current Osteoporosis Reports.2020; 18(3): 262.     CrossRef
  • Association of obesity with bone mineral density and osteoporosis in adults: a systematic review and meta-analysis
    D. Qiao, Y. Li, X. Liu, X. Zhang, X. Qian, H. Zhang, G. Zhang, C. Wang
    Public Health.2020; 180: 22.     CrossRef
  • Obesity and leptin influence vitamin D metabolism and action in human marrow stromal cells
    Jing Li, Yuan Gao, Tao Yu, Jeffrey K. Lange, Meryl S. LeBoff, Anna Gorska, Simon Luu, Shuanhu Zhou, Julie Glowacki
    The Journal of Steroid Biochemistry and Molecular Biology.2020; 198: 105564.     CrossRef
  • Gender-specific prevalence and influencing factors of osteopenia and osteoporosis in Chinese rural population: the Henan Rural Cohort Study
    Dou Qiao, Xiaotian Liu, Runqi Tu, Xia Zhang, Xinling Qian, Haiqing Zhang, Jingjing Jiang, zhongyan Tian, Yan Wang, Xiaokang Dong, Zhicheng Luo, Xue Liu, Huiling Tian, Gongyuan Zhang, Jun Pan, Chongjian Wang
    BMJ Open.2020; 10(1): e028593.     CrossRef
  • Association between Visceral Fat and Bone Mineral Density in Both Male and Female Patients with Adult Growth Hormone Deficiency
    Linman Li, Li Zhong, Xiaoya Zheng, Wenyi You, Yunting Wang, Jihui Yu, Xun Wu, Wei Ren, Gangyi Yang
    Biochemistry Research International.2020; 2020: 1.     CrossRef
  • Association between non-Caucasian-specific ASCC1 gene polymorphism and osteoporosis and obesity in Korean postmenopausal women
    Hye-Won Cho, Hyun-Seok Jin, Yong-Bin Eom
    Journal of Bone and Mineral Metabolism.2020; 38(6): 868.     CrossRef
  • BONE MINERAL DENSITY AND TRABECULAR BONE SCORE IN POSTMENOPAUSAL WOMEN WITH KNEE OSTEOARTHRITIS AND OBESITY
    Vladyslav V. Povoroznyuk, Nataliia V. Zaverukha, Anna S. Musiienko
    Wiadomości Lekarskie.2020; 73(3): 529.     CrossRef
  • Obesity in Qatar: A Case-Control Study on the Identification of Associated Risk Factors
    Md. Tawkat Islam Khondaker, Junaed Younus Khan, Mahmoud Ahmed Refaee, Nady El Hajj, M. Sohel Rahman, Tanvir Alam
    Diagnostics.2020; 10(11): 883.     CrossRef
  • Effect of Weight Loss via Severe vs Moderate Energy Restriction on Lean Mass and Body Composition Among Postmenopausal Women With Obesity
    Radhika V. Seimon, Anthony L. Wild-Taylor, Shelley E. Keating, Sally McClintock, Claudia Harper, Alice A. Gibson, Nathan A. Johnson, Hamish A. Fernando, Tania P. Markovic, Jacqueline R. Center, Janet Franklin, Peter Y. Liu, Stuart M. Grieve, Jim Lagopoulo
    JAMA Network Open.2019; 2(10): e1913733.     CrossRef
  • Lipid profiles as potential mediators linking body mass index to osteoporosis among Chinese adults: the Henan Rural Cohort Study
    D. Y. Wu, D. Qiao, X. Zhang, H. Q. Zhang, Z. C. Luo, Y. Wang, J. Pan, C. Wang
    Osteoporosis International.2019; 30(7): 1413.     CrossRef
  • ALVEOLAR BONE PATTERN AND SALIVARY LEPTIN LEVELS AMONG PREMENOPAUSAL OBESE WOMEN
    Silvia Helena de Carvalho SALES-PERES, Francisco Carlos GROPPO, Rafaela Carolina Soares BONATO, Matheus de Carvalho SALES-PERES, Francisco HAITER-NETO, Elinton Adami CHAIM
    ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo).2019;[Epub]     CrossRef
  • Associations of obesity with osteoporosis and metabolic syndrome in Korean postmenopausal women: a cross-sectional study using national survey data
    Hyun-Young Kim, Yunmi Kim
    Archives of Osteoporosis.2019;[Epub]     CrossRef
  • Analysis of bone mass and its relationship with body composition in school-aged children and adolescents based on stage of puberty and site specificity
    Cui Song, Min Zhu, Rongfei Zheng, Yujuan Hu, Rong Li, Gaohui Zhu, Long Chen, Feng Xiong
    Medicine.2019; 98(8): e14005.     CrossRef
  • Influence of increased body mass index on orthodontic tooth movement and related parameters in children and adolescents: A systematic review of longitudinal controlled clinical studies
    Dimitrios Michelogiannakis, P Emile Rossouw, Junad Khan, Zohaib Akram, Evangelos Menenakos, Fawad Javed
    Journal of Orthodontics.2019; 46(4): 323.     CrossRef
  • Metabolic Syndrome in Arab Adults with Low Bone Mineral Density
    Kaiser Wani, Sobhy M. Yakout, Mohammed Ghouse Ahmed Ansari, Shaun Sabico, Syed Danish Hussain, Majed S. Alokail, Eman Sheshah, Naji J. Aljohani, Yousef Al-Saleh, Jean-Yves Reginster, Nasser M. Al-Daghri
    Nutrients.2019; 11(6): 1405.     CrossRef
  • The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts
    Subhashis Pal, Shailendra K. Maurya, Sourav Chattopadhyay, Shyamsundar Pal China, Konica Porwal, Chirag Kulkarni, Sabyasachi Sanyal, Rohit A. Sinha, Naibedya Chattopadhyay
    Biochemical Pharmacology.2019; 164: 34.     CrossRef
  • Lean Body Mass in the Prediction of Bone Mineral Density in Postmenopausal Women
    Bolaji Lilian Ilesanmi-Oyelere, Jane Coad, Nicole Roy, Marlena Cathorina Kruger
    BioResearch Open Access.2018; 7(1): 150.     CrossRef
  • Postmenopausal osteoporosis and breast cancer: The biochemical links and beneficial effects of functional foods
    Aliyu Muhammad, Sanusi Bello Mada, Ibrahim Malami, Gilead E. Forcados, Ochuko L. Erukainure, Hadiza Sani, Ibrahim Babangida Abubakar
    Biomedicine & Pharmacotherapy.2018; 107: 571.     CrossRef
  • Bone mineral density in midlife long-term users of hormonal contraception in South Africa: relationship with obesity and menopausal status
    Mags E. Beksinska, Immo Kleinschmidt, Jenni A. Smit
    Women's Midlife Health.2018;[Epub]     CrossRef
  • Body fat has stronger associations with bone mass density than body mass index in metabolically healthy obesity
    Yuan-Yuei Chen, Wen-Hui Fang, Chung-Ching Wang, Tung-Wei Kao, Yaw-Wen Chang, Chen-Jung Wu, Yi-Chao Zhou, Yu-Shan Sun, Wei-Liang Chen, Manlio Vinciguerra
    PLOS ONE.2018; 13(11): e0206812.     CrossRef
  • Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: A systematic review and meta-analysis
    Julio Ramírez, Juan Carlos Nieto-González, Rafael Curbelo Rodríguez, Santos Castañeda, Loreto Carmona
    Seminars in Arthritis and Rheumatism.2018; 48(1): 44.     CrossRef
  • Prevalence of osteoporosis and osteopenia in an apparently healthy Indian population - a cross-sectional retrospective study
    Neelam Kaushal, Divya Vohora, Rajinder K. Jalali, Sujeet Jha
    Osteoporosis and Sarcopenia.2018; 4(2): 53.     CrossRef
  • Metabolically healthy/unhealthy components may modify bone mineral density in obese people
    Atieh Mirzababaei, Khadijeh Mirzaei, Leila Khorrami-nezhad, Zhila Maghbooli, Seyed Ali Keshavarz
    Archives of Osteoporosis.2017;[Epub]     CrossRef
  • Obesity and orthodontic treatment: is there any direct relationship?
    Alberto Consolaro
    Dental Press Journal of Orthodontics.2017; 22(3): 21.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Impact of Obesity on Orthodontic Tooth Movement in Adolescents: A Prospective Clinical Cohort Study
    H.F. Saloom, S.N. Papageorgiou, G.H. Carpenter, M.T. Cobourne
    Journal of Dental Research.2017; 96(5): 547.     CrossRef
Close layer
Review Articles
Adrenal gland
Diagnosis and Treatment of Hypopituitarism
Seong Yeon Kim
Endocrinol Metab. 2015;30(4):443-455.   Published online December 31, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.4.443
  • 12,691 View
  • 373 Download
  • 48 Web of Science
  • 58 Crossref
AbstractAbstract PDFPubReader   

Hypopituitarism is a chronic endocrine illness that caused by varied etiologies. Clinical manifestations of hypopituitarism are variable, often insidious in onset and dependent on the degree and severity of hormone deficiency. However, it is associated with increased mortality and morbidity. Therefore, early diagnosis and prompt treatment is necessary. Hypopituitarism can be easily diagnosed by measuring basal pituitary and target hormone levels except growth hormone (GH) and adrenocorticotropic hormone (ACTH) deficiency. Dynamic stimulation tests are indicated in equivocal basal hormone levels and GH/ACTH deficiency. Knowledge of the use and limitations of these stimulation tests is mandatory for proper interpretation. It is necessary for physicians to inform their patients that they may require lifetime treatment. Hormone replacement therapy should be individualized according to the specific needs of each patient, taking into account possible interactions. Long-term endocrinological follow-up of hypopituitary patients is important to monitor hormonal replacement regimes and avoid under- or overtreatment.

Citations

Citations to this article as recorded by  
  • Pituitary stem cells: past, present and future perspectives
    María Inés Pérez Millán, Leonard Y. M. Cheung, Florencia Mercogliano, Maria Andrea Camilletti, Gonzalo T. Chirino Felker, Lucia N. Moro, Santiago Miriuka, Michelle L. Brinkmeier, Sally A. Camper
    Nature Reviews Endocrinology.2024; 20(2): 77.     CrossRef
  • Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease
    E. Van Mieghem, C. De Block, C. De Herdt
    Pituitary.2024; 27(1): 23.     CrossRef
  • A comprehensive review of the new FIGO classification of ovulatory disorders
    Adam H Balen, Jennifer Tamblyn, Karolina Skorupskaite, Malcolm G Munro
    Human Reproduction Update.2024;[Epub]     CrossRef
  • Decreased mannan-binding lectin level in adults with hypopituitarism; dependence on appropriate hormone replacement therapies
    Aleksandra E. Matusiak, Jan Stępniak, Andrzej Lewiński, Małgorzata Karbownik-Lewińska
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Post-Operative Medium- and Long-Term Endocrine Outcomes in Patients with Non-Functioning Pituitary Adenomas—Machine Learning Analysis
    Ziad Hussein, Robert W. Slack, Hani J. Marcus, Evangelos B. Mazomenos, Stephanie E. Baldeweg
    Cancers.2023; 15(10): 2771.     CrossRef
  • Central Endocrine Complications Among Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review
    Greg Wheeler, Clemens Grassberger, Josephine Samers, Mary Dwyer, Kirsty Wiltshire, Patricia Daly, Beatriz Alvarez, Belinda A. Campbell, Amanda J. Kerr, Tomas Kron, Frances K. Duane, Margaret Zacharin, Peter Downie, Elizabeth Kyriakou, Cecile M. Ronckers,
    International Journal of Radiation Oncology*Biology*Physics.2023;[Epub]     CrossRef
  • The TRH test provides valuable information in the diagnosis of central hypothyroidism in patients with known pituitary disease and low T4 levels
    Sara Ellegaard Christensen, Liv Norma Smith, Christian Alexander H. Rosendal, Helga Angela Gulisano, Kåre Schmidt Ettrup, Peter Vestergaard, Eigil Husted Nielsen, Jesper Scott Karmisholt, Jakob Dal
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Sheehan’s syndrome unveiled after decades without a diagnosis: A case report
    Hadi Rabee’, Tamara Braik, Rezeq Alnatour, Alaa Shamlawi, Ammar Rashed
    SAGE Open Medical Case Reports.2023;[Epub]     CrossRef
  • PAN-HIPOPITUITARISMO SECUNDÁRIO A INFECÇÃO POR SARS-COV-2: RELATO DE CASO
    Rosyane Luz Rufino De Lima, Viviane dos Reis Vieira Yance
    REVISTA FOCO.2023; 16(12): e3832.     CrossRef
  • Perioperative growth hormone levels as an early predictor of new-onset secondary adrenal insufficiency following transsphenoidal pituitary tumor resection
    Fon-Yih Tsuang, Shyang-Rong Shih, Ham-Min Tseng, Huan-Chih Wang
    Asian Journal of Surgery.2023;[Epub]     CrossRef
  • Navigating the “specific etiology” steatohepatitis category: Evaluation and management of nonalcoholic/nonmetabolic dysfunction–associated steatohepatitis
    Mohammad Qasim Khan, Sara Hassan, Blanca C. Lizaola-Mayo, Mamatha Bhat, Kymberly D. Watt
    Hepatology.2023;[Epub]     CrossRef
  • Regulation of the Hypothalamic-Pituitary-Testicular Axis: Pathophysiology of Hypogonadism
    Aditi Sharma, Channa N. Jayasena, Waljit S. Dhillo
    Endocrinology and Metabolism Clinics of North America.2022; 51(1): 29.     CrossRef
  • Penetrating brain injury with hypopituitarism
    Rachel D. Appelbaum, Kristina E. Neri, Kristin A. Rebo, Samuel P. Carmichael
    Trauma Case Reports.2022; 38: 100628.     CrossRef
  • Risk of Mental Illnesses in Patients With Hypopituitarism: A Nationwide Population-Based Cohort Study
    I-Hua Wei, Chih-Chia Huang
    Psychiatry Investigation.2022; 19(6): 418.     CrossRef
  • Pituitary Apoplexy and Subdural Hematoma after Caesarean Section
    Van Trung Hoang, The Huan Hoang, Thanh Tam Thi Nguyen, Vichit Chansomphou, Duc Thanh Hoang, Kyousuke Takeuchi
    Case Reports in Obstetrics and Gynecology.2022; 2022: 1.     CrossRef
  • A Unique Case Mimicking Sepsis
    Vivek Dave, Anish Joshi
    Journal of Acute Care.2022; 1(1): 29.     CrossRef
  • Correlation between shift work and non-alcoholic fatty liver disease among male workers in the steel manufacturing company of Korea: a cross-sectional study
    Kiseok Kim, Yong-Jin Lee, Soon-Chan Kwon, Young-Sun Min, Hyun Kyo Lee, Gwangin Baek, Sang Hyeon Kim, Eun-Chul Jang
    Annals of Occupational and Environmental Medicine.2022;[Epub]     CrossRef
  • Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones
    Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Helda Tutunchi
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Primary hypothyroidism and postmenopause as the causes of delayed diagnosis of panhypopituitarism in a patient with nonfunctional pituitary adenoma
    E. G. Ryzhkova, D. O. Ladygina
    Problems of Endocrinology.2022; 68(5): 32.     CrossRef
  • Efficacy and Safety of Stereotactic Radiotherapy in Cushing’s Disease: A Single Center Experience
    Tugce Apaydin, Hande Mefkure Ozkaya, Sebnem Memis Durmaz, Rasim Meral, Pinar Kadioglu
    Experimental and Clinical Endocrinology & Diabetes.2021; 129(07): 482.     CrossRef
  • Metabolic and Endocrine Challenges
    Gennaro Martucci, Eleonora Bonicolini, Dhruv Parekh, Onn Shaun Thein, Mario Scherkl, Karin Amrein
    Seminars in Respiratory and Critical Care Medicine.2021; 42(01): 078.     CrossRef
  • The Effect of Pituitary Gland Disorders on Glucose Metabolism: From Pathophysiology to Management
    Guy I. Sydney, Konstantinos Michalakis, Ilias P. Nikas, Eleftherios Spartalis, Stavroula A. Paschou
    Hormone and Metabolic Research.2021; 53(01): 16.     CrossRef
  • Congenital hypopituitarism in two brothers with a duplication of the ‘acrogigantism gene’ GPR101: clinical findings and review of the literature
    Melitza S. M. Elizabeth, Annemieke J. M. H. Verkerk, Anita C. S. Hokken-Koelega, Joost A. M. Verlouw, Jesús Argente, Roland Pfaeffle, Sebastian J. C. M. M. Neggers, Jenny A. Visser, Laura C. G. de Graaff
    Pituitary.2021; 24(2): 229.     CrossRef
  • Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications
    Ana-Maria Singeap, Carol Stanciu, Laura Huiban, Cristina Maria Muzica, Tudor Cuciureanu, Irina Girleanu, Stefan Chiriac, Sebastian Zenovia, Robert Nastasa, Catalin Sfarti, Camelia Cojocariu, Anca Trifan, Branka Filipović
    Canadian Journal of Gastroenterology and Hepatology.2021; 2021: 1.     CrossRef
  • The evaluation of pituitary damage associated with cardiac arrest: An experimental rodent model
    Yu Okuma, Tomoaki Aoki, Santiago J. Miyara, Kei Hayashida, Mitsuaki Nishikimi, Ryosuke Takegawa, Tai Yin, Junhwan Kim, Lance B. Becker, Koichiro Shinozaki
    Scientific Reports.2021;[Epub]     CrossRef
  • Functional Restoration of Pituitary after Pituitary Allotransplantation into Hypophysectomized Rats
    Jai Ho Choi, Jung Eun Lee, Hong-Lim Kim, Seung Hyun Ko, Se Hoon Kim, Seung Ho Yang
    Cells.2021; 10(2): 267.     CrossRef
  • Experience of a Pituitary Clinic for US Military Veterans With Traumatic Brain Injury
    Jonathan Lee, Lindsey J Anderson, Dorota Migula, Kevin C J Yuen, Lisa McPeak, Jose M Garcia
    Journal of the Endocrine Society.2021;[Epub]     CrossRef
  • Biogenic zinc-oxide nanoparticles of Moringa oleifera leaves abrogates rotenone induced neuroendocrine toxicity by regulation of oxidative stress and acetylcholinesterase activity
    J.K. Akintunde, T.I. Farai, M.R. Arogundade, J.T. Adeleke
    Biochemistry and Biophysics Reports.2021; 26: 100999.     CrossRef
  • Heart Rate Variability in Postoperative Patients with Nonfunctioning Pituitary Adenoma
    Jeonghoon Ha, Hansang Baek, Chaiho Jeong, Minsoo Yeo, Seung-Hwan Lee, Jae Hyoung Cho, Ki-Hyun Baek, Moo Il Kang, Dong-Jun Lim
    Endocrinology and Metabolism.2021; 36(3): 678.     CrossRef
  • Aetiologies and clinical patterns of hypopituitarism in Sudanese children
    Samar Hassan, Renson Mukhwana, Salwa Musa, Areej Ibrahim, Omer Babiker, Mohamed Abdullah
    Sudanese Journal of Paediatrics.2021; : 53.     CrossRef
  • Recent advances in proteomics and its implications in pituitary endocrine disorders
    Arghya Banerjee, Atul Goel, Abhidha Shah, Sanjeeva Srivastava
    Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.2021; 1869(11): 140700.     CrossRef
  • Morning Serum Cortisol as a Predictor for the HPA Axis Recovery in Cushing’s Disease
    Q. Cui, D. Liu, B. Xiang, Q. Sun, L. Fan, M. He, Y. Wang, X. Zhu, H. Ye, Giorgio Borretta
    International Journal of Endocrinology.2021; 2021: 1.     CrossRef
  • Three different faces of TACI mutations
    Sukru Cekic, Fatih Cicek, Yasin Karali, Orhan Gorukmez, Erdal Eren, Sara Sebnem Kilic
    Scandinavian Journal of Immunology.2020;[Epub]     CrossRef
  • Treatment of a Woman with Inoperable Meningioma Using Mifepristone for 26 Years
    Maria das Dores Medina-Lopes, Luiz Augusto Casulari
    Case Reports in Neurological Medicine.2020; 2020: 1.     CrossRef
  • Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology
    Jung Hee Kim, Hyun Wook Chae, Sang Ouk Chin, Cheol Ryong Ku, Kyeong Hye Park, Dong Jun Lim, Kwang Joon Kim, Jung Soo Lim, Gyuri Kim, Yun Mi Choi, Seong Hee Ahn, Min Ji Jeon, Yul Hwangbo, Ju Hee Lee, Bu Kyung Kim, Yong Jun Choi, Kyung Ae Lee, Seong-Su Moon
    Endocrinology and Metabolism.2020; 35(2): 272.     CrossRef
  • Phenytoin- Medication That Warrants Deviation From Standard Approach for Thyroid Lab Interpretation
    Vishwanath Pattan, Narsimha Candula, Ramesh Adhikari, Rahul Kashyap
    Cureus.2020;[Epub]     CrossRef
  • Pituitary Disorders in Pregnancy
    Whitney W. Woodmansee
    Neurologic Clinics.2019; 37(1): 63.     CrossRef
  • A clinical case of partial hypopituitarism
    T. E. Pomytkina
    Fundamental and Clinical Medicine.2019; 4(3): 122.     CrossRef
  • Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Is Highly Expressed in Mouse Tissues With Metabolic Function
    Tatiana Danilova, Emilia Galli, Emmi Pakarinen, Erik Palm, Päivi Lindholm, Mart Saarma, Maria Lindahl
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Functional survival of rat pituitary gland in hypothermic storage for pituitary transplantation
    Jai Ho Choi, Jung Eun Lee, Se Hoon Kim, Hong-Lim Kim, Sin Soo Jeun, Seung Ho Yang
    Pituitary.2019; 22(4): 353.     CrossRef
  • Fertility after transsphenoidal surgery in patients with prolactinomas: A meta-analysis
    Nayan Lamba, Nadia Noormohamed, Thomas Simjian, Mona Y. Alsheikh, Alykhan Jamal, Joanne Doucette, Hasan Zaidi, Timothy R. Smith, Rania A. Mekary
    Clinical Neurology and Neurosurgery.2019; 176: 53.     CrossRef
  • Traumatic brain injury and hypopituitarism
    Sarah Leeder
    Advances in Clinical Neuroscience & Rehabilitation.2019;[Epub]     CrossRef
  • Long-acting FC-fusion rhGH (GX-H9) shows potential for up to twice-monthly administration in GH-deficient adults
    Cheol Ryong Ku, Thierry Brue, Katharina Schilbach, Stanislav Ignatenko, Sandor Magony, Yoon-Sok Chung, Byung-Joon Kim, Kyu Yeon Hur, Ho-Cheol Kang, Jung Hee Kim, Min Seon Kim, Aldona Kowalska, Marek Bolanowski, Marek Ruchala, Svetozar Damjanovic, Juraj Pa
    European Journal of Endocrinology.2018; 179(3): 169.     CrossRef
  • Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases
    Maria de Fátima de Magalhães Gonzaga, Lucas Faria de Castro, Luciana Ansaneli Naves, José Luiz Mendonça, Benicio Oton de Lima, Iruena Kessler, Luiz Augusto Casulari
    Frontiers in Endocrinology.2018;[Epub]     CrossRef
  • Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection
    Eugenie A Hsu, Jennifer L Miller, Francisco A Perez, Christian L Roth
    The Journal of Clinical Endocrinology & Metabolism.2018; 103(2): 370.     CrossRef
  • Spectrum of Sellar and Parasellar Region Lesions: A retrospective study from Basrah, Iraq
    Abbas Ali Mansour, Ali Hussain Ali Alhamza, Ammar Mohammed Saeed Abdullah Almomin, Ibrahim Abbood Zaboon, Nassar Taha Yaseen Alibrahim, Rudha Naser Hussein, Muayad Baheer Kadhim, Haider Ayad Yassin Alidrisi, Hussein Ali Nwayyir, Adel Gassab Mohammed, Dhey
    F1000Research.2018; 7: 430.     CrossRef
  • Delayed Complications After Transsphenoidal Surgery for Pituitary Adenomas
    Gmaan Alzhrani, Walavan Sivakumar, Min S. Park, Philipp Taussky, William T. Couldwell
    World Neurosurgery.2018; 109: 233.     CrossRef
  • Hypopituitarism: Case Study Involving Hypernatremia Prompting Discovery of a Pituitary Disorder in a Patient With Lymphoma
    Jace Johnny
    Clinical Journal of Oncology Nursing.2018; 22(4): E115.     CrossRef
  • Reflex and reflective testing strategies for early detection of pituitary dysfunction
    Manal Elnenaei, Derek Minney, David B. Clarke, Andrew Kumar-Misir, Syed Ali Imran
    Clinical Biochemistry.2018; 54: 78.     CrossRef
  • Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas
    Daham Kim, Cheol Ryong Ku, Se Hee Park, Ju Hyung Moon, Eui Hyun Kim, Sun Ho Kim, Eun Jig Lee
    World Neurosurgery.2018; 115: e464.     CrossRef
  • The Incidence of Anterior Pituitary Hormone Deficiencies in Patients with Pituitary Microadenoma and Idiopathic Hyperprolactinaemia. A Retrospective Single Centre Study

    Journal of Clinical Review & Case Reports.2018;[Epub]     CrossRef
  • Spectrum of Pituitary disorders: A retrospective study from Basrah, Iraq
    Abbas Ali Mansour, Ali Hussain Ali Alhamza, Ammar Mohammed Saeed Abdullah Almomin, Ibrahim Abbood Zaboon, Nassar Taha Yaseen Alibrahim, Rudha Naser Hussein, Muayad Baheer Kadhim, Haider Ayad Yassin Alidrisi, Hussein Ali Nwayyir, Adel Gassab Mohammed, Dhey
    F1000Research.2018; 7: 430.     CrossRef
  • Growth Hormone & Hypopituitarism
    Lahiry  Sandeep
    Journal of Analytical & Pharmaceutical Research.2017;[Epub]     CrossRef
  • Using the Complexity of Hypopituitarism Aetiology to Understand and Teach Hormone Function in Endocrinology
    Ayisha Qureshi
    MOJ Anatomy & Physiology.2017;[Epub]     CrossRef
  • Delayed diagnosis of pituitary stalk interruption syndrome with severe recurrent hyponatremia caused by adrenal insufficiency
    Kyung Mi Jang, Cheol Woo Ko
    Annals of Pediatric Endocrinology & Metabolism.2017; 22(3): 208.     CrossRef
  • Indicaciones e interpretación diagnóstica de las pruebas funcionales hipofisarias
    C. Tasende Fernández, M.J. Rodríguez Troyano, D.S. Trifu, P. Gómez Montes
    Medicine - Programa de Formación Médica Continuada Acreditado.2016; 12(15): 865.     CrossRef
  • Hypopituitarism in the elderly: a narrative review on clinical management of hypothalamic–pituitary–gonadal, hypothalamic–pituitary–thyroid and hypothalamic–pituitary–adrenal axes dysfunction
    L. Curtò, F. Trimarchi
    Journal of Endocrinological Investigation.2016; 39(10): 1115.     CrossRef
  • Hipopituitarismo. Panhipopituitarismo
    N. Peláez Torres, D.S. Trifu, M.P Gómez Montes, E. Atienza Sánchez
    Medicine - Programa de Formación Médica Continuada Acreditado.2016; 12(15): 857.     CrossRef
Close layer
Diabetes
A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans
Jack Alistair Sargeant, Joseph Henson, James Adam King, Thomas Yates, Kamlesh Khunti, Melanie Jane Davies
Endocrinol Metab. 2019;34(3):247-262.   Published online September 26, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.3.247
  • 10,583 View
  • 398 Download
  • 52 Web of Science
  • 58 Crossref
AbstractAbstract PDFPubReader   ePub   

Weight loss is an important goal in the management of several chronic conditions, including type 2 diabetes mellitus, and pharmacological therapies that aid weight loss are appealing. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) are novel glucose-lowering therapies that have been shown to induce clinically significant reductions in body weight. However, this weight loss may not be attributed solely to fat mass (FM). Given the importance of skeletal muscle and lean body mass (LBM) on cardio-metabolic health and physical function, we reviewed the available literature reporting the effects of GLP-1RAs and SGLT2is on body composition. Results demonstrate that, in most circumstances, the weight loss associated with both therapies predominantly comprises a reduction in FM, although significant heterogeneity exists between studies. In over half of the studies identified, the proportion of LBM reduction ranged between 20% and 50% of total weight lost, which is consistent with diet-induced weight loss and bariatric surgery. No clear differences existed between GLP-1RAs and SGLT2is. Consequently, the loss of LBM and skeletal muscle associated with weight loss induced by GLP-1RAs and SGLT2is warrants attention. Strategies to preserve skeletal muscle and improve physical function, for example through structured exercise, are of great importance.

Citations

Citations to this article as recorded by  
  • Drug‐related sarcopenia as a secondary sarcopenia
    Masafumi Kuzuya
    Geriatrics & Gerontology International.2024; 24(2): 195.     CrossRef
  • Exercise induces tissue-specific adaptations to enhance cardiometabolic health
    Stephen P. Ashcroft, Ben Stocks, Brendan Egan, Juleen R. Zierath
    Cell Metabolism.2024; 36(2): 278.     CrossRef
  • Once-weekly semaglutide administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes
    Rieko Kanai, Sachiho Kinoshita, Izumi Kanbe, Mariko Sameda, Shuhei Yamaoka, Osamu Horikawa, Yasuhiro Watanabe, Ichiro Tatsuno, Kohji Shirai, Takashi Oshiro, Atsuhito Saiki
    Obesity Pillars.2024; 9: 100098.     CrossRef
  • Twenty‐four‐hour physical behaviour profiles across type 2 diabetes mellitus subtypes
    Joseph Henson, Aikaterina Tziannou, Alex V. Rowlands, Charlotte L. Edwardson, Andrew P. Hall, Melanie J. Davies, Thomas Yates
    Diabetes, Obesity and Metabolism.2024; 26(4): 1355.     CrossRef
  • The Current Landscape of Pharmacotherapies for Sarcopenia
    Gulistan Bahat, Serdar Ozkok
    Drugs & Aging.2024; 41(2): 83.     CrossRef
  • Malnutrition and Sarcopenia as Reasons for Caution with GLP-1 Receptor Agonist Use in HFpEF
    ELISSA DRIGGIN, PARAG GOYAL
    Journal of Cardiac Failure.2024;[Epub]     CrossRef
  • Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?
    Daniel Lee, Jacqueline Capeau
    AIDS.2024; 38(4): 603.     CrossRef
  • Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
    Xin‐Hui Pan, Bryan Tan, Yip Han Chin, Ethan Cheng Zhe Lee, Gwyneth Kong, Bryan Chong, Martin Kueh, Chin Meng Khoo, Anurag Mehta, Priyanka Majety, Gowtham R. Grandhi, Georgios K. Dimitriadis, Roger Foo, Nicholas W. S. Chew, Carel W. Le Roux, Mamas A. Mamas
    Obesity.2024;[Epub]     CrossRef
  • Malnutrition in real-world patients hospitalized for heart failure with preserved ejection fraction and its potential impact on generalizability of EMPEROR-Preserved trial
    Shinsuke Takeuchi, Takashi Kohno, Ayumi Goda, Yasuyuki Shiraishi, Mike Saji, Yuji Nagatomo, Toshikazu D. Tanaka, Makoto Takei, Shintaro Nakano, Kyoko Soejima, Shun Kohsaka, Tsutomu Yoshikawa
    International Journal of Cardiology.2023; 370: 263.     CrossRef
  • Marked weight loss on liraglutide 3.0 mg: Real‐life experience of a Swiss cohort with obesity
    Sara Santini, Nathalie Vionnet, Jérôme Pasquier, Elena Gonzalez‐Rodriguez, Montserrat Fraga, Nelly Pitteloud, Lucie Favre
    Obesity.2023; 31(1): 74.     CrossRef
  • Early type 2 diabetes treatment intensification with glucagon‐like peptide‐1 receptor agonists in primary care: An Australian perspective on guidelines and the global evidence
    Roy Rasalam, Sarah Abdo, Gary Deed, Richard O'Brien, Jane Overland
    Diabetes, Obesity and Metabolism.2023; 25(4): 901.     CrossRef
  • The effects of weight‐lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta‐analysis of randomized controlled trials
    Rishi Jobanputra, Jack A. Sargeant, Abdullah Almaqhawi, Ehtasham Ahmad, Franciskos Arsenyadis, David R. Webb, Louisa Y. Herring, Kamlesh Khunti, Melanie J. Davies, Thomas Yates
    Obesity Reviews.2023;[Epub]     CrossRef
  • Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial
    Rasmus M. Sandsdal, Christian R. Juhl, Simon B. K. Jensen, Julie R. Lundgren, Charlotte Janus, Martin B. Blond, Mads Rosenkilde, Adrian F. Bogh, Lasse Gliemann, Jens-Erik B. Jensen, Charalambos Antoniades, Bente M. Stallknecht, Jens J. Holst, Sten Madsbad
    Cardiovascular Diabetology.2023;[Epub]     CrossRef
  • Impact of novel glucose‐lowering therapies on physical function in people with type 2 diabetes: A systematic review and meta‐analysis of randomised placebo‐controlled trials
    Ehtasham Ahmad, Franciskos Arsenyadis, Abdullah Almaqhawi, Mary Barker, Rishi Jobanputra, Jack A. Sargeant, David R. Webb, Thomas Yates, Melanie J. Davies
    Diabetic Medicine.2023;[Epub]     CrossRef
  • Cancer cachexia as a blueprint for treating obesity
    Nikolai P. Jaschke, Tilman D. Rachner
    Trends in Endocrinology & Metabolism.2023; 34(7): 395.     CrossRef
  • The sun is rising on a new era of pharmacotherapy for obesity: some words of caution
    Peter N. Benotti, Bruce R. Bistrian
    Surgery for Obesity and Related Diseases.2023; 19(9): 1075.     CrossRef
  • Liraglutide Protects Against Diastolic Dysfunction and Improves Ventricular Protein Translation
    Cody Rutledge, Angela Enriquez, Kevin Redding, Mabel Lopez, Steven Mullett, Stacy L. Gelhaus, Michael Jurczak, Eric Goetzman, Brett A. Kaufman
    Cardiovascular Drugs and Therapy.2023;[Epub]     CrossRef
  • Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Sha Zhang, Zhan Qi, Yidong Wang, Danfei Song, Deqiu Zhu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Cysteine‐lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose‐finding study
    Kathrine J. Vinknes, Thomas Olsen, Hasse Khiabani Zaré, Nasser E. Bastani, Emma Stolt, Anja F. Dahl, Roger D. Cox, Helga Refsum, Kjetil Retterstøl, Anders Åsberg, Amany Elshorbagy
    Diabetes, Obesity and Metabolism.2023; 25(11): 3161.     CrossRef
  • Repurposing Drugs for Diabetes Mellitus as Potential Pharmacological Treatments for Sarcopenia – A Narrative Review
    Miles D. Witham, Antoneta Granic, Ewan Pearson, Sian M. Robinson, Avan A. Sayer
    Drugs & Aging.2023; 40(8): 703.     CrossRef
  • Introduction to the dietary management of obesity in adults
    Vivian Lee
    Clinical Medicine.2023; 23(4): 304.     CrossRef
  • Efficacy and safety of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, 52‐week clinical trial (EMPA‐ELDERLY)
    Daisuke Yabe, Kosuke Shiki, Gosuke Homma, Thomas Meinicke, Yuji Ogura, Yutaka Seino
    Diabetes, Obesity and Metabolism.2023; 25(12): 3538.     CrossRef
  • Independent Link Between Use of Mineralocorticoid Receptor Antagonists and Muscle Wasting in Heart Failure Patients Not Receiving Renin-Angiotensin System Inhibitors
    Ryo Numazawa, Satoshi Katano, Toshiyuki Yano, Ryohei Nagaoka, Katsuhiko Ohori, Hidemichi Kouzu, Suguru Honma, Yusuke Fujisawa, Kotaro Yamano, Arata Osanami, Masayuki Koyama, Akiyoshi Hashimoto, Masato Furuhashi
    Circulation Journal.2023; 88(1): 10.     CrossRef
  • Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved
    Baris Afsar, Rengin Elsurer Afsar
    Clinical Nutrition.2023; 42(12): 2338.     CrossRef
  • Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study
    Sara Volpe, Giuseppe Lisco, Margherita Fanelli, Davide Racaniello, Valentina Colaianni, Valentina Lavarra, Domenico Triggiani, Lucilla Crudele, Vincenzo Triggiani, Carlo Sabbà, Giovanni De Pergola, Giuseppina Piazzolla
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative Review
    Soodeh Jahangiri, Mojtaba Malek, Sanjay Kalra, Mohammad E. Khamseh
    Diabetes Therapy.2023; 14(12): 2015.     CrossRef
  • Relationship between sodium–glucose cotransporter-2 inhibitors and muscle atrophy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Chengdong Xia, Yufeng Han, Chunhui Yin, Ruyue Geng, Zhenfei Liu, Yongle Du, Mingkun Yu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities
    Thomas A. Wadden, Ariana M. Chao, Molly Moore, Jena S. Tronieri, Adam Gilden, Anastassia Amaro, Sharon Leonard, John M. Jakicic
    Current Obesity Reports.2023; 12(4): 453.     CrossRef
  • Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age
    Giuseppe Lisco, Olga Eugenia Disoteo, Anna De Tullio, Vincenzo De Geronimo, Vito Angelo Giagulli, Fabio Monzani, Emilio Jirillo, Renato Cozzi, Edoardo Guastamacchia, Giovanni De Pergola, Vincenzo Triggiani
    Nutrients.2023; 16(1): 63.     CrossRef
  • Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis
    Sabine Kahl, Jennifer Pützer, Michael Roden
    Seminars in Liver Disease.2022; 42(01): 048.     CrossRef
  • Effect of Empagliflozin Versus Placebo on Body Fluid Balance in Patients With Acute Myocardial Infarction and Type 2 Diabetes Mellitus: Subgroup Analysis of the EMBODY Trial
    Yu Hoshika, Yoshiaki Kubota, Kosuke Mozawa, Shuhei Tara, Yukichi Tokita, Kenji Yodogawa, Yu-Ki Iwasaki, Takeshi Yamamoto, Hitoshi Takano, Yayoi Tsukada, Kuniya Asai, Masaaki Miyamoto, Yasushi Miyauchi, Eitaro Kodani, Mitsunori Maruyama, Jun Tanabe, Wataru
    Journal of Cardiac Failure.2022; 28(1): 56.     CrossRef
  • Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats
    Shohei Yamada, Yuji Ogura, Kazuho Inoue, Jun Tanabe, Takeshi Sugaya, Keiichi Ohata, Yoshio Nagai, Yasunori Natsuki, Seiko Hoshino, Shiika Watanabe, Daisuke Ichikawa, Kenjiro Kimura, Yugo Shibagaki, Atsuko Kamijo-Ikemori
    Molecular and Cellular Endocrinology.2022; 539: 111472.     CrossRef
  • Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway
    Olfa Khalifa, Neyla S. AL-Akl, Khaoula Errafii, Abdelilah Arredouani
    Scientific Reports.2022;[Epub]     CrossRef
  • Body composition changes at 12 months following different surgical weight loss interventions in adults with obesity: A systematic review and meta‐analysis of randomized control trials
    Amy Sylivris, Jakub Mesinovic, David Scott, Paul Jansons
    Obesity Reviews.2022;[Epub]     CrossRef
  • Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance study
    Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima, Hristo Lliev, Atsutaka Yasui
    Expert Opinion on Drug Safety.2022; 21(10): 1315.     CrossRef
  • Safety and effectiveness of empagliflozin according to body mass index in Japanese patients with type 2 diabetes: a subgroup analysis of a 3-year post-marketing surveillance study
    Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima, Seiko Mizuno, Daisuke Nitta
    Expert Opinion on Drug Safety.2022; 21(11): 1411.     CrossRef
  • Le risque de dénutrition chez le sujet âgé diabétique : une limite à l’utilisation des « nouvelles » classes thérapeutiques ?
    Lyse Bordier, Jean Doucet, Bernard Bauduceau
    Médecine des Maladies Métaboliques.2022; 16(5): 422.     CrossRef
  • Emerging evidence of the relationship between fat-free mass and ghrelin, glucagon-like peptide-1, and peptide-YY
    Austin J. Graybeal, Jada L. Willis, Elisa Morales-Marroquin, Grant M. Tinsley, Sarah E. Messiah, Meena Shah
    Nutrition.2022; 103-104: 111815.     CrossRef
  • The Effectiveness of GLP-1 Receptor Agonist Semaglutide on Body Composition in Elderly Obese Diabetic Patients: A Pilot Study
    Yoshinori Ozeki, Takayuki Masaki, Akari Kamata, Shotaro Miyamoto, Yuichi Yoshida, Mitsuhiro Okamoto, Koro Gotoh, Hirotaka Shibata
    Medicines.2022; 9(9): 47.     CrossRef
  • Distribution of lean mass and mortality risk in patients with type 2 diabetes
    Li Ding, Yuxin Fan, Jingting Qiao, Jing He, Ruodan Wang, Qing He, Jingqiu Cui, Zhongshu Ma, Fangqiu Zheng, Hua Gao, Chenlin Dai, Hongyan Wei, Jun Li, Yuming Cao, Gang Hu, Ming Liu
    Primary Care Diabetes.2022; 16(6): 824.     CrossRef
  • Cardio-sarcopenia: A syndrome of concern in aging
    De Rong Loh, Ru-San Tan, Wee Shiong Lim, Angela S. Koh
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Type 2 diabetes
    Ehtasham Ahmad, Soo Lim, Roberta Lamptey, David R Webb, Melanie J Davies
    The Lancet.2022; 400(10365): 1803.     CrossRef
  • Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors
    Satoshi Katano, Toshiyuki Yano, Hidemichi Kouzu, Ryohei Nagaoka, Ryo Numazawa, Kotaro Yamano, Yusuke Fujisawa, Katsuhiko Ohori, Nobutaka Nagano, Takefumi Fujito, Ryo Nishikawa, Wataru Ohwada, Masaki Katayose, Tatsuya Sato, Atsushi Kuno, Masato Furuhashi
    Cardiovascular Diabetology.2022;[Epub]     CrossRef
  • An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia
    Guilherme Wesley Peixoto Da Fonseca, Stephan von Haehling
    Expert Opinion on Pharmacotherapy.2021; 22(7): 889.     CrossRef
  • Liraglutide Does Not Adversely Impact Fat‐Free Mass Loss
    Andrew Grannell, William P. Martin, Babak Dehestani, Werd Al‐Najim, John C. Murphy, Carel W. le Roux
    Obesity.2021; 29(3): 529.     CrossRef
  • Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium–glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabet
    Daisuke Yabe, Kosuke Shiki, Keiko Suzaki, Thomas Meinicke, Yutaro Kotobuki, Kenichiro Nishida, Douglas Clark, Atsutaka Yasui, Yutaka Seino
    BMJ Open.2021; 11(4): e045844.     CrossRef
  • Cancer Risk in Normal Weight Individuals with Metabolic Obesity: A Narrative Review
    Bethina Liu, Hugh E. Giffney, Rhonda S. Arthur, Thomas E. Rohan, Andrew J. Dannenberg
    Cancer Prevention Research.2021; 14(5): 509.     CrossRef
  • Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
    Khaoula Errafii, Neyla S. Al-Akl, Olfa Khalifa, Abdelilah Arredouani
    Journal of Translational Medicine.2021;[Epub]     CrossRef
  • Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus
    Vaneza Lira W. Wolf, Ikaro Breder, Luiz Sérgio F. de Carvalho, Alexandre A. S. Soares, Riobaldo M. Cintra, Joaquim Barreto, Daniel B. Munhoz, Sheila T. Kimura-Medorima, Wilson Nadruz, Gil Guerra-Júnior, Thiago Quinaglia, Elza Muscelli, Andrei C. Sposito
    Nutrition & Diabetes.2021;[Epub]     CrossRef
  • Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors
    Marc Evans, Angharad R. Morgan, Zaheer Yousef, Gethin Ellis, Umesh Dashora, Dipesh C. Patel, Pam Brown, Wasim Hanif, Johnathan N. Townend, Naresh Kanumilli, Jim Moore, John P. H. Wilding, Stephen C. Bain
    Drugs.2021; 81(11): 1243.     CrossRef
  • Glucose-lowering Drugs and Hospitalization for Heart Failure: A Systematic Review and Additive-effects Network Meta-analysis With More Than 500 000 Patient-years
    Riobaldo M Cintra, Ana Claudia Nogueira, Isabella Bonilha, Beatriz M Luchiari, Otavio R Coelho-Filho, Otavio R Coelho, Pedro Schwartzmann, Elza Muscellie, Wilson Nadruz, Luiz Sergio F Carvalho, Andrei C Sposito
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(10): 3060.     CrossRef
  • Physical activity and exercise in the management of type 2 diabetes: where to start?
    Deirdre Harrington, Joe Henson
    Practical Diabetes.2021; 38(5): 35.     CrossRef
  • Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes

    New England Journal of Medicine.2021; 385(22): 2105.     CrossRef
  • Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus
    Satoshi Ida, Ryutaro Kaneko, Kanako Imataka, Kaoru Okubo, Yoshitaka Shirakura, Kentaro Azuma, Ryoko Fujiwara, Kazuya Murata
    Current Diabetes Reviews.2021; 17(3): 293.     CrossRef
  • Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study
    Hirotatsu Nakaguchi, Yoshinobu Kondo, Mayu Kyohara, Hiromi Konishi, Koji Oiwa, Yasuo Terauchi
    Journal of Diabetes Investigation.2020; 11(6): 1542.     CrossRef
  • Sodium Glucose Co-Transporter 2 Inhibition Does Not Favorably Modify the Physiological Responses to Dietary Counselling in Diabetes-Free, Sedentary Overweight and Obese Adult Humans
    Shane P.P. Ryan, Alissa A. Newman, Jessie R. Wilburn, Lauren D. Rhoades, S. Raj J. Trikha, Ellen C. Godwin, Hayden M. Schoenberg, Micah L. Battson, Taylor R. Ewell, Gary J. Luckasen, Laurie M. Biela, Christopher L. Melby, Christopher Bell
    Nutrients.2020; 12(2): 510.     CrossRef
  • GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report
    Eva W. Iepsen, Christian T. Have, Simon Veedfald, Sten Madsbad, Jens J. Holst, Niels Grarup, Oluf Pedersen, Ivan Brandslund, Jens-Christian Holm, Torben Hansen, Signe S. Torekov
    Cell Reports Medicine.2020; 1(1): 100006.     CrossRef
  • Glucagon‐like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle
    Haitham Abdulla, Bethan E. Phillips, Daniel J. Wilkinson, Marie Limb, Tereza Jandova, Joseph J. Bass, Debbie Rankin, Jessica Cegielski, Mariwan Sayda, Hannah Crossland, John P. Williams, Kenneth Smith, Iskandar Idris, Philip J. Atherton
    Aging Cell.2020;[Epub]     CrossRef
Close layer
Original Article
Obesity and Metabolism
Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study
Yun Yong Seo, Yong Kyun Cho, Ji-Cheol Bae, Mi Hae Seo, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
Endocrinol Metab. 2013;28(1):41-45.   Published online March 25, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.1.41
  • 4,271 View
  • 33 Download
  • 57 Crossref
AbstractAbstract PDFPubReader   
Background

Tumor necrosis factor (TNF)-α is associated with insulin resistance and systemic inflammatory responses. The aim of this study was to investigate the relationship between TNF-α and the development of nonalcoholic fatty liver disease (NAFLD) in a longitudinal study.

Methods

Three hundred and sixty-three apparently healthy subjects (mean age, 40.5±6.1 years; male, 57.6%) without NAFLD were enrolled in 2003. Anthropometric and laboratory measurements were performed. The participants were grouped into tertiles according to their serum TNF-α levels from samples taken in 2003. At a 4-year follow-up, we compared the odds ratios (ORs) of the development of NAFLD according to the tertiles of TNF-α levels measured in 2003.

Results

At the 4-year follow-up, the cumulative incidence of NAFLD was 29.2% (106/363). The group that developed NAFLD had higher levels of TNF-α than those in the group without NAFLD (3.65±1.79 pg/mL vs. 3.15±1.78 pg/mL; P=0.016). When the 2003 serum TNF-α levels were categorized into tertiles: incidence of NAFLD observed in 2007 was significantly higher with increasing tertiles (22.6%, 35.8%, and 41.5%, respectively; P<0.05). The risk of developing NAFLD was significantly greater in the highest tertile of TNF-α than in the lowest tertile after adjusting for age, smoking, and BMI (OR, 2.20; 95% confidence interval, 1.12 to 4.01; P<0.05).

Conclusion

Higher serum TNF-α levels in subjects without NAFLD were associated with the development of NAFLD. The results of study might suggest a pathologic role of inflammation in NAFLD.

Citations

Citations to this article as recorded by  
  • Nigella sativa Efficacy in Non-alcoholic Fatty Liver Disease: Mechanisms and Clinical Effects
    A.A. Sangouni, A. Jamalzehi, M. Moradpour, H. Mozaffari-Khosravi
    Journal of Herbal Medicine.2024; 43: 100833.     CrossRef
  • Berberine prevents NAFLD and HCC by modulating metabolic disorders
    Xinyue Lin, Juanhong Zhang, Yajun Chu, Qiuying Nie, Junmin Zhang
    Pharmacology & Therapeutics.2024; 254: 108593.     CrossRef
  • RGS7-ATF3-Tip60 Complex Promotes Hepatic Steatosis and Fibrosis by Directly Inducing TNFα
    Madhuri Basak, Kiran Das, Tarun Mahata, Abhishek Singh Sengar, Sumit Kumar Verma, Sayan Biswas, Kakali Bhadra, Adele Stewart, Biswanath Maity
    Antioxidants & Redox Signaling.2023; 38(1-3): 137.     CrossRef
  • The capsaicinoid nonivamide suppresses the inflammatory response and attenuates the progression of steatosis in a NAFLD‐rat model
    Naruemon Wikan, Jiraporn Tocharus, Chio Oka, Sivanan Sivasinprasasn, Waraluck Chaichompoo, Apichart Suksamrarn, Chainarong Tocharus
    Journal of Biochemical and Molecular Toxicology.2023;[Epub]     CrossRef
  • Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease
    Jarren R. Oates, Keisuke Sawada, Daniel A. Giles, Pablo C. Alarcon, Michelle S.M.A. Damen, Sara Szabo, Traci E. Stankiewicz, Maria E. Moreno-Fernandez, Senad Divanovic
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • 1,25-Dihydroxycholecalciferol down-regulates 3-mercaptopyruvate sulfur transferase and caspase-3 in rat model of non-alcoholic fatty liver disease
    Maher N. Ibrahim, Abeer A. Khalifa, Dalia A. Hemead, Amira Ebrahim Alsemeh, Marwa A. Habib
    Journal of Molecular Histology.2023; 54(2): 119.     CrossRef
  • Effects of Resveratrol Supplementation on Nonalcoholic Fatty Liver Disease Management
    Arefe Nemati, Zeinab Nikniaz, Ali Mota
    Topics in Clinical Nutrition.2023; 38(2): 144.     CrossRef
  • The effects of chicory supplementation on liver enzymes and lipid profiles in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of clinical evidence
    Elham Maleki, Ali Sadeghpour, Erfan Taherifard, Bahareh Izadi, Mehdi Pasalar, Maryam Akbari
    Clinical Nutrition ESPEN.2023; 55: 447.     CrossRef
  • Using bioinformatics and systems biology methods to identify the mechanism of interaction between COVID-19 and nonalcoholic fatty liver disease
    Wenbo Dong, Yan Jin, Hongshuo Shi, Xuecheng Zhang, Jinshu Chen, Hongling Jia, Yongchen Zhang
    Medicine.2023; 102(23): e33912.     CrossRef
  • The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
    Ilias D. Vachliotis, Stergios A. Polyzos
    Current Obesity Reports.2023; 12(3): 191.     CrossRef
  • NAFLD Is Associated With Quiescent Rather Than Active Crohn’s Disease
    Scott McHenry, Matthew Glover, Ali Ahmed, Quazim Alayo, Maria Zulfiqar, Daniel R Ludwig, Matthew A Ciorba, Nicholas O Davidson, Parakkal Deepak
    Inflammatory Bowel Diseases.2023;[Epub]     CrossRef
  • Gene-regulation modules in nonalcoholic fatty liver disease revealed by single-nucleus ATAC-seq
    Fumihiko Takeuchi, Yi-Qiang Liang, Hana Shimizu-Furusawa, Masato Isono, Mia Yang Ang, Kotaro Mori, Taizo Mori, Eiji Kakazu, Sachiyo Yoshio, Norihiro Kato
    Life Science Alliance.2023; 6(10): e202301988.     CrossRef
  • Effectiveness of Cerium Oxide Nanoparticles in Non-Alcoholic Fatty Liver Disease Evolution Using In Vivo and In Vitro Studies: A Systematic Review
    Cristian Sandoval, Carolina Reyes, Pamela Rosas, Karina Godoy, Vanessa Souza-Mello, Jorge Farías
    International Journal of Molecular Sciences.2023; 24(21): 15728.     CrossRef
  • Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation
    Lun Li, Liuqiao Sun, Xiaoping Liang, Qian Ou, Xuying Tan, Fangyuan Li, Zhiwei Lai, Chenghe Ding, Hangjun Chen, Xinxue Yu, Qiongmei Wu, Jun Wei, Feng Wu, Lijun Wang
    Nutrition Research and Practice.2023; 17(6): 1084.     CrossRef
  • Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
    Yamei Duan, Xiongfeng Pan, Jiayou Luo, Xiang Xiao, Jingya Li, Prince L. Bestman, Miyang Luo
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • A potential link between plasma short‑chain fatty acids, TNF‑α level and disease progression in non‑alcoholic fatty liver disease: A retrospective study
    Jing Xiong, Xia Chen, Zhijing Zhao, Ying Liao, Ting Zhou, Qian Xiang
    Experimental and Therapeutic Medicine.2022;[Epub]     CrossRef
  • Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review
    Fajar Dwi Astarini, Neneng Ratnasari, Widya Wasityastuti
    Iranian Biomedical Journal.2022; 26(4): 252.     CrossRef
  • Clinical significance of epicardial fat assessment in hypertensive patients with non-alcoholic fatty liver disease
    M. Е. Statsenko, A. M. Streltsova
    "Arterial’naya Gipertenziya" ("Arterial Hypertension").2022; 28(3): 260.     CrossRef
  • The biological clock enhancer nobiletin ameliorates steatosis in genetically obese mice by restoring aberrant hepatic circadian rhythm
    Sebastian Larion, Caleb A. Padgett, Joshua T. Butcher, James D. Mintz, David J. Fulton, David W. Stepp
    American Journal of Physiology-Gastrointestinal and Liver Physiology.2022; 323(4): G387.     CrossRef
  • Effect of Fiber Supplementation on Systemic Inflammation and Liver Steatosis in Mice Fed with High-Carbohydrate Diets
    Cacilda Rocha Hildebrand Budke, Débora Marchetti Chaves Thomaz, Rodrigo Juliano de Oliveira, Rita de Cássia Avellaneda Guimarães, Amariles Diniz Ramires, Doroty Mesquita Dourado, Elisvânia Freitas dos Santos, Adriana Conceicon Guercio Menezes, Andréia Con
    Metabolic Syndrome and Related Disorders.2022; 20(10): 558.     CrossRef
  • Association between inflammatory markers and non-alcoholic fatty liver disease in obese children
    Yamei Duan, Jiayou Luo, Xiongfeng Pan, Jia Wei, Xiang Xiao, Jingya Li, Miyang Luo
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials
    Sahar Rafiee, Hamed Mohammadi, Abed Ghavami, Erfan Sadeghi, Zahra Safari, Gholamreza Askari
    Complementary Therapies in Clinical Practice.2021; 42: 101281.     CrossRef
  • Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease
    Narges Damavandi, Sirous Zeinali
    Molecular Biology Reports.2021; 48(2): 1225.     CrossRef
  • Potential protective effect of curcumin in high-fat diet-induced nonalcoholic fatty liver disease in rats
    AhmedM M. Mahmouda, NohaA.-R A. El-Hagag, HusseinI El-Bitar, Abdel-HalimM Afifi
    Journal of Current Medical Research and Practice.2021; 6(1): 92.     CrossRef
  • Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease
    Mengyao Zhao, Shumin Chen, Xiaoguo Ji, Xin Shen, Jiangshan You, Xinyi Liang, Hao Yin, Liming Zhao
    Pharmacological Research.2021; 166: 105517.     CrossRef
  • Inflammation in Metabolic Diseases and Insulin Resistance
    Won-Young Lee
    Cardiovascular Prevention and Pharmacotherapy.2021; 3(2): 31.     CrossRef
  • Cellular Mechanisms of Liver Fibrosis
    Pragyan Acharya, Komal Chouhan, Sabine Weiskirchen, Ralf Weiskirchen
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • The role of insulin resistance and systemic inflammation in reducing the elasticity of the main arteries in patients with arterial hypertension and non-alcoholic fatty liver disease
    M.E. Statsenko, A.M. Streltsova, M.I. Turovets
    Profilakticheskaya meditsina.2021; 24(5): 60.     CrossRef
  • Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation
    Victoria L. Slaughter, John W. Rumsey, Rachel Boone, Duaa Malik, Yunqing Cai, Narasimhan Narasimhan Sriram, Christopher J. Long, Christopher W. McAleer, Stephen Lambert, Michael L. Shuler, J. J. Hickman
    Scientific Reports.2021;[Epub]     CrossRef
  • L-ergothioneine and metformin alleviates liver injury in experimental type-2 diabetic rats via reduction of oxidative stress, inflammation, and hypertriglyceridemia
    Ayobami Dare, Mahendra L. Channa, Anand Nadar
    Canadian Journal of Physiology and Pharmacology.2021; 99(11): 1137.     CrossRef
  • Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation
    Do Hyeon Pyun, Tae Jin Kim, Seung Yeon Park, Hyun Jung Lee, A.M. Abd El-Aty, Ji Hoon Jeong, Tae Woo Jung
    Molecular and Cellular Endocrinology.2021; 538: 111464.     CrossRef
  • Low Vitamin D Level was Associated with Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Vahid Sheikhi, Zahra Heidari
    Shiraz E-Medical Journal.2021;[Epub]     CrossRef
  • Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
    Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, Mario Masarone, Marcello Persico
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008–2011)


    Kyung Soo Hong, Min Cheol Kim, June Hong Ahn
    International Journal of Chronic Obstructive Pulmonary Disease.2020; Volume 15: 1005.     CrossRef
  • A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts
    Yen-Chun Koh, Yen-Cheng Lin, Pei-Sheng Lee, Ting-Jang Lu, Kai-Yi Lin, Min-Hsiung Pan
    Food & Function.2020; 11(9): 7545.     CrossRef
  • The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling
    Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson
    Biomedicine & Pharmacotherapy.2020; 131: 110785.     CrossRef
  • Redox Regulation by Protein S-Glutathionylation: From Molecular Mechanisms to Implications in Health and Disease
    Aysenur Musaogullari, Yuh-Cherng Chai
    International Journal of Molecular Sciences.2020; 21(21): 8113.     CrossRef
  • Long-Term Soy Protein Isolate Consumption Reduces Liver Steatosis Through Changes in Global Transcriptomics in Obese Zucker Rats
    Melisa Kozaczek, Walter Bottje, Byungwhi Kong, Sami Dridi, Diyana Albataineh, Kentu Lassiter, Reza Hakkak
    Frontiers in Nutrition.2020;[Epub]     CrossRef
  • Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats
    Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Fabiane Valentini Francisqueti-Ferron, Fabiana Kurokawa Hasimoto, Cristina Schmitt Gregolin, Dijon Henrique Salomé de Campos, Cleverton Roberto
    Antioxidants.2019; 8(8): 276.     CrossRef
  • A new method to induce nonalcoholic steatohepatitis (NASH) in mice
    Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, Anahita Rezaie, Mohammad Kazem Gharib-Naseri
    BMC Gastroenterology.2019;[Epub]     CrossRef
  • Zeaxanthin Dipalmitate in the Treatment of Liver Disease
    Nisma Lena Bahaji Azami, Mingyu Sun
    Evidence-Based Complementary and Alternative Medicine.2019; 2019: 1.     CrossRef
  • A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease
    Abbas Ali Sangouni, Saeid Ghavamzadeh, Atena Jamalzehi
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(3): 2260.     CrossRef
  • ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in Han Chinese population
    Guo-Chao Zhong, Shan Liu, Yi-Lin Wu, Mei Xia, Jin-Xian Zhu, Fa-Bao Hao, Lun Wan, Pavel Strnad
    PLOS ONE.2019; 14(12): e0225792.     CrossRef
  • Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
    Eun-Jung Rhee
    Endocrinology and Metabolism.2019; 34(3): 226.     CrossRef
  • Telmisartan improves the metabolic, hematological and inflammasome indices in non-alcoholic fatty liver infiltration: A pilot open-label placebo-controlled study
    Marwan S.M. Al-Nimer, Vian A.W. Esmail, O. Mohammad
    Electronic Journal of General Medicine.2019; 16(3): em142.     CrossRef
  • TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice
    Chang‐Jiang Yu, Qiu‐Shi Wang, Ming‐Ming Wu, Bin‐Lin Song, Chen Liang, Jie Lou, Liang‐Liang Tang, Xiao‐Di Yu, Na Niu, Xu Yang, Bao‐Long Zhang, Yao Qu, Yang Liu, Zhi‐Chao Dong, Zhi‐Ren Zhang
    Hepatology.2018; 68(5): 1769.     CrossRef
  • Association Between Tumor Necrosis Factor-α and the Risk of Hepatic Events: A Median 3 Years Follow-Up Study
    Zhi Zhu, Shuofeng Li
    Hepatitis Monthly.2018;[Epub]     CrossRef
  • Clinical Characteristics of Non-Alcoholic Fatty Liver Disease Based on Analyses from the Kangbuk Samsung Health Study
    Eun-Jung Rhee
    The Journal of Korean Diabetes.2017; 18(2): 81.     CrossRef
  • Ezetimibe alleviates non-alcoholic fatty liver disease through the miR-16 inhibiting mTOR/p70S6K1 pathway
    Xiang Wang, Yunbing Meng, Junrong Zhang
    RSC Advances.2017; 7(60): 37967.     CrossRef
  • Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
    Flavia A Cimini, Ilaria Barchetta, Simone Carotti, Laura Bertoccini, Marco G Baroni, Umberto Vespasiani-Gentilucci, Maria-Gisella Cavallo, Sergio Morini
    World Journal of Gastroenterology.2017; 23(19): 3407.     CrossRef
  • Omega-3 Fatty Acids Protect Fatty and Lean Mouse Livers After Major Hepatectomy
    Michael Linecker, Perparim Limani, Patryk Kambakamba, Philipp Kron, Christoph Tschuor, Nicolas Calo, Michelangelo Foti, Jean-François Dufour, Rolf Graf, Bostjan Humar, Pierre-Alain Clavien
    Annals of Surgery.2017; 266(2): 324.     CrossRef
  • Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK
    Y-h Lee, M R Yun, H M Kim, B H Jeon, B-C Park, B-W Lee, E S Kang, H C Lee, Y W Park, B-S Cha
    International Journal of Obesity.2016; 40(2): 356.     CrossRef
  • Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets
    Feliciano Chanana Paquissi
    Frontiers in Immunology.2016;[Epub]     CrossRef
  • Comparison of Serum Adipocytokine Levels according to Metabolic Health and Obesity Status
    Tae Hoon Lee, Won Seon Jeon, Ki Joong Han, Shin Yeoung Lee, Nam Hee Kim, Hyun Beom Chae, Choel Min Jang, Kyung Mo Yoo, Hae Jung Park, Min Kyung Lee, Se Eun Park, Hyung Geun Oh, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
    Endocrinology and Metabolism.2015; 30(2): 185.     CrossRef
  • Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study
    Min-Kyung Lee, Eun-Jung Rhee, Min Chul Kim, Byung Sub Moon, Jeong In Lee, Young Seok Song, Eun Na Han, Hyo Sun Lee, Yoonjeong Son, Se Eun Park, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
    Endocrinology and Metabolism.2015; 30(4): 522.     CrossRef
  • Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease
    Sanja Stojsavljević
    World Journal of Gastroenterology.2014; 20(48): 18070.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
Close layer
Review Articles
Thyroid
Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach
Chan Kwon Jung, Andrey Bychkov, Kennichi Kakudo
Endocrinol Metab. 2022;37(5):703-718.   Published online October 4, 2022
DOI: https://doi.org/10.3803/EnM.2022.1553
  • 14,431 View
  • 1,961 Download
  • 41 Web of Science
  • 56 Crossref
AbstractAbstract PDFPubReader   ePub   
The fifth edition of the World Health Organization (WHO) histologic classification of thyroid neoplasms released in 2022 includes newly recognized tumor types, subtypes, and a grading system. Follicular cell-derived neoplasms are categorized into three families (classes): benign tumors, low-risk neoplasms, and malignant neoplasms. The terms “follicular nodular disease” and “differentiated high-grade thyroid carcinoma” are introduced to account for multifocal hyperplastic/neoplastic lesions and differentiated thyroid carcinomas with high-grade features, respectively. The term “Hürthle cells” is replaced with “oncocytic cells.” Invasive encapsulated follicular and cribriform morular variants of papillary thyroid carcinoma (PTC) are now redefined as distinct tumor types, given their different genetic alterations and clinicopathologic characteristics from other PTC subtypes. The term “variant” to describe a subclass of tumor has been replaced with the term “subtype.” Instead, the term “variant” is reserved to describe genetic alterations. A histologic grading system based on the mitotic count, necrosis, and/or the Ki67 index is used to identify high-grade follicular-cell derived carcinomas and medullary thyroid carcinomas. The 2022 WHO classification introduces the following new categories: “salivary gland-type carcinomas of the thyroid” and “thyroid tumors of uncertain histogenesis.” This review summarizes the major changes in the 2022 WHO classification and their clinical relevance.

Citations

Citations to this article as recorded by  
  • Tumeurs de la thyroïde : nouveautés de la classification OMS 2022
    Serge Guyétant, Myriam Decaussin Petrucci, Emmanuelle Leteurtre
    Annales de Pathologie.2024; 44(1): 5.     CrossRef
  • Diagnostic Performance of [18F]TFB PET/CT Compared with Therapeutic Activity [131I]Iodine SPECT/CT and [18F]FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma
    David Ventura, Matthias Dittmann, Florian Büther, Michael Schäfers, Kambiz Rahbar, Daniel Hescheler, Michael Claesener, Philipp Schindler, Burkhard Riemann, Robert Seifert, Wolfgang Roll
    Journal of Nuclear Medicine.2024; 65(2): 192.     CrossRef
  • Clinicopathological features of differentiated thyroid carcinoma as predictors of the effects of radioactive iodine therapy
    Wen Liu, Beibei Jiang, Jingli Xue, Ruijing Liu, Yuqing Wei, Peifeng Li
    Annals of Diagnostic Pathology.2024; 69: 152243.     CrossRef
  • Management of aggressive variants of papillary thyroid cancer
    Ying Ki Lee, Aleix Rovira, Paul V. Carroll, Ricard Simo
    Current Opinion in Otolaryngology & Head & Neck Surgery.2024; 32(2): 125.     CrossRef
  • Artificial Intelligence Detected the Relationship Between Nuclear Morphological Features and Molecular Abnormalities of Papillary Thyroid Carcinoma
    Toui Nishikawa, Ibu Matsuzaki, Ayata Takahashi, Iwamoto Ryuta, Fidele Yambayamba Musangile, Kanako Sagan, Mizuki Nishikawa, Yurina Mikasa, Yuichi Takahashi, Fumiyoshi Kojima, Shin-ichi Murata
    Endocrine Pathology.2024;[Epub]     CrossRef
  • Review of the 2023 World Congress on Thyroid Cancer (WCTC 2023, London): is there light at the end of the tunnel for patients with neglected cancer?
    S.M. Cherenko
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 19(8): 609.     CrossRef
  • Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma
    Lindsay A. Bischoff, Ian Ganly, Laura Fugazzola, Erin Buczek, William C. Faquin, Bryan R. Haugen, Bryan McIver, Caitlin P. McMullen, Kate Newbold, Daniel J. Rocke, Marika D. Russell, Mabel Ryder, Peter M. Sadow, Eric Sherman, Maisie Shindo, David C. Shonk
    JAMA Otolaryngology–Head & Neck Surgery.2024;[Epub]     CrossRef
  • Malignancy in a Solitary Thyroid Nodule: A Retrospective Histopathological Evaluation
    Hassan Alzahrani
    International Journal of General Medicine.2024; Volume 17: 135.     CrossRef
  • Thyroïde : actualités et problèmes pratiques. Introduction
    Serge Guyétant
    Annales de Pathologie.2024;[Epub]     CrossRef
  • Diagnostic implication of thyroid spherules for cytological diagnosis of thyroid nodules
    Heeseung Sohn, Kennichi Kakudo, Chan Kwon Jung
    Cytopathology.2024;[Epub]     CrossRef
  • Aggressive Primary Thyroid Mucoepidermoid Carcinoma with Extensive Pulmonary Involvement
    Marius Mitrache, Dana Terzea, Anca Sirbu, Simona Fica
    Biomedicines.2024; 12(2): 285.     CrossRef
  • Unravelling the role of long non-coding RNAs in modulating the Hedgehog pathway in cancer
    Shailendra Singh Chandel, Anurag Mishra, Gaurav Dubey, Ravindra Pal Singh, Mithilesh Singh, Mohit Agarwal, Himmat Singh Chawra, Neelima Kukreti
    Pathology - Research and Practice.2024; 254: 155156.     CrossRef
  • Hürthle cell (Oncocytic) carcinoma – Is hemithyroidectomy enough?
    Taylor O. Julsrud, Trenton R. Foster, Robert A. Vierkant, Melanie L. Lyden, Travis J. McKenzie, Mabel Ryder, Benzon M. Dy
    Surgical Oncology Insight.2024; 1(1): 100010.     CrossRef
  • Échographie des carcinomes thyroïdiens différenciés de souche folliculaire
    P.Y. Marcy, M. Tassart, J.G. Marchand, J. Sanglier, A. Bizeau, E. Ghanassia
    Journal d'imagerie diagnostique et interventionnelle.2024;[Epub]     CrossRef
  • Differentiating BRAF V600E- and RAS-like alterations in encapsulated follicular patterned tumors through histologic features: a validation study
    Chankyung Kim, Shipra Agarwal, Andrey Bychkov, Jen-Fan Hang, Agnes Stephanie Harahap, Mitsuyoshi Hirokawa, Kennichi Kakudo, Somboon Keelawat, Chih-Yi Liu, Zhiyan Liu, Truong Phan-Xuan Nguyen, Chanchal Rana, Huy Gia Vuong, Yun Zhu, Chan Kwon Jung
    Virchows Archiv.2024;[Epub]     CrossRef
  • Histoséminaire SFP Thyroïde : actualités et problèmes pratiques. Cas no 5
    Myriam Decaussin-Petrucci
    Annales de Pathologie.2024;[Epub]     CrossRef
  • Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials
    Ke Wang, Ying Zhang, Yang Xing, Hong Wang, Minghua He, Rui Guo
    Discover Oncology.2024;[Epub]     CrossRef
  • Histoséminaire / Thyroïde : actualités et problèmes pratiques. Cas no 6
    Myriam Decaussin-Petrucci
    Annales de Pathologie.2024;[Epub]     CrossRef
  • Papillary Thyroid Carcinoma With Lymphoepithelial Features and Lacking Association With Epstein-Barr Virus (EBV): A Rare Case
    Ahmed Bendari, Saroja Devi Geetha, Reham Al-Refai, Xuelin Zhong, Sunder Sham, Manju Harshan
    Cureus.2024;[Epub]     CrossRef
  • Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma
    Chan Kwon Jung, Shipra Agarwal, Jen-Fan Hang, Dong-Jun Lim, Andrey Bychkov, Ozgur Mete
    Endocrine Pathology.2023; 34(1): 1.     CrossRef
  • The 5th edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma
    Fulvio Basolo, Elisabetta Macerola, Anello Marcello Poma, Liborio Torregrossa
    Endocrine.2023; 80(3): 470.     CrossRef
  • Preoperative Risk Stratification of Follicular-patterned Thyroid Lesions on Core Needle Biopsy by Histologic Subtyping and RAS Variant-specific Immunohistochemistry
    Meejeong Kim, Sora Jeon, Chan Kwon Jung
    Endocrine Pathology.2023; 34(2): 247.     CrossRef
  • Ultrasound evolution of parenchymal changes in the thyroid gland with autoimmune thyroiditis in children prior to the development of papillary thyroid carcinoma – a follow-up study
    Dominika Januś, Monika Kujdowicz, Małgorzata Wójcik, Anna Taczanowska-Niemczuk, Aleksandra Kiszka-Wiłkojć, Wojciech Górecki, Jerzy B. Starzyk
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high‐grade malignancy?
    Shin‐ichi Murata, Ibu Matsuzaki, Mitsuo Kishimoto, Naomi Katsuki, Toshinori Onishi, Mitsuyoshi Hirokawa, Fumiyoshi Kojima
    Pathology International.2023; 73(5): 207.     CrossRef
  • Multi-Omics and Management of Follicular Carcinoma of the Thyroid
    Thifhelimbilu Emmanuel Luvhengo, Ifongo Bombil, Arian Mokhtari, Maeyane Stephens Moeng, Demetra Demetriou, Claire Sanders, Zodwa Dlamini
    Biomedicines.2023; 11(4): 1217.     CrossRef
  • Molecular Genetics of Diffuse Sclerosing Papillary Thyroid Cancer
    Meshael Alswailem, Balgees Alghamdi, Anwar Alotaibi, Abeer Aljomiah, Hindi Al-Hindi, Avaniyapuram Kannan Murugan, Mohamed Abouelhoda, Yufei Shi, Ali S Alzahrani
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(9): e704.     CrossRef
  • Multifunctional Phase-Transition Nanoparticles for Effective Targeted Sonodynamic-Gene Therapy Against Thyroid Papillary Carcinoma
    Shihui Guan, Dengke Teng, Hui Wang, Qimeihui Wang, Xi Zhen, Guoqing Sui, Yang Wang, Lingyu Zhu, Yuanqiang Lin, Dan Jiao, Feng Guo
    International Journal of Nanomedicine.2023; Volume 18: 2275.     CrossRef
  • Utilizing Dynamic Risk Stratification in Patients With Tall Cell Variant Papillary Thyroid Cancer
    David Zimmer, Gilman Plitt, Brandon Prendes, Jamie Ku, Natalie Silver, Eric Lamarre, Emrullah Yilmaz, Jessica Geiger, Christian Nasr, Lea El Hage, Mario Skugor, Shauna Cambpell, Shlomo Koyfman, Jacob Miller, Neil Woody, Katherine Heiden, Nikhil Joshi, Tar
    The Laryngoscope.2023; 133(9): 2430.     CrossRef
  • Ultrasound, laboratory and histopathological insights in diagnosing papillary thyroid carcinoma in a paediatric population: a single centre follow-up study between 2000-2022
    Dominika Januś, Małgorzata Wójcik, Anna Taczanowska-Niemczuk, Aleksandra Kiszka-Wiłkojć, Monika Kujdowicz, Małgorzata Czogała, Wojciech Górecki, Jerzy B. Starzyk
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Medullary Thyroid Carcinoma: A Single Institute Experience
    Sonal Trivedi, T. Salahuddin, Mohamed Taher Mithi, Priyank Rathod, Arpit Bandi, Shashank J. Pandya, Mohit Sharma, Shailesh Patel, Vikas Warikoo, Ketul Puj, Abhijeet Salunkhe, Keval Patel, Shivam Pandya
    Indian Journal of Otolaryngology and Head & Neck Surgery.2023; 75(4): 2884.     CrossRef
  • FNAC (Fine needle aspiration cytology) and histopathological correlation and reclassification of thyroid neoplasm in accordance with WHO classification 2022
    Fareeda Joshi, Shreya Hegde
    Indian Journal of Pathology and Oncology.2023; 10(2): 132.     CrossRef
  • Papillary thyroid carcinoma associated with non‑functioning parathyroid carcinoma with Warthin's tumor of the parotid gland: A case report and brief literature review
    Ari Abdullah, Aras Qaradakhy, Yadgar Saeed, Abdulwahid Salih, Seema Karim, Osama Ali, Shko Hassan, Shalaw Nasraldeen, Shvan Mohammed, Fahmi Kakamad
    Medicine International.2023;[Epub]     CrossRef
  • Warthin-like papillary thyroid carcinoma: a case report and comprehensive review of the literature
    Abdel Mouhaymen Missaoui, Fatma Hamza, Wafa Belabed, Manel Mellouli, Mohamed Maaloul, Slim Charfi, Issam Jardak, Tahya Sellami-Boudawara, Nabila Rekik, Mohamed Abid
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Reevaluating diagnostic categories and associated malignancy risks in thyroid core needle biopsy
    Chan Kwon Jung
    Journal of Pathology and Translational Medicine.2023; 57(4): 208.     CrossRef
  • Cancer Predisposition Syndromes and Thyroid Cancer: Keys for a Short Two-Way Street
    Ioana Balinisteanu, Monica-Cristina Panzaru, Lavinia Caba, Maria-Christina Ungureanu, Andreea Florea, Ana Maria Grigore, Eusebiu Vlad Gorduza
    Biomedicines.2023; 11(8): 2143.     CrossRef
  • Deep learning prediction model for central lymph node metastasis in papillary thyroid microcarcinoma based on cytology
    Wenhao Ren, Yanli Zhu, Qian Wang, Yuntao Song, Zhihui Fan, Yanhua Bai, Dongmei Lin
    Cancer Science.2023; 114(10): 4114.     CrossRef
  • Cytology and Histology of Thyroid Nodules: Exploring Novel Insights in the Molecular Era for Enhanced Patient Management
    Beatrix Cochand-Priollet, Zahra Maleki
    Current Oncology.2023; 30(8): 7753.     CrossRef
  • Agrin is a novel oncogenic protein in thyroid cancer
    Anna Adamiok‑Ostrowska, Małgorzata Grzanka, Barbara Czarnocka
    Oncology Letters.2023;[Epub]     CrossRef
  • Analysis of Pathological Features of Thyroid Carcinoma in the Western Yunnan
    身吾 王
    Advances in Clinical Medicine.2023; 13(10): 15820.     CrossRef
  • Insight of novel biomarkers for papillary thyroid carcinoma through multiomics
    Wei Liu, Junkan Zhu, Zhen Wu, Yongxiang Yin, Qiao Wu, Yiming Wu, Jiaojiao Zheng, Cong Wang, Hongyan Chen, Talal Jamil Qazi, Jun Wu, Yuqing Zhang, Houbao Liu, Jingmin Yang, Daru Lu, Xumin Zhang, Zhilong Ai
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Identification of NIFTP-Specific mRNA Markers for Reliable Molecular Diagnosis of Thyroid Tumors
    So-Yeon Lee, Jong-Lyul Park, Kwangsoon Kim, Ja Seong Bae, Jae-Yoon Kim, Seon-Young Kim, Chan Kwon Jung
    Endocrine Pathology.2023; 34(3): 311.     CrossRef
  • Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment
    Andrea Gillis, Rui Zheng-Pywell, Chandler McLeod, Dezhi Wang, John M. Ness, Rachael Guenter, Jason Whitt, Tomas A. Prolla, Herbert Chen, Manuel Lora Gonzalez, Bart Rose, Ricardo V. Lloyd, Renata Jaskula-Sztul, Diana Lin
    Modern Pathology.2023; 36(12): 100332.     CrossRef
  • Comparison of Treatment and Prognosis Between Follicular Variant Papillary Thyroid Carcinoma and Classical Papillary Thyroid Carcinoma
    Bing Zhang, Wenming Wu, Jinjing Liu, Zhou Liang, Liang Zong
    Hormone and Metabolic Research.2023; 55(12): 855.     CrossRef
  • Sentinel lymph node mapping: current applications and future perspectives in thyroid carcinoma
    Isabella Merante Boschin, Loris Bertazza, Carla Scaroni, Caterina Mian, Maria Rosa Pelizzo
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Utility of the Growth Differentiation Factor-15 in the Differential Diagnosis of Follicular-Patterned Lesions of the Thyroid on Cytopathologic and Histopathologic Samples
    Prasanna V Perumal, Neelaiah Siddaraju, Sunil K Saxena, Soundravally Rajendiran, Ramachandra V Bhat
    Cureus.2023;[Epub]     CrossRef
  • Investigation of pre‐operative demographic, biochemical, sonographic and cytopathological findings in low‐risk thyroid neoplasms
    Muzaffer Serdar Deniz, Didem Özdemir, Narin Nasıroğlu İmga, Hüsniye Başer, Fatma Neslihan Çuhacı Seyrek, Ayşegül Aksoy Altınboğa, Oya Topaloğlu, Reyhan Ersoy, Bekir Çakır
    Clinical Endocrinology.2023; 99(5): 502.     CrossRef
  • Applications of machine and deep learning to thyroid cytology and histopathology: a review
    Greg Slabaugh, Luis Beltran, Hasan Rizvi, Panos Deloukas, Eirini Marouli
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • The Asian Thyroid Working Group, from 2017 to 2023
    Kennichi Kakudo, Chan Kwon Jung, Zhiyan Liu, Mitsuyoshi Hirokawa, Andrey Bychkov, Huy Gia Vuong, Somboon Keelawat, Radhika Srinivasan, Jen-Fan Hang, Chiung-Ru Lai
    Journal of Pathology and Translational Medicine.2023; 57(6): 289.     CrossRef
  • Anaplastic thyroid cancer: Pathogenesis, prognostic factors and genetic landscape (Review)
    Abdul-Mohsen Alhejaily, Omar Alhuzim, Yazeed Alwelaie
    Molecular and Clinical Oncology.2023;[Epub]     CrossRef
  • Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review
    Poupak Fallahi, Armando Patrizio, Giulio Stoppini, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Eugenia Balestri, Valeria Mazzi, Chiara Botrini, Gilda Varricchi, Salvatore Ulisse, Marco Ghionzoli, Alessandro Antonelli, Silvia Martina Ferrari
    Current Oncology.2023; 30(12): 10237.     CrossRef
  • Construction and validation of a nomogram for predicting cervical lymph node metastasis in diffuse sclerosing variant of papillary thyroid carcinoma
    Xunyi Lin, Jiaxing Huo, Huan Zhang, Hang Su, Fenghua Zhang
    Langenbeck's Archives of Surgery.2023;[Epub]     CrossRef
  • Canine follicular cell and medullary thyroid carcinomas: Immunohistochemical characterization
    Jana Jankovic, Eve Tièche, Martina Dettwiler, Kerstin Hahn, Stephanie Scheemaeker, Martin Kessler, Sylvie Daminet, Sven Rottenberg, Miguel Campos
    Veterinary Pathology.2023;[Epub]     CrossRef
  • A 16-Year Single-Center Series of Trachea Resections for Locally Advanced Thyroid Carcinoma
    Julia I. Staubitz-Vernazza, Sina Schwind, Oana Lozan, Thomas J. Musholt
    Cancers.2023; 16(1): 163.     CrossRef
  • Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer
    Yuji Nagayama, Koichiro Hamada
    Metabolites.2022; 12(12): 1214.     CrossRef
  • Developments to improve outcomes in thyroid surgery
    Thomas J. Musholt
    Innovative Surgical Sciences.2022; 7(3-4): 77.     CrossRef
  • The relationship of the clinicopathological characteristics and treatment results of post-Chornobyl papillary thyroid microcarcinomas with the latency period and radiation exposure
    Tetiana Bogdanova, Serhii Chernyshov, Liudmyla Zurnadzhy, Tatiana I. Rogounovitch, Norisato Mitsutake, Mykola Tronko, Masahiro Ito, Michael Bolgov, Sergii Masiuk, Shunichi Yamashita, Vladimir A. Saenko
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
Close layer
Diabetes
Therapeutic Role of Yoga in Type 2 Diabetes
Arkiath Veettil Raveendran, Anjali Deshpandae, Shashank R. Joshi
Endocrinol Metab. 2018;33(3):307-317.   Published online August 14, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.3.307
  • 10,945 View
  • 272 Download
  • 41 Web of Science
  • 56 Crossref
AbstractAbstract PDFPubReader   ePub   

Yoga originated in India more than 5,000 years ago and is a means of balancing and harmonizing the body, mind, and emotions. Yoga practice is useful in the management of various lifestyle diseases, including type 2 diabetes. Psycho-neuro-endocrine and immune mechanisms are involved in the beneficial effects of yoga on diabetes. Incorporation of yoga practice in daily life helps to attain glycaemic control and reduces the risk of complications in people with diabetes. In this review, we briefly describe the role of various yoga practices in the management of diabetes based on evidence from various clinical studies.

Citations

Citations to this article as recorded by  
  • Clinical Practice Guidelines for mental health and well-being in patients with chronic medical illnesses
    Sandeep Grover, Ajit Avasthi, Abdul Majid
    Indian Journal of Psychiatry.2024; 66(Suppl 2): S338.     CrossRef
  • Complementary and alternative system of medicine for type 2 diabetes mellitus and its complications: A scoping review
    Shradha S Parsekar, Nachiket Gudi, Sujata Chodankar Walke, Prabhu Dutta Shaw, Aditi Hombali, Anupama V Nayak, Basavaraj S Hadapad
    F1000Research.2024; 11: 526.     CrossRef
  • CLINICAL STUDY OF YOGASANA AND PATHYAAHARA IN MANAGEMENT OF MADHUMEHA (DIABETES MELLITUS-2)
    Jyoti Prajapati, Pramod Kumar Mishra, Brahmanand Sharma
    International Ayurvedic Medical Journal.2024; 12(02): 346.     CrossRef
  • Therapeutic role of yoga in hypertension
    Anjali Mangesh Joshi, Arkiath Veettil Raveendran, Muruganathan Arumugam
    World Journal of Methodology.2024;[Epub]     CrossRef
  • A self-management plus mind body intervention for adolescents and young adults with type 2 diabetes: Trial design and methodological report
    Molly McVoy, David Miller, Irina Bransteter, Rose Gubitosi-Klug, Tracy Segal, Jessica Surdam, Martha Sajatovic, Jeffery A. Dusek
    Contemporary Clinical Trials.2023; 133: 107317.     CrossRef
  • Epidemiology of type 2 diabetes mellitus and treatment utilization patterns among the elderly from the first wave of Longitudinal Aging study in India (2017-18)using a Heckman selection model
    Papai Barman, Milan Das, Madhur Verma
    BMC Public Health.2023;[Epub]     CrossRef
  • Is Type 2 Diabetes Mellitus a Behavioural Disorder? An Evidence Review for Type 2 Diabetes Mellitus Prevention and Remission through Lifestyle Modification
    Matthias Li, Mohammad Sadiq Jeeyavudeen, Ganesan Arunagirinathan, Joseph Pappachan
    European Endocrinology.2023; 19(1): 7.     CrossRef
  • Yoga practice can reduce metabolic syndrome and cardiovascular risk in climacteric women
    Laura Alves Cota e Souza, Thiago Magalhães Gouvea, Francielle Caroline Fernandes, Maria Ruth Gonçalves Gaede Carrillo, Vanja Maria Veloso, Ariosvaldo Figueiredo Santos Filho, Angélica Alves Lima
    Journal of Behavioral Medicine.2023;[Epub]     CrossRef
  • Yogic practices for dyslipidemia in type 2 diabetes mellitus: A systematic review of randomized-controlled trials
    Bandana Sairem, Khushbu Jain
    BLDE University Journal of Health Sciences.2023; 8(1): 20.     CrossRef
  • Effect of yoga protocol in primary snoring: A pilot study
    JojanJ Jerone, Ashok Patil, SavitaS Angadi, AmalS Chandran
    Journal of Ayurveda.2023; 17(2): 114.     CrossRef
  • Effects of different mind-body exercises on glucose and lipid metabolism in patients with type 2 diabetes: A network meta-analysis
    Sijun Wu, Lin Wang, Yuxuan He, Fengrui Shi, Huiqi Zhuang, Linqi Mei, Youling Qian
    Complementary Therapies in Clinical Practice.2023; 53: 101802.     CrossRef
  • Mechanisms of improved body composition among perimenopausal women practicing Meditative Movement: a proposed biobehavioral model
    Dara L. James, Linda K. Larkey, Bronwynne Evans, Ann Sebren, Kimberley Goldsmith, Erica Ahlich, Nanako A. Hawley, Afton Kechter, Dorothy D. Sears
    Menopause.2023; 30(11): 1114.     CrossRef
  • A comparative analysis of Vamana and Shamana Chikitsa in prediabetes management: A randomized clinical trial
    Uttamram Yadav, Santosh Kumar Bhatted
    Journal of Ayurveda and Integrative Medicine.2023; 14(5): 100764.     CrossRef
  • Siddha Therapeutic Approach to Diabetic Nephropathy – A Review
    P. Parvathy, G. S. Lekha, S. Aparna, A. Kanagarajan
    Journal of Natural Remedies.2023; : 1359.     CrossRef
  • Enhancing Type 2 Diabetes Management: Exploring the Synergistic Impact of Vestibular Exercise and Yoga
    Athira MS, Sheela Joice P P, Mohan Varughese, Suresh Babu Sayana
    Cureus.2023;[Epub]     CrossRef
  • Dynamic In Silico Model of Type 2 Diabetes Treated With Metformin Combined With Exercise: A Sobol Sensitivity Analysis
    Darshna M. Joshi
    Avicenna Journal of Pharmaceutical Research.2023; 3(2): 91.     CrossRef
  • Complementary and alternative system of medicine for type 2 diabetes mellitus and its complications: A scoping review
    Shradha S Parsekar, Nachiket Gudi, Sujata Chodankar Walke, Prabhu Dutta Shaw, Aditi Hombali, Anupama V Nayak, Basavaraj S Hadapad
    F1000Research.2023; 11: 526.     CrossRef
  • Exploring the Impact of Combined Thai Yoga and Elastic Band Exercise on Physical Fitness and Exercise Capacity in Older Patients with Type 2 Diabetes
    Nattha Muangritdech, Tichanon Promsrisuk, Ratchaniporn Kongsui, Napatr Sriraksa, Sitthisak Thongrong, Arunrat Srithawong
    Physical Education Theory and Methodology.2023; 23(6): 894.     CrossRef
  • Role of Yoga and Its Plausible Mechanism in the Mitigation of DNA Damage in Type-2 Diabetes: A Randomized Clinical Trial
    Rajesh G Nair, Mithila M Vasudev, Ramesh Mavathur
    Annals of Behavioral Medicine.2022; 56(3): 235.     CrossRef
  • Efficacy of Integrated Ayurveda treatment protocol in type 2 Diabetes Mellitus – A case report
    Suketha Kumari, Laxmikant S.D, Sonika B, Suman Khanal
    Journal of Ayurveda and Integrative Medicine.2022; 13(1): 100512.     CrossRef
  • Role of structured exercise therapy on cognitive markers and stress parameters in young patients with Type 2 diabetes mellitus
    Harpreet Kour, VA Kothiwale, ShivaprasadS Goudar
    Indian Journal of Health Sciences and Biomedical Research (KLEU).2022; 15(1): 70.     CrossRef
  • The Influence of Amateur Sports on Health Quality
    M. M. Vovchenko
    Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2022; 7(1): 8.     CrossRef
  • Complementary and alternative system of medicine for type 2 diabetes mellitus and its complications: A scoping review
    Shradha S Parsekar, Nachiket Gudi, Sujata Chodankar Walke, Prabhu Dutta Shaw, Aditi Hombali, Anupama V Nayak, Basavaraj S Hadapad
    F1000Research.2022; 11: 526.     CrossRef
  • Neuroimaging perspective in targeted treatment for type 2 diabetes melitus and sleep disorders
    Karen M. von Deneen, Malgorzata A. Garstka
    Intelligent Medicine.2022; 2(4): 209.     CrossRef
  • Efficacy of yoga practices on emotion regulation and mindfulness in type 2 diabetes mellitus patients
    Amit Kanthi, Singh Deepeshwar, Chidananda Kaligal, Mahadevappa Vidyashree, Dwivedi Krishna
    Yoga Mimamsa.2022; 54(1): 12.     CrossRef
  • Inside the diabetic brain: Insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies
    Bhaskar Jyoti Dutta, Shamsher Singh, Sanket Seksaria, Ghanshyam Das Gupta, Amrita Singh
    Pharmacological Research.2022; 182: 106358.     CrossRef
  • LINKAGE OF YOGA TO OXIDATIVE STRESS IN PATIENTS WITH DIABETES MELLITUS, TYPE 2
    Deepika Khatri, Yuliya Tyravska
    InterConf.2022; (15(117)): 215.     CrossRef
  • An Observational Study on the Effect of Yoga and Sudarshan Kriya in Type 2 Diabetes Mellitus Patients
    Meenakshi R Verma, Deepakkumar G Langade, Rahul D Rao, Shreya Shivangi, Sonali Khedkar, Divya Kanchibhotla
    Cureus.2022;[Epub]     CrossRef
  • The most effective exercise to prevent obesity: A longitudinal study of 33,731 Taiwan biobank participants
    Wan-Yu Lin
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Type 2 diabetes mellitus, its impact on quality of life and how the disease can be managed-a review
    Priyanka Garg, Navneet Duggal
    Obesity Medicine.2022; 35: 100459.     CrossRef
  • Effect of om chanting and yoga nidra on blood pressure and lipid profile in hypertension – A randomized controlled trial
    K. Anjana, R. Archana, J.K. Mukkadan
    Journal of Ayurveda and Integrative Medicine.2022; 13(4): 100657.     CrossRef
  • Effect of yoga intervention on skeletal muscle linked glucose homeostasis in pre-diabetic individuals: Study protocol for a randomized controlled trial
    Supriya Bhalerao, Jayshree Kharche, Shubhangi Harke
    Advances in Integrative Medicine.2022; 9(4): 230.     CrossRef
  • Popular Complementary and Alternative Therapy Methods in Different Conditions
    Akın SÜZER, Nevriye ÜNAL SÜZER, Raziye ŞAVKIN, Nihal BÜKER
    International Journal of Traditional and Complementary Medicine Research.2022; 3(3): 201.     CrossRef
  • Add on Hypoglycemic effect of customized Yoga module in diabetes mellitus: A case report
    KK Resmi, MB Kavita, Gurubasavaraj Yalagachin
    Journal of Ayurveda Case Reports.2022; 5(4): 163.     CrossRef
  • Modern Postural Yoga and the Health-Spirituality-Neoliberalism Nexus
    Matteo Di Placido, Anna Strhan, Stefania Palmisano
    Fieldwork in Religion.2022;[Epub]     CrossRef
  • Metabolic syndrome and possible treatments (consecutive therapies): a literature review
    Jitender Sorout, Sudhanshu Kacker, Neha Saboo
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(6): 351.     CrossRef
  • Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
    Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
    Diabetes & Metabolism Journal.2021; 45(2): 260.     CrossRef
  • Yoga as a complementary therapy for metabolic syndrome: A narrative review
    Dastan M. Khoshnaw, Abhijit A. Ghadge
    Journal of Integrative Medicine.2021; 19(1): 6.     CrossRef
  • Effect of yoga on glycemia and lipid parameters in type-2 diabetes: a meta-analysis
    Deep Dutta, Saptarshi Bhattacharya, Meha Sharma, Deepak Khandelwal, Vineet Surana, Sanjay Kalra
    Journal of Diabetes & Metabolic Disorders.2021; 20(1): 349.     CrossRef
  • Effect of Yoga on Glucose Control and Quality of Life in Patients of Prediabetes
    Rajesh Rajput, Karamvir Yadav, Meena Rajput, Jyoti Yadav, Neharika Saini
    Metabolic Syndrome and Related Disorders.2021; 19(8): 417.     CrossRef
  • Effect of long-term Yogic practices in type 2 diabetes mellitus: a single case study
    KetakiH Patil, Vidya Wasnik (Thatere), VijayG Patrikar
    Journal of Indian System of Medicine.2021; 9(2): 135.     CrossRef
  • Effectiveness of Yoga Lifestyle on Lipid Metabolism in a Vulnerable Population—A Community Based Multicenter Randomized Controlled Trial
    Raghuram Nagarathna, Saurabh Kumar, Akshay Anand, Ishwara N. Acharya, Amit Kumar Singh, Suchitra S. Patil, Ramesh H Latha, Purnima Datey, Hongasandra Ramarao Nagendra
    Medicines.2021; 8(7): 37.     CrossRef
  • Yoga for Healthy Aging: Science or Hype?

    Advances in Geriatric Medicine and Research.2021;[Epub]     CrossRef
  • A Prospective Study on Type-2 Diabetic Complications and Efficacy of Integrated Yoga: A Pan India 2017
    Suchitra S. Patil, Nagarathna Raghuram, Amit Singh, S. K. Rajesh, Sabzar Ahmed, Nagendra Hongasandra
    Annals of Neurosciences.2021; 28(1-2): 21.     CrossRef
  • Effects of Yoga Therapy and Walking Therapy in Reducing Blood Sugar Levels on Diabetes Mellitus Patients in the Community
    Wachidah Yuniartika, Agus Sudaryanto, Abi Muhlisin, Dian Hudiyawati, Dimas Ria Angga Pribadi
    Open Access Macedonian Journal of Medical Sciences.2021; 9(E): 906.     CrossRef
  • Yoga nidra practice shows improvement in sleep in patients with chronic insomnia: A randomized controlled trial
    KARUNA DATTA, MANJARI TRIPATHI, MANSI VERMA, DEEPIKA MASIWAL, HRUDA NANDA MALLICK
    The National Medical Journal of India.2021; 34: 143.     CrossRef
  • MANAGEMENT THROUGH AYURVEDIC MEDICATIONS AND LIFESTYLE MODIFICATION (PATHYASEVANA AND YOGASANA) IN A CASE OF POST-COVID COMPLICATION DIABETES MELLITUS (TYPE 2 DM): A SINGLE CASE STUDY
    Prajakta D. Nimje, Vidya Wasnik (Thatere), Sumeeta Jain
    International Ayurvedic Medical Journal.2021; 9(10): 2619.     CrossRef
  • Efficacy of palliative herbal decoction (Darvyadi Kwatha) with lifestyle modification in the management of prediabetes (Prameha): a single-arm clinical trial
    Uttamram Yadav, SantoshK Bhatted
    Journal of Indian System of Medicine.2021; 9(4): 265.     CrossRef
  • Role of yoga as an adjuvant therapy in the management of metabolic syndrome – A randomized control pilot study
    Rajasekaran Balaji, Meena Ramanathan, AnandaBalayogi Bhavanani
    Yoga Mimamsa.2021; 53(2): 116.     CrossRef
  • Effect of an 8-Week Yoga-Based Lifestyle Intervention on Psycho-Neuro-Immune Axis, Disease Activity, and Perceived Quality of Life in Rheumatoid Arthritis Patients: A Randomized Controlled Trial
    Surabhi Gautam, Manoj Kumar, Uma Kumar, Rima Dada
    Frontiers in Psychology.2020;[Epub]     CrossRef
  • Type 2 diabetes mellitus: pathogenesis and genetic diagnosis
    D. Himanshu, Wahid Ali, Mohd Wamique
    Journal of Diabetes & Metabolic Disorders.2020; 19(2): 1959.     CrossRef
  • Prevalence and Awareness of Stroke and Other Comorbidities Associated with Diabetes in Northwest India
    Vivek Podder, Vinod Srivastava, Saurabh Kumar, Raghuram Nagarathna, Madhava Sai Sivapuram, Navneet Kaur, Kanupriya Sharma, Amit Kumar Singh, Neeru Malik, Akshay Anand, Hongasandra R. Nagendra
    Journal of Neurosciences in Rural Practice.2020; 11: 467.     CrossRef
  • Patterns of concomitant use of Ayurveda and conventional anti-diabetic formulations - Experiences at a tertiary care Ayurveda hospital, India
    R Galib, Poonam Dang, Vijay Kumar, Rakesh Rana, Pramod Yadav, PK Prajapati
    AYU (An international quarterly journal of research in Ayurveda).2020; 41(2): 72.     CrossRef
  • A perspective on yoga as a preventive strategy for coronavirus disease 2019
    R Nagarathna, HR Nagendra, Vijaya Majumdar
    International Journal of Yoga.2020; 13(2): 89.     CrossRef
  • Effect of Ayurveda intervention, lifestyle modification and Yoga in prediabetic and type 2 diabetes under the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS)–AYUSH integration project
    Ramavtar Sharma, VinodKumar Shahi, Shruti Khanduri, Arun Goyal, Suhas Chaudhary, RakeshKumar Rana, Richa Singhal, Narayanam Srikanth, KartarSingh Dhiman
    AYU (An international quarterly journal of research in Ayurveda).2019; 40(1): 8.     CrossRef
  • Type 2 diabetes mellitus, physical activity, yoga and telomere length: A literature review
    Reepa A. Ughreja, Reena A. Ughreja
    Journal of Metabolic Health.2019;[Epub]     CrossRef
Close layer
Thyroid
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
Jierui Liu, Yanqing Liu, Yansong Lin, Jun Liang
Endocrinol Metab. 2019;34(3):215-225.   Published online September 26, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.3.215
  • 10,461 View
  • 315 Download
  • 59 Web of Science
  • 56 Crossref
AbstractAbstract PDFPubReader   ePub   

The retained functionality of the sodium iodide symporter (NIS) expressed in differentiated thyroid cancer (DTC) cells allows the further utilization of post-surgical radioactive iodine (RAI) therapy, which is an effective treatment for reducing the risk of recurrence, and even the mortality, of DTC. Whereas, the dedifferentiation of DTC could influence the expression of functional NIS, thereby reducing the efficacy of RAI therapy in advanced DTC. Genetic alternations (such as BRAF and the rearranged during transfection [RET]/papillary thyroid cancer [PTC] rearrangement) have been widely reported to be prominently responsible for the onset, progression, and dedifferentiation of PTC, mainly through activating the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) signaling cascades. These genetic alternations have been suggested to associate with the reduced expression of iodide-handling genes in thyroid cancer, especially the NIS gene, disabling iodine uptake and causing resistance to RAI therapy. Recently, novel and promising approaches aiming at various targets have been attempted to restore the expression of these iodine-metabolizing genes and enhance iodine uptake through in vitro studies and studies of RAI-refractory (RAIR)-DTC patients. In this review, we discuss the regulation of NIS, known mechanisms of dedifferentiation including the MAPK and PI3K pathways, and the current status of redifferentiation therapy for RAIR-DTC patients.

Citations

Citations to this article as recorded by  
  • Long-term impact of prophylactic central neck dissection in non-invasive classic papillary thyroid carcinoma
    Zehang Xu, Zhuochao Mao, Shitu Chen, Zhe Mo, Jie Zhou, Zhendong Chen, Rasa Zarnegar, Thomas J. Fahey III, Weibin Wang, Lisong Teng
    European Journal of Surgical Oncology.2024; 50(1): 107305.     CrossRef
  • The role of MAPK, notch and Wnt signaling pathways in papillary thyroid cancer: Evidence from a systematic review and meta-analyzing microarray datasets employing bioinformatics knowledge and literature
    Elham Amjad, Solmaz Asnaashari, Ali Jahanban-Esfahlan, Babak Sokouti
    Biochemistry and Biophysics Reports.2024; 37: 101606.     CrossRef
  • Diagnostic Performance of [18F]TFB PET/CT Compared with Therapeutic Activity [131I]Iodine SPECT/CT and [18F]FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma
    David Ventura, Matthias Dittmann, Florian Büther, Michael Schäfers, Kambiz Rahbar, Daniel Hescheler, Michael Claesener, Philipp Schindler, Burkhard Riemann, Robert Seifert, Wolfgang Roll
    Journal of Nuclear Medicine.2024; 65(2): 192.     CrossRef
  • Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer
    Qinglin Li, Lizhuo Zhang, Jiayan Lang, Zhuo Tan, Qingqing Feng, Fei Zhu, Guangna Liu, Zhangguo Ying, Xuefei Yu, He Feng, Heqing Yi, Qingliang Wen, Tiefeng Jin, Keman Cheng, Xiao Zhao, Minghua Ge
    Advanced Science.2023;[Epub]     CrossRef
  • Case Report: Regaining radioiodine uptake following PRRT in radioiodine-refractory thyroid cancer: A new re-differentiation strategy?
    Bentolhoda Hadad, Emran Askari, Seyed Rasoul Zakavi, Kamran Aryana, Soheila Erfani, Pegah Sahafi, Nima Nabavi, Atena Aghaee
    Frontiers in Nuclear Medicine.2023;[Epub]     CrossRef
  • Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy
    Yujia Liu, Jiafeng Wang, Xiaoping Hu, Zongfu Pan, Tong Xu, Jiajie Xu, Liehao Jiang, Ping Huang, Yiwen Zhang, Minghua Ge
    Drug Resistance Updates.2023; 68: 100939.     CrossRef
  • The role of miR-139-5p in radioiodine-resistant thyroid cancer
    V. Pecce, M. Sponziello, A. Verrienti, G. Grani, L. Abballe, S. Bini, S. Annunziata, G. Perotti, M. Salvatori, L. Zagaria, V. Maggisano, D. Russo, S. Filetti, C. Durante
    Journal of Endocrinological Investigation.2023; 46(10): 2079.     CrossRef
  • Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma
    Hang-Seok Chang, Yonjung Kim, So Young Lee, Hyeok Jun Yun, Ho-Jin Chang, Ki Cheong Park
    International Journal of Molecular Sciences.2023; 24(8): 7069.     CrossRef
  • Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer
    Diego Claro de Mello, Kelly Cristina Saito, Marcella Maringolo Cristovão, Edna Teruko Kimura, Cesar Seigi Fuziwara
    International Journal of Molecular Sciences.2023; 24(9): 7872.     CrossRef
  • Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer
    Kenta Nomura, Michihiro Nakayama, Atsutaka Okizaki
    Annals of Nuclear Medicine.2023; 37(8): 462.     CrossRef
  • Could Oxidative Stress Play a Role in the Development and Clinical Management of Differentiated Thyroid Cancer?
    Maria Kościuszko, Angelika Buczyńska, Adam Jacek Krętowski, Anna Popławska-Kita
    Cancers.2023; 15(12): 3182.     CrossRef
  • The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib
    Yuanna Ling, Xiaoli Xiong, Jiaxin Luo, Quanliang Zou, Pan Chen, Liqin Pan, Man Long, Huijuan Feng, Wei Ouyang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer
    Lu Zhang, Zhi Li, Meng Zhang, Huangren Zou, Yuke Bai, Yanlin Liu, Juan Lv, Ling Lv, Pengjie Liu, Zhiyong Deng, Chao Liu
    Medical Oncology.2023;[Epub]     CrossRef
  • Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer
    Yansong Lin, Shukui Qin, Hui Yang, Feng Shi, Aimin Yang, Xingmin Han, Bin Liu, Zhiyong Li, Qinghai Ji, Lijun Tang, Zhiyong Deng, Yong Ding, Wei Fu, Xianhe Xie, Linfa Li, Xiaohui He, Zhongwei Lv, Qingjie Ma, Zan Shen, Zhuming Guo, Zhendong Chen, Yali Cui,
    Clinical Cancer Research.2023; 29(15): 2791.     CrossRef
  • A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
    Riya Thapa, Gaurav Gupta, Asif Ahmad Bhat, Waleed Hassan Almalki, Sami I. Alzarea, Imran Kazmi, Shakir Saleem, Ruqaiyah Khan, Najla Altwaijry, Harish Dureja, Sachin Kumar Singh, Kamal Dua
    International Journal of Biological Macromolecules.2023; 253: 127375.     CrossRef
  • Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer
    Yuna Kim, Hyeok Jun Yun, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Seok-Mo Kim, Ki Cheong Park
    International Journal of Molecular Sciences.2023; 24(22): 16413.     CrossRef
  • Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas
    A.C.L. Mortensen, J. Imgenberg-Kreuz, D. Spiegelberg, J. Botling, M. Nestor
    Heliyon.2023; 9(12): e22594.     CrossRef
  • Canine follicular cell and medullary thyroid carcinomas: Immunohistochemical characterization
    Jana Jankovic, Eve Tièche, Martina Dettwiler, Kerstin Hahn, Stephanie Scheemaeker, Martin Kessler, Sylvie Daminet, Sven Rottenberg, Miguel Campos
    Veterinary Pathology.2023;[Epub]     CrossRef
  • Advancements in theranostic applications: exploring the role of fibroblast activation protein inhibition tracers in enhancing thyroid health assessment
    Yuhua Wang, Ye Liu, Huixia Geng, Wanchun Zhang
    EJNMMI Research.2023;[Epub]     CrossRef
  • Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer
    Christos Cortas, Haris Charalambous
    Life.2023; 14(1): 22.     CrossRef
  • microRNA-181a promotes the oncogene S100A2 and enhances papillary thyroid carcinoma growth by mediating the expression of histone demethylase KDM5C
    Y. Wang, H. Ye, Y. Yang, J. Li, A. Cen, L. Zhao
    Journal of Endocrinological Investigation.2022; 45(1): 17.     CrossRef
  • Systemic Therapy in Thyroid Cancer
    Amit Kumar Agrawal, Vanita Noronha, Vijay Patil, Nandini Menon, Akhil Kapoor, Anuradha Chougule, Pratik Chandrani, Kumar Prabhash
    Indian Journal of Surgical Oncology.2022; 13(1): 68.     CrossRef
  • Small activating RNA-activated NIS gene promotes 131I uptake and inhibits thyroid cancer via AMPK/mTOR pathway
    Li Jia, Yan Chen, Fukun Chen, Juan Lv, Yanling Li, Fei Hou, Zhixian Yang, Zhiyong Deng
    Pathology - Research and Practice.2022; 229: 153735.     CrossRef
  • Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid Cancer
    Hyeok Jun Yun, Minki Kim, Sang Yong Kim, Sungsoon Fang, Yonjung Kim, Hang-Seok Chang, Ho-Jin Chang, Ki Cheong Park
    International Journal of Molecular Sciences.2022; 23(2): 699.     CrossRef
  • Comprehensive Analysis of the Prognosis and Drug Sensitivity of Differentiation-Related lncRNAs in Papillary Thyroid Cancer
    Wenlong Wang, Ning Bai, Xinying Li
    Cancers.2022; 14(5): 1353.     CrossRef
  • American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment
    David C. Shonka, Alan Ho, Ashish V. Chintakuntlawar, Jessica L. Geiger, Jong C. Park, Nagashree Seetharamu, Sina Jasim, Amr H. Abdelhamid Ahmed, Keith C. Bible, Marcia S. Brose, Maria E. Cabanillas, Kirsten Dabekaussen, Louise Davies, Dora Dias‐Santagata,
    Head & Neck.2022; 44(6): 1277.     CrossRef
  • State of the Art in the Current Management and Future Directions of Targeted Therapy for Differentiated Thyroid Cancer
    Horatiu Silaghi, Vera Lozovanu, Carmen Emanuela Georgescu, Cristina Pop, Bogdana Adriana Nasui, Adriana Florinela Cătoi, Cristina Alina Silaghi
    International Journal of Molecular Sciences.2022; 23(7): 3470.     CrossRef
  • Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
    Ji Min Oh, Ramya Lakshmi Rajendran, Prakash Gangadaran, Chae Moon Hong, Ju Hye Jeong, Jaetae Lee, Byeong-Cheol Ahn
    Cancers.2022; 14(7): 1782.     CrossRef
  • The Role of the Kinase Inhibitors in Thyroid Cancers
    Francesca Cuomo, Claudio Giani, Gilda Cobellis
    Pharmaceutics.2022; 14(5): 1040.     CrossRef
  • In Silico Screening and Validation of PDGFRA Inhibitors Enhancing Radioiodine Sensitivity in Thyroid Cancer
    Xuefei Yu, Xuhang Zhu, Lizhuo Zhang, Jiang-Jiang Qin, Chunlai Feng, Qinglin Li
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma
    Ling Zhan, Hong-fang Feng, Xi-zi Yu, Ling-rui Li, Jun-long Song, Yi Tu, Jing-ping Yuan, Chuang Chen, Sheng-rong Sun
    BMC Surgery.2022;[Epub]     CrossRef
  • Radionuclide 131I-labeled albumin-indocyanine green nanoparticles for synergistic combined radio-photothermal therapy of anaplastic thyroid cancer
    Xuemei Zhang, Ziyu Yan, Zhaowei Meng, Ning Li, Qiang Jia, Yiming Shen, Yanhui Ji
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Re-evaluation of the role of autophagy in thyroid cancer treatment
    Darya Kazakova, Mika Shimamura, Tomomi Kurashige, Koichiro Hamada, Yuji Nagayama
    Endocrine Journal.2022; 69(7): 847.     CrossRef
  • Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges
    Suliman Salih, Ajnas Alkatheeri, Wijdan Alomaim, Aisyah Elliyanti
    Molecules.2022; 27(16): 5231.     CrossRef
  • Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma
    Seok-Mo Kim, Keunwan Park, Jin Hong Lim, Hyeok Jun Yun, Sang Yong Kim, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Cheol-Ho Pan, Ki Cheong Park
    International Journal of Molecular Sciences.2022; 23(18): 10378.     CrossRef
  • Research Progress of BRAF V600E Gene Mutation in Papillary Thyroid Carcinoma
    延泽 刘
    Advances in Clinical Medicine.2022; 12(09): 8499.     CrossRef
  • Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary Thyroid Cancer
    Jing Zhang, Aomei Zhao, Xi Jia, Xinru Li, Yiqian Liang, Yan Liu, Xin Xie, Xijie Qu, Qi Wang, Yuemin Zhang, Rui Gao, Yan Yu, Aimin Yang
    International Journal of Molecular Sciences.2022; 23(18): 10709.     CrossRef
  • miR-451a suppresses papillary thyroid cancer cell proliferation and invasion and facilitates apoptosis through targeting DCBLD2 and AKT1
    Jiuting Tan, Chunpu Li, Lijue Ren, Xiaohui Zhu, Fei Hua, Yuming Fu
    Molecular and Cellular Probes.2022; 66: 101863.     CrossRef
  • Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
    Tingting Qiao, Dingwei Gao, Junyu Tong, Yun Shen, Jiayue Ma, Zhongwei Lv, Dan Li
    Supportive Care in Cancer.2022; 30(12): 10169.     CrossRef
  • Different Expression of Thyroid-Specific Proteins in Thyroid Cancer Cells between 2-Dimensional (2D) and 3-Dimensional (3D) Culture Environment
    Ji Min Oh, Prakash Gangadaran, Ramya Lakshmi Rajendran, Chae Moon Hong, Jaetae Lee, Byeong-Cheol Ahn
    Cells.2022; 11(22): 3559.     CrossRef
  • Histone acetylation modifications: A potential targets for the diagnosis and treatment of papillary thyroid cancer
    Chongyang Chen, Jingfang Liu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter
    Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Tadashi Watabe, Kazuhiro Ooe, Takashi Yoshimura, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Koichi Fukase
    International Journal of Molecular Sciences.2022; 23(24): 15509.     CrossRef
  • Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
    Maaike Dotinga, Dennis Vriens, Floris H. P. van Velden, Mette K. Stam, Jan W. T. Heemskerk, Petra Dibbets-Schneider, Martin Pool, Daphne D. D. Rietbergen, Lioe-Fee de Geus-Oei, Ellen Kapiteijn
    Diagnostics.2022; 12(12): 3154.     CrossRef
  • Non-Apoptotic Programmed Cell Death in Thyroid Diseases
    Feihong Ji, Xinguang Qiu
    Pharmaceuticals.2022; 15(12): 1565.     CrossRef
  • Donafenib in Progressive Locally Advanced or Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Results of a Randomized, Multicenter Phase II Trial
    Yan-Song Lin, Hui Yang, Yong Ding, Yi-Zhuang Cheng, Feng Shi, Jian Tan, Zhi-Yong Deng, Zhen-Dong Chen, Rong-Fu Wang, Qing-Hai Ji, Rui Huang, Lin-Fa Li
    Thyroid.2021; 31(4): 607.     CrossRef
  • Radioactive iodine therapy may not improve disease‐specific survival in follicular variant papillary thyroid cancer without distant metastasis: A propensity score‐matched analysis
    Xiaofei Wang, Xun Zheng, Jingqiang Zhu, Zhihui Li, Tao Wei
    Head & Neck.2021; 43(6): 1730.     CrossRef
  • Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis
    Chaiho Jeong, Jeongmin Lee, Hyukjin Yoon, Jeonghoon Ha, Min-Hee Kim, Ja-Seong Bae, Chan-Kwon Jung, Jeong-Soo Kim, Moo-Il Kang, Dong-Jun Lim
    Cancers.2021; 13(4): 811.     CrossRef
  • Radio-Iodide Treatment: From Molecular Aspects to the Clinical View
    Antonio De la Vieja, Garcilaso Riesco-Eizaguirre
    Cancers.2021; 13(5): 995.     CrossRef
  • Advances of Nanomedicine in Radiotherapy
    Wei Liu, Bo Chen, Haocheng Zheng, Yun Xing, Guiyuan Chen, Peijie Zhou, Liting Qian, Yuanzeng Min
    Pharmaceutics.2021; 13(11): 1757.     CrossRef
  • Treatment Effect of Combining Lenvatinib and Vemurafenib for BRAF Mutated Anaplastic Thyroid Cancer
    Chae Moon Hong, Ji Min Oh, Prakash Gangadaran, Ramya Lakshmi Rajendran, Byeong-Cheol Ahn
    International Journal of Thyroidology.2021; 14(2): 127.     CrossRef
  • TNFα-mediated activation of NF-κB downregulates sodium-iodide symporter expression in thyroid cells
    Márcia Faria, Rita Domingues, Francisca Paixão, Maria João Bugalho, Paulo Matos, Ana Luísa Silva, Salvatore Papa
    PLOS ONE.2020; 15(2): e0228794.     CrossRef
  • Novel Targeted Therapies for Metastatic Thyroid Cancer—A Comprehensive Review
    Mohammad Al-Jundi, Shilpa Thakur, Sriram Gubbi, Joanna Klubo-Gwiezdzinska
    Cancers.2020; 12(8): 2104.     CrossRef
  • Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy
    Maaike Dotinga, Dennis Vriens, Floris van Velden, Linda Heijmen, James Nagarajah, Rodney Hicks, Ellen Kapiteijn, Lioe-Fee de Geus-Oei
    The Quarterly Journal of Nuclear Medicine and Molecular Imaging.2020;[Epub]     CrossRef
  • Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-β signaling and radioiodine resistance
    Hongwei Gao, Peirong Bai, Lin Xiao, Mengjia Shen, Qiuxiao Yu, Yuanyuan Lei, Wenting Huang, Xiang Lin, Xinyi Zheng, Tao Wei, Yong Jiang, Feng Ye, Hong Bu
    Journal of Biological Chemistry.2020; 295(31): 10726.     CrossRef
  • Peptide Receptor Radionuclide Therapy in Patients With Differentiated Thyroid Cancer
    Dong Yun Lee, Yong-il Kim
    Clinical Nuclear Medicine.2020; 45(8): 604.     CrossRef
  • Combination of peroxisome proliferator–activated receptor gamma and retinoid X receptor agonists induces sodium/iodide symporter expression and inhibits cell growth of human thyroid cancer cells
    Jui-Yu Chen, Jane-Jen Wang, Hsin-Chen Lee, Chin-Wen Chi, Chen-Hsen Lee, Yi-Chiung Hsu
    Journal of the Chinese Medical Association.2020; 83(10): 923.     CrossRef
Close layer
Original Articles
Bone Metabolism
Age-Related Changes in the Prevalence of Osteoporosis according to Gender and Skeletal Site: The Korea National Health and Nutrition Examination Survey 2008-2010
Jongseok Lee, Sungwha Lee, Sungok Jang, Ohk Hyun Ryu
Endocrinol Metab. 2013;28(3):180-191.   Published online September 13, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.3.180
  • 4,962 View
  • 76 Download
  • 56 Crossref
AbstractAbstract PDFPubReader   
Background

The incidence of osteoporosis and its related fractures are expected to increase significantly in the rapidly aging Korean population. Reliable data on the prevalence of this disease is essential for treatment planning. However, sparse data on Korean patients is available.

Methods

We analyzed data from the Korea National Health and Nutrition Examination Survey (KNHANES) 2008 to 2010. Bone mineral density (BMD) was measured at the femoral neck and lumbar spine using dual-energy X-ray absorptiometry. Osteopenia and osteoporosis were diagnosed according to the World Health Organization T-score criteria. We analyzed the BMD data of 17,208 people (men, 7,837; women, 9,368).

Results

The adjusted prevalence of osteoporosis was 7.8% in men versus 37.0% in women. No significant difference was observed in the prevalence of osteopenia between genders (men, 47.0%; women, 48.7%). The prevalence of osteoporosis in men in their 50s was 4.0%, in their 60s was 7.2%, in their 70s was 15.1%, and in their 80s was 26.7%. The figures in women were 15.2%, 36.5%, 62.7%, and 85.8%, respectively. The age group with the maximal BMD differed between genders. In the men, 20s had the highest value in all the skeletal sites. However, in the women, the maximal BMD in the femoral neck, lumbar spine, and the total hip was observed in their 20s, 30s, and 40s, respectively. The onset age of osteoporosis differed between genders. Osteoporosis in the femoral neck began at 55 years in the women and at 60 years in the men.

Conclusion

The prevalence of osteoporosis in Korea was significantly high. In addition, the age-related changes in the prevalence of osteoporosis differed according to gender and skeletal site.

Citations

Citations to this article as recorded by  
  • The entrancing role of dietary polyphenols against the most frequent aging‐associated diseases
    Muhammad Ajmal Shah, Hafiza Ishmal Faheem, Ayesha Hamid, Rimsha Yousaf, Muhammad Haris, Uzma Saleem, Ghulam Mujtaba Shah, Reem H. Alhasani, Norah A. Althobaiti, Ifat Alsharif, Ana Sanches Silva
    Medicinal Research Reviews.2024; 44(1): 235.     CrossRef
  • Chronic health conditions after childhood Langerhans cell histiocytosis: Results from the Swiss Childhood Cancer Survivor Study
    Tomáš Sláma, Luzius Mader, Maša Žarković, Reta Malär, Alexandra Schifferli, Nicolas X. von der Weid, Claudia E. Kuehni, Christina Schindera
    Journal of Cancer Survivorship.2024;[Epub]     CrossRef
  • Osteoporosis and its associated factors among patients attending Manakamana Hospital, Chitwan, Nepal
    Shankar Dhakal, Kalpana Sharma, Kishor Adhikari, Alisha Joshi, Sunita Poudyal, Chiranjivi Adhikari
    PLOS ONE.2024; 19(2): e0289517.     CrossRef
  • Closed-wedge high tibial osteotomy is more advantageous to maintain the correction than open-wedge high tibial osteotomy in osteopenic patients
    Sang Jun Song, Kyoung Ho Yoon, Kang Il Kim, Cheol Hee Park
    Knee Surgery, Sports Traumatology, Arthroscopy.2023; 31(4): 1563.     CrossRef
  • Influence of the Changes in the Bone Mineral Density on the Guided Bone Regeneration Using Bioinspired Grafts: A Systematic Review and Meta-analysis
    Angelica M. Castillo-Paz, Brandon A. Correa-Piña, Harol D. Martinez-Hernandez, Omar M. Gomez-Vazquez, Dorian F. Cañon-Davila, Luis F. Zubieta-Otero, Sandra M. Londoño-Restrepo, Esther Perez-Torrero, Mario E. Rodriguez-Garcia
    Biomedical Materials & Devices.2023; 1(1): 162.     CrossRef
  • Effective Treatment of Femur Diaphyseal Fracture with Compression Plate – A Finite Element and In Vivo Study Comparing the Healing Outcomes of Nailing and Plating
    Sandeep Rathor, Rashmi Uddanwadiker, Nandram Saryam, Ashutosh Apte
    Indian Journal of Orthopaedics.2023; 57(1): 146.     CrossRef
  • Vertebral trabecular bone texture analysis in opportunistic MRI and CT scan can distinguish patients with and without osteoporotic vertebral fracture: A preliminary study
    François Poullain, Pierre Champsaur, Vanessa Pauly, Paul Knoepflin, Thomas Le Corroller, Maud Creze, Martine Pithioux, David Bendahan, Daphne Guenoun
    European Journal of Radiology.2023; 158: 110642.     CrossRef
  • INFLUENCE OF FIXATION STABILIZATION ON FEMUR DIAPHYSEAL FRACTURE HEALING — A FINITE ELEMENT STUDY COMPARING HEALING OUTCOMES OF NAILING AND PLATING
    SANDEEP RATHOR, RASHMI UDDANWADIKER, ASHUTOSH APTE
    Journal of Mechanics in Medicine and Biology.2023;[Epub]     CrossRef
  • Vitamin C Deficiency Deteriorates Bone Microarchitecture and Mineralization in a Sex-Specific Manner in Adult Mice
    Stéphane Blouin, Farzaneh Khani, Phaedra Messmer, Paul Roschger, Markus A. Hartmann, Andre J. van Wijnen, Roman Thaler, Barbara M. Misof
    Journal of Bone and Mineral Research.2023; 38(10): 1509.     CrossRef
  • Comparison of HU histogram analysis and BMD for proximal femoral fragility fracture assessment: a retrospective single-center case–control study
    Sun-Young Park, Hong Il Ha, Injae Lee, Hyun Kyung Lim
    European Radiology.2022; 32(3): 1448.     CrossRef
  • Effect of osteoporosis-related reduction in the mechanical properties of bone on the acetabular fracture during a sideways fall: A parametric finite element approach
    Shahab Khakpour, Amir Esrafilian, Petri Tanska, Mika E. Mononen, Rami K. Korhonen, Timo Jämsä, Ewa Tomaszewska
    PLOS ONE.2022; 17(2): e0263458.     CrossRef
  • Evaluation of the bone mineral density in the Mexican female population using the Radiofrequency Echographic Multi Spectrometry (REMS) technology
    Rosales-Ortiz Sergio, Rivera García Elaín Nayelli
    Archives of Osteoporosis.2022;[Epub]     CrossRef
  • Non‐fermented tea consumption protects against osteoporosis among Chinese male elders using the Taiwan biobank database
    Chiao-Lin Hsu, Wei-Lun Huang, Hung-Hui Chen, Jerry Cheng-Yen Lai
    Scientific Reports.2022;[Epub]     CrossRef
  • Prevalence of osteopenic syndrome and osteoporosis among residents of the older age group of Kyrgyzstan
    T. J. Tagaev, F. E. Imanalieva, S. M. Mamatov, E. Marishbek kyzy, B. T. Tagaeva
    Acta Biomedica Scientifica.2022; 7(4): 130.     CrossRef
  • Do antihypertensive medications effect the mandibular cortical bone thickness? A study using cone beam computed tomography images
    Brett Spenrath, Antonia Kolokythas
    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2022; 134(6): 687.     CrossRef
  • Topical application of the plant extract SDTL-E in ovariectomized rats: A potential new approach for treating osteoporosis
    Hui-Yuan Shih, Jun-Hua Lu, Ai-Hua Xiong, Juliana Man-Wai Tse, Ben Siu-Tak Wong
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Measures of physical performance as a predictor of fracture risk independent of BMD: The Chungju metabolic disease cohort study
    Yejee Lim, Jeonghoon Ha, Kun Ho Yoon, Ki Hyun Baek, Moo-Il Kang
    Bone.2021; 145: 115878.     CrossRef
  • Alendronate use in older patients with reduced renal function: challenges and opportunities in clinical practice
    N. Naganathar, W. -P. Yau, Z. H. Mok, Z. Y. F. Tan, S. T. H. Chew
    Osteoporosis International.2021; 32(10): 1981.     CrossRef
  • Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
    Yi Chen, Jun Zhu, Yiqin Zhou, Jinhui Peng, Bo Wang
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Chronic active non-lethal human-type tuberculosis in a high royal Bavarian officer of Napoleonic times–a mummy study
    Andreas G. Nerlich, Sonja M. Kirchhoff, Stephanie Panzer, Christine Lehn, Beatrice E. Bachmeier, Birgit Bayer, Katja Anslinger, Pascale Röcker, Oliver K. Peschel, Mark Spigelman
    PLOS ONE.2021; 16(5): e0249955.     CrossRef
  • Sex-related differences in bone metabolism in osteoporosis observational study
    Kyu Hwan Choi, Jong Ho Lee, Dong Gyu Lee
    Medicine.2021; 100(21): e26153.     CrossRef
  • Analysis of Bone Mineral Density of Ankle Fracture Patients
    Tae Hyung Kim, Jae Hyung Lee, Seung-Hwan Park
    Journal of the Korean Orthopaedic Association.2021; 56(4): 334.     CrossRef
  • The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis
    Nader Salari, Hooman Ghasemi, Loghman Mohammadi, Mohammad hasan Behzadi, Elham Rabieenia, Shamarina Shohaimi, Masoud Mohammadi
    Journal of Orthopaedic Surgery and Research.2021;[Epub]     CrossRef
  • Systemic oxidative stress in old rats is associated with both osteoporosis and cognitive impairment
    María Luz Torres, Nahuel Ezequiel Wanionok, Antonio Desmond McCarthy, Gustavo Ramón Morel, Juan Manuel Fernández
    Experimental Gerontology.2021; 156: 111596.     CrossRef
  • Association of Sarcopenia with Osteopenia and Osteoporosis in Community-Dwelling Older Korean Adults: A Cross-Sectional Study
    Do-Youn Lee, Sunghoon Shin
    Journal of Clinical Medicine.2021; 11(1): 129.     CrossRef
  • Prevalence of osteopenia and osteoporosis in elderly and senile individuals of Kyrgyzstan
    Tugolbai J. Tagaev
    Science and Innovations in Medicine.2021; 7(1): 26.     CrossRef
  • Young cancer survivors have lower bone mineral density compared with healthy controls: a nationwide population-based study in Korea
    Hyoeun Kim, Sunmi Yoo, Seung Guk Park
    Scientific Reports.2020;[Epub]     CrossRef
  • Underestimated fracture risk in postmenopausal women—application of the hybrid intervention threshold
    Y. Wang, S. Yu, C. Hsu, C. Tsai, T. Cheng
    Osteoporosis International.2020; 31(3): 475.     CrossRef
  • Does the skull Hounsfield unit predict shunt dependent hydrocephalus after decompressive craniectomy for traumatic acute subdural hematoma?
    In-Suk Bae, Jae Min Kim, Jin Hwan Cheong, Je Il Ryu, Kyu-Sun Choi, Myung-Hoon Han, Michael C. Burger
    PLOS ONE.2020; 15(4): e0232631.     CrossRef
  • The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options
    Manju Chandran, Tang Ching Lau, Isabelle Gagnon-Arpin, Alexandru Dobrescu, Wenshan Li, Man Yee Mallory Leung, Narendra Patil, Zhongyun Zhao
    Archives of Osteoporosis.2019;[Epub]     CrossRef
  • Prevalence and Predictors of Osteoporosis Among the Chinese Population in Klang Valley, Malaysia
    Shaanthana Subramaniam, Chin-Yi Chan, Ima-Nirwana Soelaiman, Norazlina Mohamed, Norliza Muhammad, Fairus Ahmad, Mohd Rizal Abd Manaf, Pei-Yuen Ng, Nor Aini Jamil, Kok-Yong Chin
    Applied Sciences.2019; 9(9): 1820.     CrossRef
  • Elevated Red Blood Cell Distribution Width Is Associated with Morphometric Vertebral Fracture in Community-Dwelling Older Adults, Independent of Anemia, Inflammation, and Nutritional Status: The Korean Urban Rural Elderly (KURE) Study
    Namki Hong, Chang Oh Kim, Yoosik Youm, Jin-Young Choi, Hyeon Chang Kim, Yumie Rhee
    Calcified Tissue International.2019; 104(1): 26.     CrossRef
  • Different impacts of dementia on two-year mortality after osteosynthesis and hemiarthroplasty in treating geriatric hip fractures
    Yu-Cheng Lai, Pei-Ling Tang, Tsu-Jen Kuo, Chien-Jen Hsu
    Archives of Gerontology and Geriatrics.2018; 79: 116.     CrossRef
  • Association between metabolic syndrome and blepharoptosis in the Korean adults: the Korea National Health and Nutrition Examination Survey 2010–2012
    Changhyun Koh, Geunyeong Kim, Kyungdo Han, Juwan Park
    Journal of Cosmetic Medicine.2018; 2(2): 85.     CrossRef
  • The Relationship of Serum Serotonin Levels to the Rate of Bone Loss and Fractures in Men
    Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Moo-Il Kang, Ki-Hyun Baek
    Journal of Clinical Densitometry.2018; 21(1): 35.     CrossRef
  • Utilization of Osteoporosis-Related Health Services: Use of Data from the Korean National Health Insurance Database 2008–2012
    Tae Yang Yu, Hyemin Cho, Tae-Young Kim, Yong-Chan Ha, Sunmee Jang, Ha Young Kim
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • Association between liver enzymes and bone mineral density in Koreans: a cross-sectional study
    Ho Jeong Do, Joon-Shik Shin, Jinho Lee, Yoon Jae Lee, Me-riong Kim, Dongwoo Nam, Eun-Jung Kim, Yeoncheol Park, Kristin Suhr, In-Hyuk Ha
    BMC Musculoskeletal Disorders.2018;[Epub]     CrossRef
  • The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study
    Y. Lim, K. Jo, H.-S. Ha, H.-W. Yim, K.-H. Yoon, W.-C. Lee, H.-Y. Son, K. H. Baek, M.-I. Kang
    Osteoporosis International.2017; 28(4): 1453.     CrossRef
  • Strong familial association of bone mineral density between parents and offspring: KNHANES 2008–2011
    H. S. Choi, J. H. Park, S. H. Kim, S. Shin, M. J. Park
    Osteoporosis International.2017; 28(3): 955.     CrossRef
  • Gender- and age-group-specific associations between physical performance and bone mineral density, falls, and osteoporotic fractures in Koreans: the Chungju Metabolic Disease Cohort study
    Yejee Lim, Kyunghee Kim, Sun-Hee Ko, Kwanhoon Cho, Eun-Hee Jang, Seung-Hwan Lee, Dong Jun Lim, Ki Hyun Baek, Hee-Sung Ha, Mi Sun Park, Hyeon-Woo Yim, Won-Chul Lee, Kun-Ho Yoon, Ho Young Son, Ki Won Oh, Moo-Il Kang
    Journal of Bone and Mineral Metabolism.2016; 34(3): 336.     CrossRef
  • Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008–2010 Korea National Health and Nutrition Examination Surveys
    Myong Ki Baeg, Seung Kew Yoon, Sun-Hye Ko, Kyung-Do Han, Hye Jin Choi, Si Hyun Bae, Jong Young Choi, Myung-Gyu Choi
    Hepatology International.2016; 10(3): 470.     CrossRef
  • Age- and Sex-Specific Relationships between Household Income, Education, and Diabetes Mellitus in Korean Adults: The Korea National Health and Nutrition Examination Survey, 2008-2010
    So-Ra Kim, Kyungdo Han, Jin-Young Choi, Jennifer Ersek, Junxiu Liu, Sun-Jin Jo, Kang-Sook Lee, Hyeon Woo Yim, Won-Chul Lee, Yong Gyu Park, Seung-Hwan Lee, Yong-Moon Park, C. Mary Schooling
    PLOS ONE.2015; 10(1): e0117034.     CrossRef
  • A novel criterion for identifying metabolically obese but normal weight individuals using the product of triglycerides and glucose
    S-H Lee, K Han, H K Yang, H-S Kim, J-H Cho, H-S Kwon, Y-M Park, B-Y Cha, K-H Yoon
    Nutrition & Diabetes.2015; 5(4): e149.     CrossRef
  • Hydrogeochemistry of the drinking water sources of Derebogazi Village (Kahramanmaras) and their effects on human health
    Yusuf Uras, Yagmur Uysal, Tugba Atilan Arikan, Alican Kop, Mustafa Caliskan
    Environmental Geochemistry and Health.2015; 37(3): 475.     CrossRef
  • Lower serum zinc levels are associated with unhealthy metabolic status in normal-weight adults: The 2010 Korea National Health and Nutrition Examination Survey
    H.K. Yang, S.H. Lee, K. Han, B. Kang, S.Y. Lee, K.H. Yoon, H.S. Kwon, Y.M. Park
    Diabetes & Metabolism.2015; 41(4): 282.     CrossRef
  • The effects of the Korean reference value on the prevalence of osteoporosis and the prediction of fracture risk
    Sungwha Lee, Moon-Gi Choi, Jaemyung Yu, Ohk-Hyun Ryu, Hyung Joon Yoo, Sung-Hee Ihm, Doo-Man Kim, Eun-Gyung Hong, Kyutae Park, Myungjin Choi, Hyunhee Choi
    BMC Musculoskeletal Disorders.2015;[Epub]     CrossRef
  • Gender Difference in Osteoporosis Prevalence, Awareness and Treatment: Based on the Korea National Health and Nutrition Examination Survey 2008~2011
    Yunmi Kim, Jung Hwan Kim, Dong Sook Cho
    Journal of Korean Academy of Nursing.2015; 45(2): 293.     CrossRef
  • The effects of thyrotropin-suppressing therapy on bone metabolism in patients with well-differentiated thyroid carcinoma
    Mee Kyoung Kim, Kyung-Jin Yun, Min-Hee Kim, Dong-Jun Lim, Hyuk-Sang Kwon, Ki-Ho Song, Moo-Il Kang, Ki Hyun Baek
    Bone.2015; 71: 101.     CrossRef
  • Prevalence and clinical characteristics of blepharoptosis in patients with diabetes in the Korea National Health and Nutrition Examination Survey (KNHANES) 2009–2010
    Seong-Su Moon, Young-Sil Lee
    Endocrine.2015; 48(2): 504.     CrossRef
  • Biomechanical rationale for implant choices in femoral neck fracture fixation in the non-elderly
    Michalis Panteli, Paul Rodham, Peter V. Giannoudis
    Injury.2015; 46(3): 445.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
  • Discordance in Diagnosis of Osteoporosis by Skeletal Site in Korean Women: KNHANES 2008-2010
    Jongseok Lee, Sungwha Lee
    Journal of the Korea Academia-Industrial cooperation Society.2014; 15(3): 1590.     CrossRef
  • Effect of Transdermal Estrogen Therapy on Bone Mineral Density in Postmenopausal Korean Women
    Hyo Jeong Kim, Yoon Kyung Oh, Ji Soo Lee, Dong-Yun Lee, DooSeok Choi, Byung-Koo Yoon
    Journal of Menopausal Medicine.2014; 20(3): 111.     CrossRef
  • New Reference Data on Bone Mineral Density and the Prevalence of Osteoporosis in Korean Adults Aged 50 Years or Older: The Korea National Health and Nutrition Examination Survey 2008-2010
    Kyung-Shik Lee, Su-Hyun Bae, Seung Hwa Lee, Jungun Lee, Dong Ryul Lee
    Journal of Korean Medical Science.2014; 29(11): 1514.     CrossRef
  • Two Sides of Obesity: Metabolic Syndrome and Osteoporosis in Elderly Women, Gangwon-do, Korea
    Sungok Jang, Sungwha Lee, Jongseok Lee
    Korean Journal of Health Education and Promotion.2014; 31(1): 13.     CrossRef
  • Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
    Se Hwa Kim
    Endocrinology and Metabolism.2014; 29(1): 30.     CrossRef
Close layer
Thyroid
Associations between Hashimoto Thyroiditis and Clinical Outcomes of Papillary Thyroid Cancer: A Meta-Analysis of Observational Studies
Shinje Moon, Hye Soo Chung, Jae Myung Yu, Hyung Joon Yoo, Jung Hwan Park, Dong Sun Kim, Young Joo Park
Endocrinol Metab. 2018;33(4):473-484.   Published online November 30, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.4.473
  • 7,755 View
  • 113 Download
  • 56 Web of Science
  • 55 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Epidemiological studies have suggested an association between Hashimoto thyroiditis (HT) and papillary thyroid cancer (PTC) development. Other studies, however, have reported a protective role of HT against PTC progression. Through this updated meta-analysis, we aimed to clarify the effects of HT on the progression of PTC.

Methods

We searched citation databases, including PubMed and Embase, for relevant studies from inception to September 2017. From these studies, we calculated the pooled odds ratios (ORs) of clinicopathologic features and the relative risk (RR) of PTC recurrence with 95% confidence intervals (CIs) using the Mantel-Haenszel method. Additionally, the Higgins I2 statistic was used to test for heterogeneity.

Results

The meta-analysis included 71 published studies with 44,034 participants, among whom 11,132 had HT. We observed negative associations between PTC with comorbid HT and extrathyroidal extension (OR, 0.74; 95% CI, 0.68 to 0.81), lymph node metastasis (OR, 0.82; 95% CI, 0.72 to 0.94), distant metastasis (OR, 0.49; 95% CI, 0.32 to 0.76), and recurrence (RR, 0.50; 95% CI, 0.41 to 0.61).

Conclusion

In this meta-analysis, PTC patients with HT appeared to exhibit more favorable clinicopathologic characteristics and a better prognosis than those without HT.

Citations

Citations to this article as recorded by  
  • Malignancy risk of indeterminate lymph node at the central compartment in patients with thyroid cancer and concomitant sonographic thyroiditis
    Jung Hyo Rhim, Ji Ye Lee, Sun‐Won Park, Younghen Lee, So Lyung Jung, Tae Jin Yun, Eun Ju Ha, Jung Hwan Baek, Jinna Kim, Dong Gyu Na, Ji‐hoon Kim
    Head & Neck.2024;[Epub]     CrossRef
  • Hashimoto Thyroiditis and Mortality in Patients with Differentiated Thyroid Cancer: The National Epidemiologic Survey of Thyroid Cancer in Korea and Meta-Analysis
    Injung Yang, Jae Myung Yu, Hye Soo Chung, Yoon Jung Kim, Yong Kyun Roh, Min Kyu Choi, Sung-ho Park, Young Joo Park, Shinje Moon
    Endocrinology and Metabolism.2024;[Epub]     CrossRef
  • Interaction of BANCR in the relationship between Hashimoto’s thyroiditis and papillary thyroid carcinoma expression patterns and possible molecular mechanisms
    Jiabo Zhang, Lingli Yao, Yu Guo
    The Journal of Gene Medicine.2024;[Epub]     CrossRef
  • Association between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis
    Jie Liu
    Clinical Thyroidology®.2024; 36(1): 26.     CrossRef
  • Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021
    Yu Zhao, Wei Shi, Fang Dong, Xiuhua Wang, Chong Lu, Chunping Liu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study
    Shirzad Nasiri, Seyed Mostafa Meshkati Yazd, Mahsa Gholami, Sepehr Shahriarirad, Sina Sharghi, Reza Shahriarirad
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • Hashimoto’s Thyroiditis: A Protective Factor against Recurrence in BRAF-Wild Type Differentiated Thyroid Carcinoma
    Peter P. Issa, Mahmoud Omar, Yusef Buti, Mohamed Aboueisha, Ruhul Munshi, Mohammad Hussein, Muhib Haidari, Graham Blair, Chad P. Issa, Mohamed Shama, Eman Toraih, Emad Kandil
    Cancers.2023; 15(8): 2371.     CrossRef
  • VITAMIN D AND AUTOIMMUNE THYROIDITIS
    K. V. Pivtorak, O. V Ivanhuk O. V
    Bulletin of Problems Biology and Medicine.2023; 1(1): 44.     CrossRef
  • Does the Association of Hashimoto's Thyroiditis with Differentiated Thyroid Cancer Really Have a Protective Role?
    Ahmet Numan Demir, Zehra Kara, Cem Sulu, Serhat Uysal, Serdar Sahin, Guldana Zulfaliyeva, Oznur Aydin Atar, Nahida Valikhanova, Tulin Ozturk, Hande Mefkure Ozkaya, Mustafa Sait Gonen
    Hormone and Metabolic Research.2023; 55(06): 388.     CrossRef
  • Ultrasound, laboratory and histopathological insights in diagnosing papillary thyroid carcinoma in a paediatric population: a single centre follow-up study between 2000-2022
    Dominika Januś, Małgorzata Wójcik, Anna Taczanowska-Niemczuk, Aleksandra Kiszka-Wiłkojć, Monika Kujdowicz, Małgorzata Czogała, Wojciech Górecki, Jerzy B. Starzyk
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Early Post-operative Stimulated Serum Thyroglobulin: Role in Preventing Unnecessary Radioactive Iodine Treatment in Low to Intermediate Risk Papillary Thyroid Cancer
    Havva Sezer, Dilek Yazıcı, Tarık Terzioğlu, Serdar Tezelman, Hande Bulut Canbaz, Aslıhan Yerlikaya, Mehmet Onur Demirkol, Yersu Kapran, Bülent Çolakoğlu, Eda Nur Çilingiroğlu, Faruk Alagöl
    The American Surgeon™.2023; 89(12): 5996.     CrossRef
  • 2023 Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules
    Young Joo Park, Eun Kyung Lee, Young Shin Song, Soo Hwan Kang, Bon Seok Koo, Sun Wook Kim, Dong Gyu Na, Seung-Kuk Baek, So Won Oh, Min Kyoung Lee, Sang-Woo Lee, Young Ah Lee, Yong Sang Lee, Ji Ye Lee, Dong-Jun Lim, Leehi Joo, Yuh-Seog Jung, Chan Kwon Jung
    International Journal of Thyroidology.2023; 16(1): 1.     CrossRef
  • Clonal redemption of B cells in cancer
    Tyler R. McCaw, Serena Y. Lofftus, Joseph G. Crompton
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto’s thyroiditis: a systematic review with meta-analysis
    Lukasz Janicki, Agastya Patel, Jarosław Jendrzejewski, Andrzej Hellmann
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis
    Nese E. GULCELIK, Safak AKIN, Kadriye AYDIN, Cisel AYDIN MERICOZ, Yesim G. GULER TEZEL, Aydan USMAN
    Minerva Endocrinology.2023;[Epub]     CrossRef
  • Chronic Lymphocytic Thyroiditis and Aggressiveness of Pediatric Differentiated Thyroid Cancer
    Richard M. Yeker, Amber D. Shaffer, Pushpa Viswanathan, Selma F. Witchel, Kevin Mollen, Linwah Yip, Sara E. Monaco, Umamaheswar Duvvuri, Jeffrey P. Simons
    The Laryngoscope.2022; 132(8): 1668.     CrossRef
  • Bisphenol A drives di(2-ethylhexyl) phthalate promoting thyroid tumorigenesis via regulating HDAC6/PTEN and c-MYC signaling
    Xuan Zhang, Nan Guo, Hao Jin, Renqi Liu, Zhen Zhang, Cheng Cheng, Zhijun Fan, Guopei Zhang, Mingyang Xiao, Shengwen Wu, Yuejiao Zhao, Xiaobo Lu
    Journal of Hazardous Materials.2022; 425: 127911.     CrossRef
  • Squamous Differentiation in the Thyroid: Metaplasia, Neoplasia, or Bystander?
    Meagan A. Chambers, Peter M. Sadow, Darcy A. Kerr
    International Journal of Surgical Pathology.2022; 30(4): 385.     CrossRef
  • Vitamin D Implications and Effect of Supplementation in Endocrine Disorders: Autoimmune Thyroid Disorders (Hashimoto’s Disease and Grave’s Disease), Diabetes Mellitus and Obesity
    Dorina Galușca, Mihaela Simona Popoviciu, Emilia Elena Babeș, Mădălina Vidican, Andreea Atena Zaha, Vlad Victor Babeș, Alexandru Daniel Jurca, Dana Carmen Zaha, Florian Bodog
    Medicina.2022; 58(2): 194.     CrossRef
  • Central Compartment Lymph Nodes Have Distinct Metastatic Patterns in Different Age Groups
    Caigu Yan, Xianghui He, Zuoyu Chen, Yizeng Wang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Synchronous occurrence of papillary thyroid microcarcinoma, medullary thyroid carcinoma and Hashimoto thyroiditis in a single thyroid: A case report with literature review
    Ari M. Abdullah, Rawa M. Ali, Karzan M. Salih, Karukh K. Mohammed, Fahmi H. Kakamad, Abdulwahid M. Salih
    International Journal of Surgery Case Reports.2022; 93: 106888.     CrossRef
  • Benign and malignant thyroid nodules with autoimmune thyroiditis
    Georgia N. Kassi, Catherine C. Evangelopoulou, Konstantinos D. Papapostolou, Helen J. Karga
    Archives of Endocrinology and Metabolism.2022;[Epub]     CrossRef
  • Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis
    Qizhi Tang, Weiyu Pan, Liangyue Peng, Francis Moore
    PLOS ONE.2022; 17(6): e0269995.     CrossRef
  • A Narrative Review of Preventive Central Lymph Node Dissection in Patients With Papillary Thyroid Cancer - A Necessity or an Excess
    David D. Dolidze, Alexey V. Shabunin, Robert B. Mumladze, Arshak V. Vardanyan, Serghei D. Covantsev, Alexander M. Shulutko, Vasiliy I. Semikov, Khalid M. Isaev, Airazat M. Kazaryan
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Role of papillary thyroid carcinoma patients with Hashimoto thyroiditis: evaluation of oxidative stress and inflammatory markers
    Natália Medeiros Dias Lopes, Hannah Hamada Mendonça Lens, Walison Augusto da Silva Brito, Julya Karen Bianchi, Poliana Camila Marinello, Rubens Cecchini, André Armani, Alessandra Lourenço Cecchini
    Clinical and Translational Oncology.2022; 24(12): 2366.     CrossRef
  • Emerging trends and hot spots in autoimmune thyroiditis research from 2000 to 2022: A bibliometric analysis
    Qiuxian Li, Wanyu Yang, Jiashu Li, Zhongyan Shan
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • The Immune Landscape of Papillary Thyroid Cancer in the Context of Autoimmune Thyroiditis
    Fabiana Pani, Paola Caria, Yoshinori Yasuda, Miyara Makoto, Stefano Mariotti, Laurence Leenhardt, Solmaz Roshanmehr, Patrizio Caturegli, Camille Buffet
    Cancers.2022; 14(17): 4287.     CrossRef
  • Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto’s thyroiditis
    Yuepeng Zhang, Yueli Tian
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Elastographic Evaluation of Thyroid Nodules in Children and Adolescents with Hashimoto’s Thyroiditis and Nodular Goiter with Reference to Cytological and/or Histopathological Diagnosis
    Hanna Borysewicz-Sańczyk, Beata Sawicka, Filip Bossowski, Janusz Dzięcioł, Artur Bossowski
    Journal of Clinical Medicine.2022; 11(21): 6339.     CrossRef
  • Prognostic value of the preoperative and early trends in postoperative serum thyroglobulin antibody levels among patients with papillary thyroid carcinoma and concomitant Hashimoto’s thyroiditis
    Siyuan Xu, Hui Huang, Jiaxin Qian, Xiaolei Wang, Zhengang Xu, Shaoyan Liu, Jie Liu
    Endocrine.2022; 80(2): 392.     CrossRef
  • What has changed in the last 20 years in the postoperative specimen findings of the papillary thyroid cancer cases? A retrospective analysis
    Burak Bakar, Pınar Taşar, Turkay Kırdak, Sadık Kılıçturgay
    Turkish Journal of Surgery.2022; 38(4): 345.     CrossRef
  • A nomogram model based on the preoperative clinical characteristics of papillary thyroid carcinoma with Hashimoto's thyroiditis to predict central lymph node metastasis
    Wanjun Zhao, Linye He, Jingqiang Zhu, Anping Su
    Clinical Endocrinology.2021; 94(2): 310.     CrossRef
  • The Association of Histologically Proven Chronic Lymphocytic Thyroiditis with Clinicopathological Features, Lymph Node Metastasis, and Recurrence Rates of Differentiated Thyroid Cancer
    Berna İmge Aydoğan, Adile Begüm Bahçecioğlu Mutlu, Seher Yüksel, Sevim Güllü, Rıfat Emral, Özgür Demir, Mustafa Şahin, Vedia Tonyukuk Gedik, Demet Çorapçıoğlu, Serpil Dizbay Sak, Murat Faik Erdoğan
    Endocrine Pathology.2021; 32(2): 280.     CrossRef
  • Beneficial autoimmunity improves cancer prognosis
    Laurence Zitvogel, Claude Perreault, Olivera J. Finn, Guido Kroemer
    Nature Reviews Clinical Oncology.2021; 18(9): 591.     CrossRef
  • Influence Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: Hashimoto’s Thyroiditis Has a Weak Effect on Central or Lateral Lymph Node Metastasis
    Liguang Zhou, Gang Chen, Lei Sheng, Nan Liu, Bin Zhang, Qingdong Zeng, Bo Chen
    Cancer Management and Research.2021; Volume 13: 3953.     CrossRef
  • Implications of a background of Hashimoto’s thyroiditis on the current conservative surgical trend towards papillary thyroid carcinoma
    Shadi Hamouri, Sohail Bakkar, Almoutuz Aljaafreh, Mohammed Bani Hani, Hussein Heis, Ghazi Qasaimeh, Nasr Alrabadi, Wisam Al Gargaz, Haitham Odat, Yazan Alkurdi, Tarek Manasreh, Mohammad Matalka, Moamin Badwan
    Updates in Surgery.2021; 73(5): 1931.     CrossRef
  • Thyroid nodules in childhood‐onset Hashimoto's thyroiditis: Frequency, risk factors, follow‐up course and genetic alterations of thyroid cancer
    Yun Jeong Lee, Yeon Jin Cho, You Joung Heo, Eun‐Jae Chung, Young Hun Choi, Jong‐Il Kim, Young Joo Park, Choong Ho Shin, Young Ah Lee
    Clinical Endocrinology.2021; 95(4): 638.     CrossRef
  • Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes
    Siyuan Xu, Hui Huang, Jiaxin Qian, Yang Liu, Ying Huang, Xiaolei Wang, Shaoyan Liu, Zhengang Xu, Jie Liu
    JAMA Network Open.2021; 4(7): e2118526.     CrossRef
  • The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer
    Davut Sakiz, Muhammed Erkam Sencar, Murat Calapkulu, Ilknur Ozturk Unsal, Levent Aktas, Bekir Ucan, Mustafa Ozbek, Erman Cakal
    Endocrine Practice.2021; 27(12): 1199.     CrossRef
  • Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto’s Thyroiditis
    Xiao-xiong Gan, Ya-yi Li, Si-jin Li, Shi-sen Mo, Jian-hua Feng, Fei Shen, Wen-song Cai, Ye-qian Lai, Bo Xu
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Pre-existing Thyroiditis Ameliorates Papillary Thyroid Cancer: Insights From a New Mouse Model
    Fabiana Pani, Yoshinori Yasuda, Giulia Di Dalmazi, Paulina Chalan, Kathleen Gabrielson, Luigi Adamo, Elena Sabini, Stefano Mariotti, Patrizio Caturegli
    Endocrinology.2021;[Epub]     CrossRef
  • Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma
    Juliette Paillet, Céleste Plantureux, Sarah Lévesque, Julie Le Naour, Gautier Stoll, Allan Sauvat, Pamela Caudana, Jimena Tosello Boari, Norma Bloy, Sylvie Lachkar, Isabelle Martins, Paule Opolon, Andrea Checcoli, Agathe Delaune, Noémie Robil, Pierre de l
    Journal of Experimental Medicine.2021;[Epub]     CrossRef
  • Papillary Thyroid Cancer Prognosis: An Evolving Field
    Salvatore Ulisse, Enke Baldini, Augusto Lauro, Daniele Pironi, Domenico Tripodi, Eleonora Lori, Iulia Catalina Ferent, Maria Ida Amabile, Antonio Catania, Filippo Maria Di Matteo, Flavio Forte, Alberto Santoro, Piergaspare Palumbo, Vito D’Andrea, Salvator
    Cancers.2021; 13(21): 5567.     CrossRef
  • Overexpression of PD-L1 in Papillary Carcinoma and Its Association with Clinicopathological Variables
    Servet KOCAÖZ, Gülay TURAN
    Düzce Tıp Fakültesi Dergisi.2021; 23(3): 252.     CrossRef
  • Correlation Between Hashimoto's Thyroiditis–Related Thyroid Hormone Levels and 25-Hydroxyvitamin D
    Guanqun Chao, Yue Zhu, Lizheng Fang
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma
    Dongbin Ahn, Gil J. Lee, Jin H. Sohn, Jae H. Jeon
    Head & Neck.2020; 42(5): 1004.     CrossRef
  • Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1
    Li Jianming, Liu Jibin, Qian Linxue
    European Journal of Radiology.2020; 123: 108801.     CrossRef
  • Unexpected high‐risk pathologic features following thyroidectomy in the chinese immigrant population
    Arvind K. Badhey, Erin Moshier, Ameya Jategaonkar, Anni Wong, Kristen Echanique, Raymond L. Chai
    The Laryngoscope.2020; 130(7): 1844.     CrossRef
  • Hashimoto's thyroiditis attenuates progression of papillary thyroid carcinoma: deciphering immunological links
    Oksana Sulaieva, Oleksii Selezniov, Dmytro Shapochka, Nataliia Belemets, Oleksandr Nechay, Yelizaveta Chereshneva, Dibakhan Tsomartova, Marina Ivanova
    Heliyon.2020; 6(1): e03077.     CrossRef
  • Changes in Treg numbers and activity in papillary thyroid carcinoma with and without Hashimoto’s thyroiditis
    Na Zhao, Xin Liu, Chao Wu, Yuanchao Liu, Xiangnan Zhao, Xianghui He
    Journal of International Medical Research.2020; 48(4): 030006052091922.     CrossRef
  • Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis
    Ohoud Subhi, Hans-Juergen Schulten, Nadia Bagatian, Roa'a Al-Dayini, Sajjad Karim, Sherin Bakhashab, Reem Alotibi, Alaa Al-Ahmadi, Manar Ata, Aisha Elaimi, Saad Al-Muhayawi, Majid Mansouri, Khalid Al-Ghamdi, Osman Abdel Hamour, Awatif Jamal, Jaudah Al-Mag
    PLOS ONE.2020; 15(6): e0234566.     CrossRef
  • Hashimoto's thyroiditis as a risk factor for thyroid cancer
    Ulla Feldt-Rasmussen
    Current Opinion in Endocrinology, Diabetes & Obesity.2020; 27(5): 364.     CrossRef
  • Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Brafv600e Mutation: A Single Center Study of 1,207 Chinese Patients
    Shuai Xue, Li Zhang, Peisong Wang, Jia Liu, Yue Yin, Meishan Jin, Liang Guo, Yuhua Zhou, Guang Chen
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy
    Francesca Ragusa, Poupak Fallahi, Giusy Elia, Debora Gonnella, Sabrina Rosaria Paparo, Claudia Giusti, Leonid P. Churilov, Silvia Martina Ferrari, Alessandro Antonelli
    Best Practice & Research Clinical Endocrinology & Metabolism.2019; 33(6): 101367.     CrossRef
  • Características anatomopatológicas del carcinoma papilar de tiroides en especimenes con y sin tiroiditis linfocitica crónica.
    Carlos Osorio Covo, Jorge Ballestas Barrera, Jorge Martínez Castro, Zully Acevedo Meza, Diego Barrios Castellar, Francisco Herrera Sáenz, Cesar Redondo Bermúdez, Katherine Redondo De Oro
    Revista Ciencias Biomédicas.2019; 8(2): 32.     CrossRef
Close layer
Review Articles
Thyroid
Genome-Wide Association Studies of Autoimmune Thyroid Diseases, Thyroid Function, and Thyroid Cancer
Yul Hwangbo, Young Joo Park
Endocrinol Metab. 2018;33(2):175-184.   Published online June 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.175
  • 7,736 View
  • 133 Download
  • 55 Web of Science
  • 54 Crossref
AbstractAbstract PDFPubReader   ePub   

Thyroid diseases, including autoimmune thyroid diseases and thyroid cancer, are known to have high heritability. Family and twin studies have indicated that genetics plays a major role in the development of thyroid diseases. Thyroid function, represented by thyroid stimulating hormone (TSH) and free thyroxine (T4), is also known to be partly genetically determined. Before the era of genome-wide association studies (GWAS), the ability to identify genes responsible for susceptibility to thyroid disease was limited. Over the past decade, GWAS have been used to identify genes involved in many complex diseases, including various phenotypes of the thyroid gland. In GWAS of autoimmune thyroid diseases, many susceptibility loci associated with autoimmunity (human leukocyte antigen [HLA], protein tyrosine phosphatase, non-receptor type 22 [PTPN22], cytotoxic T-lymphocyte associated protein 4 [CTLA4], and interleukin 2 receptor subunit alpha [IL2RA]) or thyroid-specific genes (thyroid stimulating hormone receptor [TSHR] and forkhead box E1 [FOXE1]) have been identified. Regarding thyroid function, many susceptibility loci for levels of TSH and free T4 have been identified through genome-wide analyses. In GWAS of differentiated thyroid cancer, associations at FOXE1, MAP3K12 binding inhibitory protein 1 (MBIP)-NK2 homeobox 1 (NKX2-1), disrupted in renal carcinoma 3 (DIRC3), neuregulin 1 (NRG1), and pecanex-like 2 (PCNXL2) have been commonly identified in people of European and Korean ancestry, and many other susceptibility loci have been found in specific populations. Through GWAS of various thyroid-related phenotypes, many susceptibility loci have been found, providing insights into the pathogenesis of thyroid diseases and disease co-clustering within families and individuals.

Citations

Citations to this article as recorded by  
  • A new, all‐encompassing aetiology of type 1 diabetes
    Piet C. de Groen
    Immunology.2024; 171(1): 77.     CrossRef
  • The role of primary cilia in thyroid diseases
    Zijiao Tian, Xinlin Li, Xue Yu, Shuxin Yan, Jingwei Sun, Wenxin Ma, Xiaoyun Zhu, Yang Tang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Exome sequencing to explore the possibility of predicting genetic susceptibility to the joint occurrence of polycystic ovary syndrome and Hashimoto’s thyroiditis
    Natalia Zeber-Lubecka, Katarzyna Suchta, Maria Kulecka, Anna Kluska, Magdalena Piątkowska, Michal J. Dabrowski, Katarzyna Jankowska, Monika Grymowicz, Roman Smolarczyk, Ewa E. Hennig
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Molecular Mechanisms in Autoimmune Thyroid Disease
    Hernando Vargas-Uricoechea
    Cells.2023; 12(6): 918.     CrossRef
  • Identification of multiple novel susceptibility genes associated with autoimmune thyroid disease
    Xueying Liu, Yahu Miao, Chao Liu, Wan Lu, Qing Feng, Qiu Zhang
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Novel Susceptibility Genes Drive Familial Non-Medullary Thyroid Cancer in a Large Consanguineous Kindred
    Pierre Majdalani, Uri Yoel, Tayseer Nasasra, Merav Fraenkel, Alon Haim, Neta Loewenthal, Raz Zarivach, Eli Hershkovitz, Ruti Parvari
    International Journal of Molecular Sciences.2023; 24(9): 8233.     CrossRef
  • An Optimized Flow Cytometric Method to Demonstrate the Differentiation Stage-Dependent Ca2+ Flux Responses of Peripheral Human B Cells
    Anna Bajnok, Timea Serény-Litvai, Viktória Temesfői, Jasper Nörenberg, Róbert Herczeg, Ambrus Kaposi, Timea Berki, Emese Mezosi
    International Journal of Molecular Sciences.2023; 24(10): 9107.     CrossRef
  • FOXE1 Contributes to the Development of Psoriasis by Regulating WNT5A
    Meng Liu, Guanfei Zhang, Ziyang Wang, Xinyi Liu, Ke He, Ruiting Luo, Qiqi Duan, Ruimin Bai, Yuqian Wang, Wenqian Du, Yan Zheng, Yongping Shao
    Journal of Investigative Dermatology.2023; 143(12): 2366.     CrossRef
  • Correlation analysis of HHV-6A viral load and anti-TPO antibody levels in patients with Hashimoto's thyroiditis
    Noorossadat Seyyedi, Fariba Esfandiyari, Gholamreza Rafiei Dehbidi, Ali Farhadi, Farahnaz Zare, Sepide Namdari, Golrokh Bahmani, Banafsheh Rastegari, Farzaneh Zarghampoor, Abbas Behzad-Behbahani
    Future Virology.2023; 18(8): 527.     CrossRef
  • Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin
    Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Armando Patrizio, Sabrina Rosaria Paparo, Gianni Marone, Maria Rosaria Galdiero, Giovanni Guglielmi, Rudy Foddis, Alfonso Cristaudo, Alessandro Antonelli
    Seminars in Cancer Biology.2022; 79: 203.     CrossRef
  • The Relationship between PTPN22 R620W Polymorphisms and the Susceptibility to Autoimmune Thyroid Diseases: An Updated Meta-analysis
    Huaiyong Wu, Siyuan Wan, Mengying Qu, Bingxuan Ren, Lixiang Liu, Hongmei Shen
    Immunological Investigations.2022; 51(2): 438.     CrossRef
  • Identification of Transcriptional Pattern Related to Immune Cell Infiltration With Gene Co-Expression Network in Papillary Thyroid Cancer
    Meiye Li, Jimei Zhang, Zongjing Zhang, Ying Qian, Wei Qu, Zhaoshun Jiang, Baochang Zhao
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank
    Sean J. Jurgens, Seung Hoan Choi, Valerie N. Morrill, Mark Chaffin, James P. Pirruccello, Jennifer L. Halford, Lu-Chen Weng, Victor Nauffal, Carolina Roselli, Amelia W. Hall, Matthew T. Oetjens, Braxton Lagerman, David P. vanMaanen, Goncalo Abecasis, Xiao
    Nature Genetics.2022; 54(3): 240.     CrossRef
  • Factors affecting recurrence in subacute granulomatous thyroiditis
    Çiğdem Tura Bahadir, Merve Yilmaz, Elif Kiliçkan
    Archives of Endocrinology and Metabolism.2022;[Epub]     CrossRef
  • Shared etiology of type 1 diabetes and Hashimoto’s thyroiditis: a population-based twin study
    Jakob Skov, Ralf Kuja-Halkola, Patrik K E Magnusson, Soffia Gudbjörnsdottir, Olle Kämpe, Sophie Bensing
    European Journal of Endocrinology.2022; 186(6): 677.     CrossRef
  • High Prevalence of Common Human Viruses in Thyroid Tissue
    Therese Weider, Angelo Genoni, Francesco Broccolo, Trond H. Paulsen, Knut Dahl-Jørgensen, Antonio Toniolo, Sara Salehi Hammerstad
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • B cells from anti-thyroid antibody positive, infertile women show hyper-reactivity to BCR stimulation
    Timea Serény-Litvai, Anna Bajnok, Viktoria Temesfoi, Jasper Nörenberg, Greta Pham-Dobor, Ambrus Kaposi, Akos Varnagy, Kalman Kovacs, Sandor Pentek, Tamas Koszegi, Emese Mezosi, Timea Berki
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • What do the structures of GCN5-containing complexes teach us about their function?
    Dominique Helmlinger, Gábor Papai, Didier Devys, László Tora
    Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms.2021; 1864(2): 194614.     CrossRef
  • Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto’s Thyroiditis: How Far Is Our Understanding?
    Natalia Zeber-Lubecka, Ewa E. Hennig
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Type 1 Diabetes and Autoimmune Thyroid Disease—The Genetic Link
    Lara Frommer, George J. Kahaly
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Familial Risk of Hashimoto's Thyroiditis Among First-Degree Relatives: A Population-Based Study in Korea
    Hyun Jung Kim, Sayada Zartasha Kazmi, Taeuk Kang, Seo Young Sohn, Dong-Sook Kim, Hoo Jae Hann, Hyeong Sik Ahn
    Thyroid.2021; 31(7): 1096.     CrossRef
  • Limited Genetic Overlap Between Overt Hashimoto’s Thyroiditis and Graves’ Disease in Twins: A Population-based Study
    Jakob Skov, Jan Calissendorff, Daniel Eriksson, Patrik Magnusson, Olle Kämpe, Sophie Bensing, Ralf Kuja-Halkola
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(4): e1101.     CrossRef
  • Endogenous and Synthetic Regulators of the Peripheral Components of the Hypothalamo-Hypophyseal-Gonadal and -Thyroid Axes
    A. O. Shpakov
    Neuroscience and Behavioral Physiology.2021; 51(3): 332.     CrossRef
  • Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients
    Jee Hee Yoon, Min-ho Shin, Hee Nam Kim, Wonsuk Choi, Ji Yong Park, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
    Endocrinology and Metabolism.2021; 36(3): 599.     CrossRef
  • Predisposition to Graves’ disease and Graves’ ophthalmopathy by genetic variants of IL2RA
    Juan Du, Xin Wang, Guiqin Tan, Wenwen Wei, Fangyu Zhou, Zhongzhi Liang, Hua Li, Hongsong Yu
    Journal of Molecular Medicine.2021; 99(10): 1487.     CrossRef
  • Association of IL-1β, NLRP3, and COX-2 Gene Polymorphisms with Autoimmune Thyroid Disease Risk and Clinical Features in the Iranian Population
    Zahra Heidari, Saeedeh Salimi, Mohsen Rokni, Mahnaz Rezaei, Neshat Khalafi, Mahdieh Jafari Shahroudi, Azizallah Dehghan, Mohsen Saravani, Rafael S. De Molon
    BioMed Research International.2021; 2021: 1.     CrossRef
  • Genetic polymorphisms in the PCNXL2 gene are risk factors for thyroid cancer in the Chinese population
    Runmei Hao, Peng Han, Ling Zhang, Ying Bi, Jinfeng Yan, Honghui Li, Yanxia Bai, Chongwen Xu, Baiya Li, Huajing Li
    Future Oncology.2021; 17(34): 4677.     CrossRef
  • Genetic Variants Associated with Thyroid Cancer Risk: Comprehensive Research Synopsis, Meta-Analysis, and Cumulative Epidemiological Evidence
    Ran Ran, Gang Tu, Hui Li, Hao Wang, Exian Mou, Caiyang Liu, Yuan Seng Wu
    Journal of Oncology.2021; 2021: 1.     CrossRef
  • The Identification of Three Key Genes Related to Stemness in Thyroid Carcinoma through Comprehensive Analysis
    Tonglong Zhang, Chunhong Yan, Zhengdu Ye, Xingling Yin, Tian-an Jiang
    Combinatorial Chemistry & High Throughput Screening.2021; 24(3): 423.     CrossRef
  • Епідеміологія автоімунного тиреоїдиту
    V.I. Кravchenko, О.А. Тоvkay, О.V. Rakov, М.D. Тronko
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(2): 136.     CrossRef
  • Thyroid autoimmune disorders and cancer
    Silvia Martina Ferrari, Poupak Fallahi, Giusy Elia, Francesca Ragusa, Ilaria Ruffilli, Sabrina Rosaria Paparo, Alessandro Antonelli
    Seminars in Cancer Biology.2020; 64: 135.     CrossRef
  • Association of FCRL3 rs7528684 polymorphism with risk of Hashimoto's thyroiditis in Iranian patients
    Kurosh Kalantar, Farzad Ghandehari, Saeed Malek-Hosseini, Hossein Golmoghaddam, Davood Rostamzadeh, Mohamad Hossein Dabbaghmanesh, Zahra Amirghofran
    Meta Gene.2020; 24: 100663.     CrossRef
  • Differentiated thyroid cancer and Hashimoto thyroiditis: Utility of the Afirma gene expression classifier
    Vardan Papoian, Jennifer E. Rosen, Wen Lee, Leonard Wartofsky, Erin A. Felger
    Journal of Surgical Oncology.2020; 121(7): 1053.     CrossRef
  • Familial risks between Graves disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden
    Hauke Thomsen, Xinjun Li, Kristina Sundquist, Jan Sundquist, Asta Försti, Kari Hemminki
    Journal of Translational Autoimmunity.2020; 3: 100058.     CrossRef
  • Association of rs944289, rs965513, and rs1443434 in TITF1/TITF2 with Risks of Papillary Thyroid Carcinoma and with Nodular Goiter in Northern Chinese Han Populations
    Xin Zhang, Yulu Gu, Yong Li, Heran Cui, Xiaoli Liu, Hui Sun, Qiong Yu, Yaqin Yu, Yawen Liu, Siyan Zhan, Yi Cheng
    International Journal of Endocrinology.2020; 2020: 1.     CrossRef
  • FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease
    Saedis Saevarsdottir, Thorunn A. Olafsdottir, Erna V. Ivarsdottir, Gisli H. Halldorsson, Kristbjorg Gunnarsdottir, Asgeir Sigurdsson, Ari Johannesson, Jon K. Sigurdsson, Thorhildur Juliusdottir, Sigrun H. Lund, Asgeir O. Arnthorsson, Edda L. Styrmisdottir
    Nature.2020; 584(7822): 619.     CrossRef
  • Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis
    Ohoud Subhi, Hans-Juergen Schulten, Nadia Bagatian, Roa'a Al-Dayini, Sajjad Karim, Sherin Bakhashab, Reem Alotibi, Alaa Al-Ahmadi, Manar Ata, Aisha Elaimi, Saad Al-Muhayawi, Majid Mansouri, Khalid Al-Ghamdi, Osman Abdel Hamour, Awatif Jamal, Jaudah Al-Mag
    PLOS ONE.2020; 15(6): e0234566.     CrossRef
  • Thyroid cancer and thyroid autoimmune disease: A review of molecular aspects and clinical outcomes
    Natália Medeiros Dias Lopes, Hannah Hamada Mendonça Lens, André Armani, Poliana Camila Marinello, Alessandra Lourenço Cecchini
    Pathology - Research and Practice.2020; 216(9): 153098.     CrossRef
  • Immune gene signature delineates a subclass of thyroid cancer with unfavorable clinical outcomes
    Jingtai Zhi, Jiaoyu Yi, Mengran Tian, Huijuan Wang, Ning Kang, Xiangqian Zheng, Ming Gao
    Aging.2020; 12(7): 5733.     CrossRef
  • VARIETY OF COMBINATIONS OF HASHIMOTO’S THYROIDITIS WITH OTHER BACKGROUND PATHOLOGY OF THYROID PARENCHEMA IN DIFFERENT FORMS OF THYROID CANCER
    Yu. I. Karachentsev, V. M. Dubovik, I. V. Gopkalova, V. V. Khaziev, S. S. Sokolova, Y. P. Korchagin, N. G. Filonenko, M. Y. Sazonov, L. V. Gerasimenko
    Bulletin of Problems Biology and Medicine.2020; 3(1): 105.     CrossRef
  • Analysis of Polymorphisms rs7093069-IL-2RA, rs7138803-FAIM2, and rs1748033-PADI4 in the Group of Adolescents With Autoimmune Thyroid Diseases
    Beata Sawicka, Hanna Borysewicz-Sańczyk, Natalia Wawrusiewicz-Kurylonek, Tommaso Aversa, Domenico Corica, Joanna Gościk, Adam Krętowski, Małgorzata Waśniewska, Artur Bossowski
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Familial associations for rheumatoid autoimmune diseases
    Hauke Thomsen, Xinjun Li, Kristina Sundquist, Jan Sundquist, Asta Försti, Kari Hemminki
    Rheumatology Advances in Practice.2020;[Epub]     CrossRef
  • Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden
    Hauke Thomsen, Xinjun Li, Kristina Sundquist, Jan Sundquist, Asta Försti, Kari Hemminki
    Scientific Reports.2020;[Epub]     CrossRef
  • The Association of Obesity with Autoimmune Thyroiditis and Thyroid Function-Possible Mechanisms of Bilateral Interaction
    Agnieszka Baranowska-Bik, Wojciech Bik, Henrik Falhammar
    International Journal of Endocrinology.2020; 2020: 1.     CrossRef
  • The Risk of Recurrence of Subacute Thyroiditis Is HLA-Dependent
    Magdalena Stasiak, Bogusław Tymoniuk, Bartłomiej Stasiak, Andrzej Lewiński
    International Journal of Molecular Sciences.2019; 20(5): 1089.     CrossRef
  • FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA
    Zheng Ding, Ronghu Ke, Yong Zhang, Youben Fan, Jianxia Fan
    Molecular and Cellular Endocrinology.2019; 493: 110420.     CrossRef
  • Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer
    Kinga Hińcza, Artur Kowalik, Aldona Kowalska
    Genes.2019; 10(7): 482.     CrossRef
  • Thyroid Cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes
    Santos, Gomes, Bastos, Gil, Azevedo, Ferreira, Limbert, Silva, Rueff
    Genes.2019; 10(8): 586.     CrossRef
  • Genetic Polymorphisms on 4q21.1 Contributed to the Risk of Hashimoto's Thyroiditis
    Dachao Mo, Junjiu Li, Liang Peng, Zhiyuan Liu, Jieyun Wang, Jiru Yuan
    Genetic Testing and Molecular Biomarkers.2019; 23(12): 837.     CrossRef
  • A Weighted Genetic Risk Score Using Known Susceptibility Variants to Predict Graves Disease Risk
    Yu-Ru Ma, Shuang-Xia Zhao, Lu Li, Feng Sun, Xiao-Ping Ye, Fei-Fei Yuan, Dan Jiang, Zheng Zhou, Qian-Yue Zhang, Yue-Yue Wan, Guang-Ya Zhang, Jing Wu, Rui-Jia Zhang, Ya Fang, Huai-Dong Song
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(6): 2121.     CrossRef
  • Architects meets Repairers: The interplay between homeobox genes and DNA repair
    Bruno César Feltes
    DNA Repair.2019; 73: 34.     CrossRef
  • Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer
    Peng Lin, Yi-nan Guo, Lin Shi, Xiao-jiao Li, Hong Yang, Yun He, Qing Li, Yi-wu Dang, Kang-lai Wei, Gang Chen
    Aging.2019; 11(2): 480.     CrossRef
  • Selenium and Selenoproteins in Immune Mediated Thyroid Disorders
    Liliana Santos, Celestino Neves, Miguel Melo, Paula Soares
    Diagnostics.2018; 8(4): 70.     CrossRef
  • Sex-specific genetic influence on thyroid-stimulating hormone and free thyroxine levels, and interactions between measurements: KNHANES 2013–2015
    Young Ki Lee, Dong Yeob Shin, Hyejung Shin, Eun Jig Lee, Silvia Naitza
    PLOS ONE.2018; 13(11): e0207446.     CrossRef
Close layer
Thyroid
The Diagnosis and Management of Hyperthyroidism in Korea: Consensus Report of the Korean Thyroid Association
Jae Hoon Moon, Ka Hee Yi
Endocrinol Metab. 2013;28(4):275-279.   Published online December 12, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.4.275
  • 5,111 View
  • 63 Download
  • 54 Crossref
AbstractAbstract PDFPubReader   

Hyperthyroidism is one of the causes of thyrotoxicosis and the most common cause of hyperthyroidism in Korea is Graves disease. The diagnosis and treatment of Graves disease are different according to geographical area. Recently, the American Thyroid Association and the American Association of Clinical Endocrinologists suggested new management guidelines for hyperthyroidism. However, these guidelines are different from clinical practice in Korea and are difficult to apply. Therefore, the Korean Thyroid Association (KTA) conducted a survey of KTA members regarding the diagnosis and treatment of hyperthyroidism, and reported the consensus on the management of hyperthyroidism. In this review, we summarized the KTA report on the contemporary practice patterns in the diagnosis and management of hyperthyroidism, and compared this report with guidelines from other countries.

Citations

Citations to this article as recorded by  
  • Effect of previous administration of potassium iodine and different durations of low iodine diets for radioiodine therapy on the treatment of Graves' disease in iodine-rich areas
    Mika Tamura, Kunihiro Nakada, Haruna Iwanaga, Naotoshi Fujita, Katsuhiko Kato
    European Journal of Nuclear Medicine and Molecular Imaging.2024; 51(4): 1060.     CrossRef
  • Effects of altitude on thyroid disorders according to Chinese three-rung, ladder-like topography: national cross-sectional study
    Boshen Gong, Youmin Wang, Jin-an Zhang, Qiao Zhang, Jiajun Zhao, Jiashu Li, Xichang Wang, Yutong Han, Ziwei Yu, Chenyu Zhang, Bingcong Peng, Yumin Xing, Qiuxian Li, Ping Wang, Yongze Li, Weiping Teng, Zhongyan Shan
    BMC Public Health.2024;[Epub]     CrossRef
  • MACE and Hyperthyroidism Treated With Medication, Radioactive Iodine, or Thyroidectomy
    Carol Chiung-Hui Peng, Yu-Jie Lin, Sun Y. Lee, Shu-Man Lin, Cheng Han, Ching-Hui Loh, Huei-Kai Huang, Elizabeth N. Pearce
    JAMA Network Open.2024; 7(3): e240904.     CrossRef
  • Increased risk of incident gout in patients with hyperthyroidism: a nationwide retrospective cohort study
    Ju-Yeun Lee, So-Yeon Park, Seo Young Sohn
    Rheumatology International.2023; 44(3): 451.     CrossRef
  • The Current Status of Hyperthyroidism in Korea
    Hyemi Kwon
    Endocrinology and Metabolism.2023; 38(4): 392.     CrossRef
  • A machine learning-assisted system to predict thyrotoxicosis using patients’ heart rate monitoring data: a retrospective cohort study
    Kyubo Shin, Jongchan Kim, Jaemin Park, Tae Jung Oh, Sung Hye Kong, Chang Ho Ahn, Joon Ho Moon, Min Joo Kim, Jae Hoon Moon
    Scientific Reports.2023;[Epub]     CrossRef
  • Immunometabolic signatures predict recovery from thyrotoxic myopathy in patients with Graves' disease
    Daiki Setoyama, Ho Yeop Lee, Ji Sun Moon, Jingwen Tian, Yea Eun Kang, Ju Hee Lee, Minho Shong, Dongchon Kang, Hyon‐Seung Yi
    Journal of Cachexia, Sarcopenia and Muscle.2022; 13(1): 355.     CrossRef
  • Comparison of 99mTc Pertechnetate Thyroid Uptake Rates by Gamma Probe and Gamma Camera Methods for Differentiating Graves’ Disease and Thyroiditis
    Meihua Jin, Jonghwa Ahn, Seong-gil Jo, Jangwon Park, Min Ji Jeon, Won Gu Kim, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Jin-Sook Ryu
    Nuclear Medicine and Molecular Imaging.2022; 56(1): 42.     CrossRef
  • KSNM60 in Nuclear Endocrinology: from the Beginning to the Future
    Chae Moon Hong, Young Jin Jeong, Hae Won Kim, Byeong-Cheol Ahn
    Nuclear Medicine and Molecular Imaging.2022; 56(1): 17.     CrossRef
  • Graves’ disease and the risk of Parkinson’s disease: a Korean population-based study
    Yoon Young Cho, Bongseong Kim, Dong Wook Shin, Jinyoung Youn, Ji Oh Mok, Chul-Hee Kim, Sun Wook Kim, Jae Hoon Chung, Kyungdo Han, Tae Hyuk Kim
    Brain Communications.2022;[Epub]     CrossRef
  • Graves’ Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study
    Yoon Young Cho, Bongseong Kim, Dong Wook Shin, Hye Ryoun Jang, Bo-Yeon Kim, Chan-Hee Jung, Jae Hyeon Kim, Sun Wook Kim, Jae Hoon Chung, Kyungdo Han, Tae Hyuk Kim
    Endocrinology and Metabolism.2022; 37(2): 281.     CrossRef
  • Evaluation and Management of Bone Health in Patients with Thyroid Diseases: a Position Statement from the Korean Thyroid Association
    A Ram Hong, Hwa Young Ahn, Bu Kyung Kim, Seong Hee Ahn, So Young Park, Min-Hee Kim, Jeongmin Lee, Sun Wook Cho, Ho-Cheol Kang
    International Journal of Thyroidology.2022; 15(1): 1.     CrossRef
  • Patient Population and Test Utilization for Thyroid Function in Local Clinics and Hospitals in Korea
    Rihwa Choi, Sang Gon Lee, Eun Hee Lee
    Diagnostics.2022; 12(7): 1638.     CrossRef
  • 2021 Asia-Pacific Graves’ Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves’ Disease
    Rajeev Parameswaran, Mechteld Christine de Jong, James Lee Wai Kit, Kathleen Sek, Tran Quang Nam, Tran Viet Thang, Nguyen Thy Khue, Than Than Aye, Phone Myint Tun, Timothy Cole, Julie A. Miller, Michael Villa, Benjapa Khiewvan, Sirinart Sirinvaravong, Yon
    Endocrine.2022; 79(1): 135.     CrossRef
  • Graves’ disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study
    Yoon Young Cho, Bongseong Kim, Dughyun Choi, Chul-Hee Kim, Dong Wook Shin, Jee Soo Kim, Seung-Jung Park, Sun Wook Kim, Jae Hoon Chung, Kyungdo Han, Tae Hyuk Kim
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Forty Years Together, New Leap Forward! The 40th Anniversary of the Korean Endocrine Society
    Jong Chul Won, Ki-Hyun Baek
    Endocrinology and Metabolism.2022; 37(6): 851.     CrossRef
  • Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis
    Carolina M. Perdomo, Marta García‐Goñi, Lidia Sancho, José J. Paricio, María D. Lozano, Magdalena de la Higuera, María Currás, Javier Arbizu, Juan C. Galofré
    Clinical Endocrinology.2021; 94(3): 466.     CrossRef
  • Treatment of patients with Graves’ disease in Sweden compared to international surveys of an ‘index patient’
    Gabriel Sjölin, Kristina Byström, Mats Holmberg, Ove Törring, Selwan Khamisi, Jan Calissendorff, Mikael Lantz, Bengt Hallengren, Helena Filipsson Nyström, Tereza Planck, Göran Wallin
    Endocrinology, Diabetes & Metabolism.2021;[Epub]     CrossRef
  • Secular Trends in Ablation Therapy for Graves’ Disease: An Analysis of a 15-Year Experience at a Tertiary Hospital in South Korea
    Min Joo Kim, Ye An Kim, Sun Wook Cho, Su-jin Kim, Kyu Eun Lee, Young Joo Park, Do Joon Park, Bo Youn Cho
    Journal of Clinical Medicine.2021; 10(8): 1629.     CrossRef
  • Long-Term Antithyroid Drug Treatment of Graves’ Disease in Children and Adolescents: A 20-Year Single-Center Experience
    Ari Song, Su Jin Kim, Min-Sun Kim, Jiyeon Kim, Insung Kim, Ga Young Bae, Eunseop Seo, Young Seok Cho, Joon Young Choi, Sung Yoon Cho, Dong-Kyu Jin
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Association of Polygenetic Risk Scores Related to Immunity and Inflammation with Hyperthyroidism Risk and Interactions between the Polygenetic Scores and Dietary Factors in a Large Cohort
    Mi Young Song, Sunmin Park, Anjali Mishra
    Journal of Thyroid Research.2021; 2021: 1.     CrossRef
  • Treatment Modality and Risk of Heart Failure in Patients With Long-Standing Graves’ Disease: A Nationwide Population-Based Cohort Study
    Eyun Song, Mina Kim, Sojeong Park, Min Jeong Park, Jung A. Kim, Eun Roh, Ji Hee Yu, Nam Hoon Kim, Ji A. Seo, Sin Gon Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Hye Jin Yoo
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Risk of Diabetes in Patients with Long-Standing Graves’ Disease: A Longitudinal Study
    Eyun Song, Min Ji Koo, Eunjin Noh, Soon Young Hwang, Min Jeong Park, Jung A Kim, Eun Roh, Kyung Mook Choi, Sei Hyun Baik, Geum Joon Cho, Hye Jin Yoo
    Endocrinology and Metabolism.2021; 36(6): 1277.     CrossRef
  • Diabetes and Hyperthyroidism: Is There a Causal Link?
    Sang Yong Kim
    Endocrinology and Metabolism.2021; 36(6): 1175.     CrossRef
  • Incidence and Mortality of Myocardial Infarction and Stroke in Patients with Hyperthyroidism: A Nationwide Cohort Study in Korea
    Hyun Jung Kim, Taeuk Kang, Min Ji Kang, Hyeong Sik Ahn, Seo Young Sohn
    Thyroid.2020; 30(7): 955.     CrossRef
  • Diagnosis and Management of Graves’ Disease in Thailand: A Survey of Current Practice
    Chutintorn Sriphrapradang
    Journal of Thyroid Research.2020; 2020: 1.     CrossRef
  • The success rate of radioactive iodine therapy for Graves’ disease in iodine-replete area and affecting factors: a single-center study
    Hyunju Park, Hye In Kim, Jun Park, So Young Park, Tae Hyuk Kim, Jae Hoon Chung, Joon Young Choi, Sun Wook Kim
    Nuclear Medicine Communications.2020; 41(3): 212.     CrossRef
  • Tirotoksikoz nedenli erektil disfonksiyon üzerine sildenafil etkisinin histopatolojik olarak değerlendirilmesi
    Murat ÖZDEMİR, Canberk TOMRUK, Gürkan YİĞİTTÜRK, Varlık EROL, Emel Öykü ÇETİN, Ilgın YILDIRIM ŞİMŞİR, Çiğdem YENİSEY, Yiğit UYANIKGİL, Adnan ŞİMŞİR, Özer MAKAY
    Ege Tıp Dergisi.2020; 59(3): 215.     CrossRef
  • The Management of Thyroid Disease in COVID-19 Pandemic
    Won Sang Yoo, Hyun-Kyung Chung
    International Journal of Thyroidology.2020; 13(2): 65.     CrossRef
  • Is Hyperthyroidism Diagnosed and Treated Appropriately in the United States?
    Ammar Asban, Sophie Dream, Brenessa Lindeman
    Advances in Surgery.2019; 53: 117.     CrossRef
  • Long-term remission following antithyroid drug withdrawal in patients with Graves’ hyperthyroidism: parameters with prognostic value
    Ricardo V. García-Mayor, Paula Álvarez-Vázquez, Enrique Fluiters, Diana Valverde, Amalia Andrade
    Endocrine.2019; 63(2): 316.     CrossRef
  • Safety of long-term antithyroid drug treatment? A systematic review
    F. Azizi, R. Malboosbaf
    Journal of Endocrinological Investigation.2019; 42(11): 1273.     CrossRef
  • Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy
    Yun Mi Choi, Mi Kyung Kwak, Sang Mo Hong, Eun-Gyoung Hong
    Endocrinology and Metabolism.2019; 34(3): 268.     CrossRef
  • Prevalence and Annual Incidence of Thyroid Disease in Korea from 2006 to 2015: A Nationwide Population-Based Cohort Study
    Hyemi Kwon, Jin-hyung Jung, Kyung-Do Han, Yong-Gyu Park, Jung-Hwan Cho, Da Young Lee, Ji Min Han, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    Endocrinology and Metabolism.2018; 33(2): 260.     CrossRef
  • An update in the treatment preference for hyperthyroidism
    Obin Kwon
    Nature Reviews Endocrinology.2018; 14(7): 438.     CrossRef
  • Clinical Feasibility of Monitoring Resting Heart Rate Using a Wearable Activity Tracker in Patients With Thyrotoxicosis: Prospective Longitudinal Observational Study
    Jie-Eun Lee, Dong Hwa Lee, Tae Jung Oh, Kyoung Min Kim, Sung Hee Choi, Soo Lim, Young Joo Park, Do Joon Park, Hak Chul Jang, Jae Hoon Moon
    JMIR mHealth and uHealth.2018; 6(7): e159.     CrossRef
  • Graves' Disease Patients with Large Goiters Respond Best to Radioactive Iodine Doses of at Least 15 mCi: a Sonographic Volumetric Study
    Yun Ah Jeong, Jee Hee Yoon, Hee Kyung Kim, Ho-Cheol Kang
    International Journal of Thyroidology.2018; 11(2): 137.     CrossRef
  • Chylothorax Associated with Substernal Goiter in Graves’ Disease Treated with Radioactive Iodine
    Seo Young Oh, Bo Hyun Kim, Do Young Kim, Kyu Min Lee, Min Jin Lee, Sung Su Kim, Jong Ho Kim, Yun Kyung Jeon, Sang Soo Kim, Yong Ki Kim, In Joo Kim
    International Journal of Endocrinology and Metabolism.2017;[Epub]     CrossRef
  • Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea
    Jung Min Bae, June Hyunkyung Lee, Jae Seung Yun, Byeol Han, Tae Young Han
    Journal of the American Academy of Dermatology.2017; 76(5): 871.     CrossRef
  • Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based Study in Korea
    Jae-Seung Yun, Jung Min Bae, Ki-Jo Kim, Yu Seok Jung, Gyong Moon Kim, Hyung-Rae Kim, Jun-Seok Lee, Seung-Hyun Ko, Seon-Ah Cha, Yu-Bae Ahn, Ludmila Prokunina-Olsson
    PLOS ONE.2017; 12(6): e0179088.     CrossRef
  • The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study
    Ye An Kim, Sun Wook Cho, Hoon Sung Choi, Shinje Moon, Jae Hoon Moon, Kyung Won Kim, Do Joon Park, Ka Hee Yi, Young Joo Park, Bo Youn Cho
    Thyroid.2017; 27(4): 491.     CrossRef
  • Free Thyroxine, Anti-Thyroid Stimulating Hormone Receptor Antibody Titers, and Absence of Goiter Were Associated with Responsiveness to Methimazole in Patients with New Onset Graves' Disease
    Hoon Sung Choi, Won Sang Yoo
    Endocrinology and Metabolism.2017; 32(2): 281.     CrossRef
  • Long-Term Antithyroid Drug Treatment: A Systematic Review and Meta-Analysis
    Fereidoun Azizi, Ramin Malboosbaf
    Thyroid.2017; 27(10): 1223.     CrossRef
  • The Recurrence Rate of Graves' Disease among Patients with Subclinical Thyrotoxicosis after Initial Remission with Antithyroid Agents
    Myoung Sook Shim, Soo Min Nam, Jin Sae Yoo, Hae Kyung Kim, Sang Jun Lee, Mi Young Lee
    International Journal of Thyroidology.2017; 10(2): 77.     CrossRef
  • Serum 25-hydroxyvitamin D might be an independent prognostic factor for Graves disease recurrence
    Hwa Young Ahn, Yun Jae Chung, Bo Youn Cho
    Medicine.2017; 96(31): e7700.     CrossRef
  • Recent Advances in Autoimmune Thyroid Diseases
    Won Sang Yoo, Hyun Kyung Chung
    Endocrinology and Metabolism.2016; 31(3): 379.     CrossRef
  • Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease
    Hyemi Kwon, Won Gu Kim, Eun Kyung Jang, Mijin Kim, Suyeon Park, Min Ji Jeon, Tae Yong Kim, Jin-Sook Ryu, Young Kee Shong, Won Bae Kim
    Endocrinology and Metabolism.2016; 31(2): 300.     CrossRef
  • Hyperthyroidism
    Simone De Leo, Sun Y Lee, Lewis E Braverman
    The Lancet.2016; 388(10047): 906.     CrossRef
  • Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine
    Chutintorn Sriphrapradang, Adikan Bhasipol
    Annals of Medicine and Surgery.2016; 10: 69.     CrossRef
  • Management of hyperthyroid patients in dental emergencies: a case report
    Kyung-Jin Lee, Wonse Park, Nan-Sim Pang, Jin-Hyung Cho, Kee-Deog Kim, Bock Young Jung, Eun-Jung Kwak
    Journal of Dental Anesthesia and Pain Medicine.2016; 16(2): 147.     CrossRef
  • The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves’ Disease
    Sun Wook Cho, Jae Hyun Bae, Gyeong Woon Noh, Ye An Kim, Min Kyong Moon, Kyoung Un Park, Junghan Song, Ka Hee Yi, Do Joon Park, June-Key Chung, Bo Youn Cho, Young Joo Park, Jung-Eun Kim
    PLOS ONE.2015; 10(12): e0144599.     CrossRef
  • Refractory Graves' Disease Successfully Cured by Adjunctive Cholestyramine and Subsequent Total Thyroidectomy
    Yeoree Yang, Seawon Hwang, Minji Kim, Yejee Lim, Min-Hee Kim, Sohee Lee, Dong-Jun Lim, Moo-Il Kang, Bong-Yun Cha
    Endocrinology and Metabolism.2015; 30(4): 620.     CrossRef
  • Improved quality of life in hyperthyroidism patients after surgery
    Branka Bukvic, Vladan Zivaljevic, Sandra Sipetic, Aleksandar Diklic, Katarina Tausanovic, Dragos Stojanovic, Dejan Stevanovic, Ivan Paunovic
    Journal of Surgical Research.2015; 193(2): 724.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
Close layer
Obesity and Metabolism
Recent Advances in Diagnostic Strategies for Diabetic Peripheral Neuropathy
Jong Chul Won, Tae Sun Park
Endocrinol Metab. 2016;31(2):230-238.   Published online May 27, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.2.230
  • 7,405 View
  • 126 Download
  • 50 Web of Science
  • 53 Crossref
AbstractAbstract PDFPubReader   

Diabetes is an increasing epidemic in Korea, and associated diabetic peripheral neuropathy (DPN) is its most common and disabling complication. DPN has an insidious onset and heterogeneous clinical manifestations, making it difficult to detect high-risk patients of DPN. Early diagnosis is recommended and is the key factor for a better prognosis and preventing diabetic foot ulcers, amputation, or disability. However, diagnostic tests for DPN are not clearly established because of the various pathophysiology developing from the nerve injury to clinical manifestations, differences in mechanisms according to the type of diabetes, comorbidities, and the unclear natural history of DPN. Therefore, DPN remains a challenge for physicians to screen, diagnose, follow up, and evaluate for treatment response. In this review, diagnosing DPN using various methods to assess clinical symptoms and/or signs, sensorineural impairment, and nerve conduction studies will be discussed. Clinicians should rely on established modalities and utilize current available testing as complementary to specific clinical situations.

Citations

Citations to this article as recorded by  
  • The Relationship Between UA/HDL and Diabetic Peripheral Neuropathy: A Cross-Sectional Analysis
    Ruoxi Zhen, Shuqi Wang, Shuchun Chen
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 969.     CrossRef
  • Role of Regenerative Therapeutics in Diabetic Peripheral Neuropathy: Current Advances and Future Prospects
    Sanjay Sharma, Ravi Velamoor Rangarajan
    European Journal of Medical and Health Sciences.2024; 6(2): 1.     CrossRef
  • DSPNet: A Self-ONN Model for Robust DSPN Diagnosis From Temperature Maps
    Amith Khandakar, Muhammad E. H. Chowdhury, Mamun Bin Ibne Reaz, Serkan Kiranyaz, Anwarul Hasan, Tawsifur Rahman, Sawal Hamid Md. Ali, Mohd Ibrahim bin Shapiai @ Abd. Razak, Ahmad Ashrif A. Bakar, Kanchon Kanti Podder, Moajjem Hossain Chowdhury, Md. Ahasan
    IEEE Sensors Journal.2023; 23(5): 5370.     CrossRef
  • A Machine Learning-Based Severity Prediction Tool for the Michigan Neuropathy Screening Instrument
    Fahmida Haque, Mamun B. I. Reaz, Muhammad E. H. Chowdhury, Mohd Ibrahim bin Shapiai, Rayaz A. Malik, Mohammed Alhatou, Syoji Kobashi, Iffat Ara, Sawal H. M. Ali, Ahmad A. A. Bakar, Mohammad Arif Sobhan Bhuiyan
    Diagnostics.2023; 13(2): 264.     CrossRef
  • Screening for diabetic peripheral neuropathy in resource-limited settings
    Ken Munene Nkonge, Dennis Karani Nkonge, Teresa Njeri Nkonge
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Assessment of Lumbosacral Nerve Roots in Patients with Type 2 Diabetic Peripheral Neuropathy Using Diffusion Tensor Imaging
    He Chen, Yanyan Xu, Wei Wang, Ruifen Deng, Zhaoqing Li, Sheng Xie, Jinsong Jiao
    Brain Sciences.2023; 13(5): 828.     CrossRef
  • Evidence of impaired H-reflex and H-reflex rate-dependent depression in diabetes, prediabetes and obesity: a mini-review
    Rebeca Kababie-Ameo, Gabriela Gutiérrez-Salmeán, Carlos A. Cuellar
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The effect of polyneuropathy severity on nerve conduction and pain syndrome in patients with type 2 diabetes
    A.Ya. Sabovchyk, M.M. Oros
    INTERNATIONAL NEUROLOGICAL JOURNAL.2023; 19(6): 161.     CrossRef
  • Effects of Neural Mobilization in Diabetic Peripheral Neuropathy: A Scoping Review
    Muhammad Azharuddin, Sarah Parveen, Majumi M. Noohu
    Journal of Chiropractic Medicine.2023; 22(4): 313.     CrossRef
  • Effect of massage, passive neural mobilization and transcutaneous electrical nerve stimulation on magnetic resonance diffusion tensor imaging (MR-DTI) of the tibial nerve in a patient with type 2 diabetes mellitus induced neuropathy: a case report
    Goyal Manu, Mittal Amit, Samuel Asir John
    Physiotherapy Theory and Practice.2022; 38(13): 3273.     CrossRef
  • Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy
    WeiZheng So, NatalieShi Qi Wong, HongChang Tan, MollyTzu Yu Lin, IsabelleXin Yu Lee, JodhbirS Mehta, Yu-Chi Liu
    Neural Regeneration Research.2022; 17(10): 2172.     CrossRef
  • SUDOSCAN in Combination with the Michigan Neuropathy Screening Instrument Is an Effective Tool for Screening Diabetic Peripheral Neuropathy
    Tae Jung Oh, Yoojung Song, Hak Chul Jang, Sung Hee Choi
    Diabetes & Metabolism Journal.2022; 46(2): 319.     CrossRef
  • Performance Analysis of Conventional Machine Learning Algorithms for Diabetic Sensorimotor Polyneuropathy Severity Classification Using Nerve Conduction Studies
    Fahmida Haque, Mamun B. I. Reaz, Muhammad E. H. Chowdhury, Serkan Kiranyaz, Sawal H. M. Ali, Mohammed Alhatou, Rumana Habib, Ahmad A. A. Bakar, Norhana Arsad, Geetika Srivastava, Paolo Crippa
    Computational Intelligence and Neuroscience.2022; 2022: 1.     CrossRef
  • The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
    Tae Jung Oh, Han Song, Youngil Koh, Sung Hee Choi
    Endocrinology and Metabolism.2022; 37(2): 243.     CrossRef
  • Advances in traditional Chinese medicine as adjuvant therapy for diabetic foot
    Fa-Shun Liu, Yue Li, Xian-Shan Guo, Rui-Chen Liu, Hong-Ya Zhang, Zhen Li
    World Journal of Diabetes.2022; 13(10): 851.     CrossRef
  • Magnitude of diabetic peripheral neuropathy in Saudi Arabia: a systematic review and meta-analysis
    Lukman Femi Owolabi, Mushabab Alghamdi, Bappa Adamu, Magaji Garba Taura, Abubakar Jibo, Mohammed Almansour, Saeed Naseer Alaklabi, Mohammed Ali Alghamdi, Yousef Ayesh Alotaibi, Isa Adamu Imam, Reda Abdelrazak, Ahmad Rafaat, Muktar Hassan Aliyu
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Artificial Intelligence Methodologies Applied to Technologies for Screening, Diagnosis and Care of the Diabetic Foot: A Narrative Review
    Gaetano Chemello, Benedetta Salvatori, Micaela Morettini, Andrea Tura
    Biosensors.2022; 12(11): 985.     CrossRef
  • Diabetic foot ulcer: Challenges and future
    Li Yang, Gui-Chuan Rong, Qi-Nan Wu
    World Journal of Diabetes.2022; 13(12): 1014.     CrossRef
  • A review of the current evidence on the sensitivity and specificity of the Ipswich touch test for the screening of loss of protective sensation in patients with diabetes mellitus
    Arnold Hu, Beatrice Koh, Melissa- Raye Teo
    Diabetology International.2021; 12(2): 145.     CrossRef
  • Prevalence of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus at a tertiary referral centre in Singapore
    Arnold Hu Hanquan, Melissa-Raye Teo Li Wen
    Proceedings of Singapore Healthcare.2021; 30(4): 265.     CrossRef
  • Performance Analysis of Conventional Machine Learning Algorithms for Diabetic Sensorimotor Polyneuropathy Severity Classification
    Fahmida Haque, Mamun Bin Ibne Reaz, Muhammad Enamul Hoque Chowdhury, Geetika Srivastava, Sawal Hamid Md Ali, Ahmad Ashrif A. Bakar, Mohammad Arif Sobhan Bhuiyan
    Diagnostics.2021; 11(5): 801.     CrossRef
  • Thai version of the Questionnaire for Diabetes-Related Foot Disease (Thai Q-DFD): validity and reliability
    Rapeepun Thungtak, Jirabhorn Wannapakhe, Saitida Lapanantasin
    Heliyon.2021; 7(8): e07832.     CrossRef
  • A nomogram-based diabetic sensorimotor polyneuropathy severity prediction using Michigan neuropathy screening instrumentations
    Fahmida Haque, Mamun Bin Ibne Reaz, Muhammad E.H. Chowdhury, Sawal Hamid Md Ali, Ahmad Ashrif A Bakar, Tawsifur Rahman, Syoji Kobashi, Chitra A. Dhawale, Mohammad Arif Sobhan Bhuiyan
    Computers in Biology and Medicine.2021; 139: 104954.     CrossRef
  • Correlation Between Hemoglobin Glycosylation Index and Nerve Conduction Velocity in Patients with Type 2 Diabetes Mellitus
    Zelin Li, Yuan Gao, Yujiao Jia, Shuchun Chen
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 4757.     CrossRef
  • Liver fibrosis indices are related to diabetic peripheral neuropathy in individuals with type 2 diabetes
    Kyuho Kim, Tae Jung Oh, Hyen Chung Cho, Yun Kyung Lee, Chang Ho Ahn, Bo Kyung Koo, Jae Hoon Moon, Sung Hee Choi, Hak Chul Jang
    Scientific Reports.2021;[Epub]     CrossRef
  • Standard clinical screening tests, sural radial amplitude ratio and f wave latency compared to conventional nerve conduction studies in the assessment of sensorimotor polyneuropathy in patients with type 2 diabetes mellitus
    Saraswathi Ramanathan, Raji Thomas, AsemRangita Chanu, Dukhabandu Naik, Felix Jebasingh, Ajit Sivadasan, Nihal Thomas
    Indian Journal of Endocrinology and Metabolism.2021; 25(6): 509.     CrossRef
  • IFN‐γ/mTORC1 decreased Rab11 in Schwann cells of diabetic peripheral neuropathy, inhibiting cell proliferation via GLUT1 downregulation
    Wei Du, Song Zhao, Fan Gao, Mengyu Wei, Jiahui An, Keqi Jia, Fan Li, Lin Zhu, Jun Hao
    Journal of Cellular Physiology.2020; 235(7-8): 5764.     CrossRef
  • Diagnosis and treatment of the early stages of diabetic polyneuropathy
    V. N. Khramilin, A. N. Zavyalov, I. Yu. Demidova
    Meditsinskiy sovet = Medical Council.2020; (7): 56.     CrossRef
  • Diabetic Peripheral Neuropathy: Is it Underdiagnosed?
    Rizaldy T. Pinzon, M. Kes, Rosa De Lima R. Sa
    Asian Journal of Biological Sciences.2020; 13(2): 168.     CrossRef
  • The Effects of Tocotrienol-Rich Vitamin E (Tocovid) on Diabetic Neuropathy: A Phase II Randomized Controlled Trial
    Yeek Tat Ng, Sonia Chew Wen Phang, Gerald Chen Jie Tan, En Yng Ng, Nevein Philip Botross Henien, Uma Devi M. Palanisamy, Badariah Ahmad, Khalid Abdul Kadir
    Nutrients.2020; 12(5): 1522.     CrossRef
  • Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis
    Wondimeneh Shibabaw Shiferaw, Tadesse Yirga Akalu, Yeshamble Work, Yared Asmare Aynalem
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Choosing a Vibratory Test to Pair With Semmes Weinstein Monofilament Testing for Evaluating Lower Extremity Sensation in Patients With Diabetes: A Comparison of Three Vibratory Methodologies
    Bryan Raymond, James Steriovski, KaNesha Gillyard, Chalen Yang, Stephanie C. Wu, Ryan T. Crews
    Journal of Diabetes Science and Technology.2020; 14(1): 8.     CrossRef
  • Is it possible to substitute the monofilament test for the Ipswich Touch Test in screening for peripheral diabetic neuropathy?
    Luz Marina Alfonso Dutra, Mirian Conceição Moura, Flaviene Alves do Prado, Giselle De Oliveira Lima, Manuela Costa Melo, Rubens Nelson Morato Fernandez, Maria Rita Carvalho Garbi Novaes
    Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
  • Correlation Between Thioredoxin-Interacting Protein and Nerve Conduction Velocity in Patients With Type 2 Diabetes Mellitus
    Yuan Gao, Shuchun Chen, Minmin Peng, Zi Wang, Luping Ren, Shumin Mu, Meiling Zheng
    Frontiers in Neurology.2020;[Epub]     CrossRef
  • Performance analysis of noninvasive electrophysiological methods for the assessment of diabetic sensorimotor polyneuropathy in clinical research: a systematic review and meta-analysis with trial sequential analysis
    Fahmida Haque, Mamun Bin Ibne Reaz, Sawal Hamid Md Ali, Norhana Arsad, Muhammad Enamul Hoque Chowdhury
    Scientific Reports.2020;[Epub]     CrossRef
  • The impact of demographic and clinical characteristics on diabetic painful neuropathy
    António Assunção, Dina Campos, Rui Marques, Inês Cunha, Patrícia Santos, Adriana Martins, Ana Sofia Gonçalves, Ana Rebelo, Carolina Lima, César Matos, Ana Cristina Prata, José Tiago Teixeira, Luís Duarte, Mariana Belo, Patrícia Figueiredo, Tiago Letras Ro
    Romanian Journal of Internal Medicine.2020; 58(1): 13.     CrossRef
  • Nanotechnology in peripheral nerve repair and reconstruction
    Cristiana R. Carvalho, Joana Silva-Correia, Joaquim M. Oliveira, Rui L. Reis
    Advanced Drug Delivery Reviews.2019; 148: 308.     CrossRef
  • The risk factors for diabetic peripheral neuropathy: A meta-analysis
    Xiuxiu Liu, Yuyan Xu, Miaomiao An, Qibing Zeng, Antonio Palazón-Bru
    PLOS ONE.2019; 14(2): e0212574.     CrossRef
  • Association between deterioration in muscle strength and peripheral neuropathy in people with diabetes
    Tae Jung Oh, Sunyoung Kang, Jie-Eun Lee, Jae Hoon Moon, Sung Hee Choi, Soo Lim, Hak Chul Jang
    Journal of Diabetes and its Complications.2019; 33(8): 598.     CrossRef
  • Characterizing distal peripheral neuropathy in type 2 diabetes mellitus in a semi-urban community setting in Peru
    Meera F Iyengar, Antonio Bernabe-Ortiz
    Journal of Global Health Reports.2019;[Epub]     CrossRef
  • A study protocol on nerve mobilization induced diffusion tensor imaging values in posterior tibial nerve in healthy controls and in patients with diabetic neuropathy-multigroup pretest posttest design
    Manu Goyal, Vandana Esht, Amit Mittal
    Contemporary Clinical Trials Communications.2019; 16: 100451.     CrossRef
  • The Akt/mTOR cascade mediates high glucose-induced reductions in BDNF via DNMT1 in Schwann cells in diabetic peripheral neuropathy
    Cui-Hong Zhang, Xin Lv, Wei Du, Mei-Juan Cheng, Ya-Ping Liu, Lin Zhu, Jun Hao
    Experimental Cell Research.2019; 383(1): 111502.     CrossRef
  • Transcriptome analysis of dorsal root ganglia's diabetic neuropathy reveals mechanisms involved in pain and regeneration
    Maria Carolina Pedro Athie, Andre Schwambach Vieira, Juliana Maia Teixeira, Gilson Gonçalves dos Santos, Elayne Vieira Dias, Claudia Herrera Tambeli, Cesar Renato Sartori, Carlos A. Parada
    Life Sciences.2018; 205: 54.     CrossRef
  • Diagnosis and Management of Diabetic Peripheral Neuropathy
    Seong-Su Moon
    The Journal of Korean Diabetes.2018; 19(3): 153.     CrossRef
  • Efficacy of epalrestat plus α-lipoic acid combination therapy versus monotherapy in patients with diabetic peripheral neuropathy: a meta-analysis of 20 randomized controlled trials
    Ming Zhao, Jia-Yi Chen, Yu-Dong Chu, Ya-Bin Zhu, Lin Luo, Shi-Zhong Bu
    Neural Regeneration Research.2018; 13(6): 1087.     CrossRef
  • Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients
    Hong Shen, Junrong Zhao, Ying Liu, Guangdong Sun
    Journal of Diabetes Research.2018; 2018: 1.     CrossRef
  • Evaluation of the healthy median nerve elasticity
    Bihui Zhu, Feng Yan, Ying He, Liyun Wang, Xi Xiang, Yuanjiao Tang, Yujia Yang, Li Qiu
    Medicine.2018; 97(43): e12956.     CrossRef
  • Association between thermal threshold abnormalities and peripheral artery disease in patients with type 2 diabetes
    Yi-Jing Sheen, Tsai-Chung Li, Jiann-Liang Lin, Wen-Chen Tsai, Chuen-Der Kao, Cho-Tsan Bau, Wayne H.-H. Sheu
    Medicine.2018; 97(51): e13803.     CrossRef
  • Neurogenic Pain Disorder in the Foot and Ankle: Peripheral Neuropathy
    Hak Jun Kim, Young Hwan Park, Soo Hyun Kim
    Journal of the Korean Orthopaedic Association.2017; 52(4): 305.     CrossRef
  • Diabetes-Related Microvascular Complications: What Every Nurse Practitioner Needs to Know
    Eileen Egan
    The Journal for Nurse Practitioners.2017; 13(3): 192.     CrossRef
  • Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy
    Amit Goel, Channabasappa Shivaprasad, Anish Kolly, Vijaya Sarathi H. A., Sridevi Atluri, Rayaz Ahmed Malik
    PLOS ONE.2017; 12(9): e0183973.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Nailfold capillary abnormalities are associated with type 2 diabetes progression and correlated with peripheral neuropathy
    Po-Chi Hsu, Pei-Yung Liao, Hen-Hong Chang, John Y. Chiang, Yu-Chuen Huang, Lun-Chien Lo
    Medicine.2016; 95(52): e5714.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism